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ABSTRACT 
Cancer is responsible for one fourth of the total deaths and is the second leading cause of 
death, behind heart disease, in the United States. However, there are as many approaches to 
curing cancer as there are types of cancer. One important issue in solid tumors is hypoxia, a lack 
of oxygen, which promotes angiogenesis and anaerobic metabolism, which can increase cancer 
progression and metastasis. The HIF transcription factor is responsible for the mediation of many 
processes involved during hypoxia and is linked to poor patient prognosis, increased cancer 
progression, and invasiveness of tumors. With this in mind, the HIF pathway has become an 
attractive target for small molecule inhibition. Herein, we describe the design and synthesis of 
small molecules that inhibit the HIF pathway. These compounds are based off an initial “hit” 
compound, KCN-1, from screening of a 10,000 compound library. KCN1 is both highly effective 
and has a low toxicity profile. Over 200 compounds have been synthesized by the Wang lab, 
with the best compound IVSR64b having an IC50 of 0.28 µM. Of special interest is that these 
compounds do not appear to have any inherent toxicity toward healthy tissues, but only affect 
cancer cells. Moreover, x-ray crystal structures for both KCN-1 and IVSR64b were obtained and 
used as the basis for computational modeling, which is still in progress. 
 
INDEX WORDS: Small-molecule inhibitors, HIF, Hypoxia, Anti-cancer therapeutics, Medicinal 
chemistry  
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When people as what I do for a living, and I say that I am researching anti-cancer drugs; 
they always ask if I think we will find a cure for cancer. I have to explain that there are as many 
different approaches to curing cancer as there are types of cancer. One of the major 
disadvantages to most cancer treatments is the toxicity to healthy cells and thus the unwanted 
side effects such as hair loss, nausea, fatigue, loss of appetite, and bone marrow suppression. In 
order to combat these undesired side effects, many researchers focus on trying to find new ways 
to target cancer itself and not healthy tissue. Our research is focused on one specific aspect of 
cancer, hypoxia (a lack of oxygen), which occurs in solid tumors. The major advantage to 
targeting hypoxia is that it is not typically found in healthy tissues and by only affecting hypoxia 
areas, we can selectively treat the cancer without damaging the healthy tissue. Detailed 
information on hypoxia and the HIF pathway is included in the first chapter of this dissertation. 
This dissertation is broken up into 4 chapters: the first is a review paper on anti-cancer 
HIF therapeutics which has been published as an invited review in Future Medicinal Chemistry; 
the other 3 are manuscripts of papers in preparation for publication. For each chapter, I wrote the 
manuscript, designed and synthesized many of the compounds, and helped conceive the concept 
as a whole.  The biological testing was carried out by the Dr. Erwin G. Van Meir laboratory at 
Emory University. Other group members, including Dr. Krishna Damera, Dr. Bowen Ke, Dr. 
Suazette Mooring, Jalisa Holmes, and Zeus de los Santos synthesized compounds that are 
included with their permission, as noted.  
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2 HYPOXIA INDUCIBLE FACTOR PATHWAY INHIBITORS AS ANTI-CANCER 
THERAPEUTICS 
This work is reproduced with permission from the review paper: “Hypoxia inducible 
factor pathway inhibitors as anti-cancer therapeutics.” Sarah Kathryn Burroughs, Stefan Kaluz, 
Danzhu Wang, Ke Wang, Erwin G. Van Meir, and Binghe Wang. Future Medicinal Chemistry 
(2013) 5 (5) 553-572.  
2.1 Abstract 
Hypoxia is a significant feature of solid tumor cancers. Hypoxia leads to a more 
malignant phenotype that is resistant to chemotherapy and radiation, is more invasive and has 
greater metastatic potential. Hypoxia activates the hypoxia inducible factor (HIF) pathway, 
which mediates the biological effects of hypoxia in tissues. The HIF complex acts as a 
transcription factor for many genes that increase tumor survival and proliferation. To date, many 
HIF pathway inhibitors indirectly affect HIF but there have been no clinically approved direct 
HIF inhibitors. This can be attributed to the complexity of the HIF pathway, as well as to the 
challenges of inhibiting protein–protein interactions. 
2.2 Hypoxia in cancer 
Cancer is the second most common cause of death in the USA, with practically one in 
every four deaths due to cancer [301]. Moreover, the most recent data report that in 2008 there 
were over 12.5 million new cases of cancer diagnosed worldwide and that by 2030 this number 
is anticipated to swell to over 20 million [302]. Many cancers involve solid tumor formation, and 
during periods of rapid growth, tumors outgrow existing blood supply, leading to the 
development of hypoxic (partial oxygen pressure of less than 5 Torr) and anoxic regions [1]. 
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Tumors remedy this by producing angiogenic factors that lead to the formation of tumor 
vasculature, although, with structural and functional anomalies. These include arteriovenous 
shunts, blind ends, occlusions, high angle branching patterns, and broken, leaky vessels [2]. 
Abnormalities in the tumor vasculature limit oxygen delivery, leading to acute hypoxia [3]. 
Hypoxic tumors are more resistant to radiation and chemotherapy, are more invasive, are 
genetically unstable, resist apoptosis and have greater metastatic potential; all of which leads to 
poorer prognosis overall for patients [4,5]. It has been demonstrated that tumor irradiation is 
three-times more effective when carried out under oxygen-rich versus anoxic conditions. 
Moreover, the effectiveness of anticancer therapeutics that target rapidly dividing cells is 
reduced against hypoxic cells due to the decreased rate of cell proliferation that increases with 
distance from vasculature [6]. Another factor in treatment resistance is due to the cancer stem-
like cells (CSCs), which are a relatively rare subpopulation of tumor cells with self- renewal 
capacity. CSCs reside in hypoxic niches of tumors and are more resistant to radio- and chemo-
therapy-induced DNA damage, allowing them to survive the treatment and repopulate the tumor 
with their progeny. Typically, prolonged hypoxia triggers cell apoptosis, but in tumors, it can 
lead to the selection of tumor cells with mutant p53, which are resistant to apoptosis and confer a 
more malignant phenotype [7]. Clinical studies have shown that many cancers with hypoxic 
tumors are more likely to be metastatic, including soft tissue sarcomas, squamous cell head and 
neck carcinomas, cervical carcinomas and malignant melanomas [8]. Therefore, hypoxia can 
either lead to cell death through apoptotic or necrotic pathways, or to cell proliferation through 
activation of various other pathways [3]. 
 4 
2.3 The HIF pathway  
 
Figure 2.1 The HIF-1 Pathway 
Under normoxic conditions, HIF-1a is rapidly hydroxylated by prolyl hydroxylases, which 
mediates binding by the VHL ubiquitin ligase complex, addition of poly-Ub which tags it for 
proteosomal degradation. Under hypoxic conditions, prolyl hydroxylases cannot hydroxylate 
HIF-1a, preventing VHL binding which leads to HIF-1α stabilization. HIF-1 α then 
heterodimerizes with HIF-1β, recruits the p3oo/CBP co-factors and forms an active HIF 
transcription complex in the nucleus that binds to HREs on target genes and activates their 
transcription.  HIF: Hypoxia inducible factor; HRE: Hypoxia response element; Ub: Ubiquitin 
chains; VHL: von Hippel-Lindau tumor suppressor protein. 
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The hypoxia inducible factor (HIF) pathway is a major mediator of the biological effects 
of hypoxia in tissues (Figure 2.1) [9]. HIFs are basic-loop-helix-loop motif heterodimeric 
transcription factors composed of two subunits: an oxygen-regulated a subunit (HIF-1α, -2α, or -
3α) and the constitutively expressed HIF-1β (also called aryl hydrocarbon receptor nuclear 
translocator) [10]. Under normoxic conditions, HIF-α subunits are hydroxylated by Fe2+- 
dependent HIF prolyl hydroxylases (PHD), mostly PHD2, at two proline residues (402 and 564 
in human HIF-1α) located in the oxygen- dependent degradation domain [11,12]. This 
dihydroxylated form of HIF-α is bound by VHL, which is an E3 ubiquitin ligase that leads to the 
ubiquitination of HIF-α and subsequent proteasomal degradation [13,14]. This interaction 
between VHL and HIF-1α has been shown in some instances to be promoted by acetylation of 
HIF by the ARD1 acetyltransferase at lysine 532, increasing ubiquitination and degradation [15]. 
However, the role of acetylation of HIF is still somewhat controversial and needs further 
exploration. 
Conversely, under hypoxic conditions, PHDs lose activity and HIF-α units are no longer 
degraded. As HIF-1α or HIF-2α accumulate, they bind to HIF1-β and form the HIF 
heterodimers, which translocate to the nucleus and, along with co-activators (p300 and CBP), 
form the transcriptional complexes that bind to hypoxic response elements (HREs) in the 
regulatory regions of many genes [16]. HREs are composite cis-acting elements, comprising the 
necessary but not sufficient HIF-βinding site with the consensus sequence RCGTG (where R = 
purine A or G) and a HIF-αncillary sequence [17]. The transactivation potential of the HIF-α/ 
p300 complexes is regulated via deacetylation of p300 by histone deacetylase [18]. 
HIF activity is also regulated in an oxygen- dependent manner by an asparaginyl 
hydroxylase, Factor Inhibiting HIF-1 (FIH1), which hydroxylates an asparagine in the C-
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terminal activation domain (CAD) of the a subunit (N-803 in human HIF-1α) under normoxia 
and mild hypoxia. Hydroxylation of N-803 blocks interactions between HIF-1α and p300/ CBP 
coactivators preventing HIF activation [19]. Because FIH1 is less sensitive to oxygen drop than 
PHDs, it remains active under moderate hypoxia and maintains the inactivity of the HIF-α 
molecules that avoid the PHD-mediated degradation that occurs in mild hypoxia [20]. 
PHDs and FIH1 are dioxygenases that, in addition to molecular oxygen, require Fe2+ and 
2-oxoglutarate (2-OG) co-factors for activity [20]. This provides an opportunity for regulation of 
their activity and in turn HIF-1α levels/ HIF activity. Iron chelation is frequently used for 
activation of HIF-1 in cell culture [20]. There has also been some evidence of mitochondrial 
involvement in HIF regulation in that, under moderately hypoxic conditions, mitochondria will 
produce reactive oxygen species (ROS) from complex III of the electron-transport chain, which 
inhibit the activity of PHDs by oxidizing Fe2+ to Fe3+, thus accelerating the stabilization of HIF 
[21,22]. 2-OG is an intermediate in the tricarboxylic acid (TCA) cycle and structurally related 
compounds (e.g., dimethyloxalylglycine or other TCA cycle intermediates, fumarate and 
succinate) can inhibit activity of PHDs directly by reversibly competing for the active site with 
2-OG or indirectly via increasing cellular levels of ROS [23]. Recently, heterozygous mutations 
in IDH1 or IDH2 genes were described in glioma and acute myeloid leukemia. Mutant proteins, 
acting in a dominant-negative fashion, are defective in their ability to oxidize isocitrate to 2-OG 
[24]. This initial report suggested that in cells with mutant IDH HIF-1α is indirectly stabilized 
because reduced synthesis of 2-OG lessens PHD function [24]. However, further studies found 
comparable levels of 2-OG in both wild-type and mutant cells; instead, the mutant IDHs acquire 
a neomorphic activity, which reduces 2-OG to 2-hydroxyglutarate (2-HG) [25]. Moreover, it was 
reported that (R)-2-HG, the product of mutant IDH, can be utilized in place of 2-OG in the active 
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center of PHDs. Here, (R)-2-HG (but not (S)-2-HG which acts as an inhibitor of PHDs) is 
oxidized into 2-OG, resulting in increased PHD activity and correspondingly decreased HIF-α 
levels and HIF activity [26]. More work will be required to finalize the functional consequences 
of IDH mutations on activity of the HIF pathway and tumor growth. 
Finally, HIF-α is situated at the convergence of multiple oncogenic and tumor suppressor 
pathways, including the PI3K/AKT and MAPK/ ERK pathways, which regulate HIF 
nonspecifically in an oxygen-independent manner. Activation of the PI3K/AKT pathway has 
been demonstrated to increase translation of HIF-1α mRNA and HIF-1a production [27,28]. 
Tumor suppressors (p53, GSK3b, and so forth) interfere with HIF function by decreasing HIF-1α 
stability or transcriptional activity [23]. One important type of regulation is that of HIF-1α 
phosphorylation, which can affect both HIF-1α stability and its transactivation potential. HIF-1α 
can be phosphorylated by GSK3 at three serine residues (551, 555 and 589) within the human 
HIF-1α N-terminal transactivation domain [29,30]. This recruits Fbw7 and USP28, which then 
mediates HIF-1α ubiquitination and subsequent VHL- independent proteasomal degradation 
[31]. PLK3 also destabilizes HIF-1α by phosphorylation at two serine resides (576 and 657) [32]. 
Conversely, phosphorylation of HIF-1α can have a stabilization effect. It has been demonstrated 
that ATM can phosphorylate HIF-1α at Ser-696, which increases its stability [33]. HIF-1α is also 
phosphorylated in its CAD by ERK1, which increases its transcriptional activity, but not its 
stability [34]. Thr-796 in HIF-1α is phosphorylated by CK2 and this phosphorylation is also 
important for its transactivation potential and not stability [35,36]. The p42 and p44 MAPK 
pathways regulate HIF-1α post-translationally by phosphorylating two serine residues (641 and 
643). This phosphorylation promotes nuclear accumulation of HIF-1α, which leads to an increase 
of HIF-1-activated transcription [37,38]. In addition, HIF-1α Ser 247 phosphorylation 
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coregulates the dimerization of HIF-1α/HIF-1β complex. HIF-1α can be phosphorylated on Ser-
247 in the PAS-B domain by CK1, which destabilizes the HIF-1α/-1β complex, and thus 
diminishes its transcriptional activity [39]. HIF-1α/-1β dimerization is also regulated by means 
other than HIF-1α phosphorylation. For example, COMMD1 binds to the N-terminal domain of 
HIF-1α, competing with HIF-1β binding, and subsequently decreases the DNA binding and 
transcriptional activation of the complex [40]. Finally, the HIF-1α/p300 interaction is also post-
translationally regulated. Both hydroxylation of asparagine 803 and S-nitrosylation of cysteine 
800 in the C-TAD of HIF-1α decrease p300 binding, while phosphorylation of Thr-796 in the C-
TAD does not affect p300 binding [41]. 
2.3.1 Distinct roles of HIF-α subunits 
Among the three members of the HIF-α family, HIF-1α and HIF-2α (also called EPAS1, 
MOP2 or HLF) have been extensively studied, whereas significantly less is known about the 
third member, HIF-3α. HIF-α proteins exhibit high conservation in overall amino acid sequence, 
as well as similar domain structure, mechanisms of activation, heterodimerization with HIF-1β, 
and binding to the same HIF-binding site [20]. HIF- 1α and HIF-2α each contain an N-terminal 
activation domain and CAD, and both act as positive transcriptional regulators. In contrast, the 
truncated HIF-3α lacks a CAD and acts as a dominant negative regulator of transcription and its 
expression is suppressed in renal cell carcinoma [23]. 
Despite the above-mentioned similarities, there is mounting evidence that HIF-1α and 
HIF-2α subunits are functionally distinct. The fact that neither HIF-1α-/- nor HIF-2α-/- embryos 
can survive suggests a lack of functional complementation between the two isoforms [42]. The 
ubiquitous expression of HIF-1α, as opposed to the more cell type-specific expression of HIF-2α, 
also suggests different physiological roles. Knockdown of HIF-1α or HIF-2α by siRNA elicits 
 9 
remarkably different cell-specific effects: in endothelial and breast cancer cells hypoxia-
inducible gene expression has been demonstrated to be critically dependent on HIF-1α but not 
HIF-2α [43]; whereas in renal carcinoma cells, expression was critically dependent on HIF-2α 
[44]. HIF-α isoforms display unexpected reciprocal suppressive interactions in renal cell 
carcinoma: enhanced expression of HIF-2α suppresses HIF-1α and vice versa [44]. 
In certain cancers, HIF-1α and HIF-2α have been shown to play contrasting roles in 
tumorigenesis. Contrary to earlier conclusions, HIF- 1α expression was found to correlate with 
lower disease stages in clear cell renal cell carcinoma (ccRCC), non-small-cell lung cancer, head 
and neck squamous cell carcinoma and neuroblastoma; whereas HIF-2α expression was found to 
correlate with more advanced stages and was consistently scored as a negative prognostic factor 
[45]. The most compelling evidence about the distinct roles of HIF-1α and HIF-2α has been 
accumulated in the VHL-deficient ccRCC: while ccRCC always overexpress HIF-2α and 
sometimes overexpress HIF-1α, only HIF-2α is required for their growth [46]. In addition, both 
HIF-1α and HIF-2α, stabilized upon VHL inactivation, can transcriptionally down-regulate 
transcription of HIF-1α in ccRCC through a mechanism that involves binding of either sub- unit 
to a reverse HRE in the HIF-1α proximal promoter followed by a series of repressive his- tone 
modifications [47]. This observation is in agreement with previous reports suggesting that in the 
early stages of ccRCC HIF-1α provides a metabolic advantage due to activating glycolytic 
enzymes, but hinders progression by inducing cell-cycle arrest or apoptosis. Inactivation of HIF-
1α and its replacement with HIF-2α discontinues this inhibitory effect and ccRCC rapidly 
progresses [45,48,49]. Together, these data support the notion that HIF-2α has a greater 
oncogenic potential than HIF-1α in ccRCC [50]. 
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2.3.2 Distinct functions of HIF-1α and HIF-2α in certain types of cancer can be explained 
by differential direct and indirect transcriptional effects 
HIF-1α and HIF-2α activate different sets of transcriptional targets (direct transcriptional 
effect). Several studies have shown that HIF-1α and HIF-2α differ in their capability to 
transactivate hypoxia-inducible genes. Some genes were transactivated exclusively by HIF-1α 
(notably glycolytic and proapoptotic genes) whereas others were transactivated by both isoforms 
[43,51]. HIF-2α, on the other hand, is a more efficient activator of genes encoding stem cell 
markers (see below). In a report that used siRNA methodology, HIF-2α preferentially regulated a 
small group of genes that had in common binding sites for the ETS family of transcription 
factors in their promoter regions. Knockdown of ELK-1, the most prominent member of the ETS 
family, significantly reduced hypoxic induction of the HIF-2α-dependent genes [52]. A number 
of regulatory elements (e.g., ATF-1, CREB-1, AP-1 and Sp1)have been described to cooperate 
with HREs, [16]; however data on whether their cognate factors preferentially engage in 
cooperation with HIF-1α or HIF-2α are scarce. Together, these studies suggest that, of the two 
isoforms, HIF-1α is a more universal activator [51], whereas HIF-2α is the more selective 
activator of transcription and the observed significant quantitative differences/specificity of 
activation could be accounted for by preferential cooperation of one isoform with transcription 
factors binding to the regulatory elements juxtaposed to HREs [23]. Sirtuins, a family of stress-
responsive nicotinamide adenine dinucleotide-dependent histone deacetylases that serve as 
sensors of the cellular redox state, also control transcriptional activity of HIF-1α and HIF-2α 
[23]. Sirt1 was reported to deacetylate both HIF-1α and HIF-2α with different functional 
outcomes: deacetylation of HIF-1α decreases its transcriptional activity [53], whereas 
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deacetylation of HIF-2α resulted in enhanced transcriptional activity [54]. Thus, conditions of 
cellular redox/metabolic stress fine-tune activity of HIF-1α and HIF-2α. 
HIF-1α and HIF-2α differentially modulate the activity of other transcription factors 
(indirect transcriptional effects). HIF-1α and HIF-2α have been reported to modulate (through 
direct or indirect interactions) the transcriptional activity of certain critical oncogenes/tumor 
suppressors with opposite outcomes. Notable in this respect is MYC, the function of which is 
antagonized by HIF-1α but enhanced by HIF-2α [46,55]. Differential regulation of the tumor 
suppressor protein p53 by HIF-1α and HIF-2α was also reported. On the one side, HIF-1α 
directly binds p53, inducing its stabilization, and eventually causing cell death [56,57]. 
Conversely, inhibition of HIF-2α has been shown to promote p53 activity and higher levels of 
HIF-2α contribute to increased radio- and chemo- resistance [58]. In this way, HIF-1α and HIF-
2α can achieve opposing effects on tumor behavior through indirect transcriptional effects. 
HIF-1α and HIF-2α also have different effects on CSCs, also known as tumor-initiating 
or tumor-propagating cells, which are undifferentiated cells with the capacity to self-renew and 
reconstitute tumors in vivo that are phenotypically similar to the parental tumor [59]. An 
important feature of CSCs is their enhanced resistance to radio- and chemo-therapy that limits 
DNA damage, allowing them to survive the treatment and repopulate the tumor with their 
progeny. CSCs thus represent an important therapeutic target and their complete elimination is 
expected to greatly enhance the treatment efficacy [59,60]. There are numerous reports 
implicating hypoxia and HIFs in CSC biology. For example, populations of cells enriched for 
CSCs can be isolated from glioblastoma tumors using the cell surface marker CD133 and 
hypoxia may promote the expansion of the CD133-positive cells through activation of HIF-1 
[61]. Other reports highlight the prominent role of HIF-2α in CSCs: this isoform is selectively 
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expressed in CSCs, whereas HIF- 1α was expressed at comparable levels in both CSC and non-
CSC (CD133-negative) populations [62]. In the same study, only targeting HIF- 2α by shRNA 
decreased the growth of CSC populations in vitro, inhibited CSC-mediated angiogenesis and 
significantly prolonged the survival of mice intracranially implanted with CSCs. In a separate 
study, HIF-2α colocalized with neural crest markers in a subset of immature cells in 
neuroblastoma tumors and HIF- 2α knockdown induced differentiation of these cells [63]. HIFs 
thus help maintain an undifferentiated state in some populations of CSCs as well as other stem 
and progenitor cells [60]. HIFs apparently control self-renewal and differentiation processes in 
these cells by means of trans- activating critical genes and the key transcription factors involved 
in these processes. In this category, interaction of HIF-1α with Notch1 helps maintain the 
undifferentiated cell state [64], whereas HIF-2α induces expression and transcriptional activity of 
the marker of the undifferentiated state – Oct4 [65]. HIF-2α also regulates the transcription factor 
Sox2 [66], which, in turn, controls pluripotency by direct regulation of Oct4 levels [67]. 
Recently, reprogramming of somatic cells into induced pluripotent cells was achieved through 
transduction of four defined transcription factors (c-MYC, KLF4, SOX2 and Oct4) all of which 
are transactivated by HIF [55,65,66]. Together, these reports provide evidence that HIFs directly 
control markers of the undifferentiated state (stemness) and are necessary for maintaining CSCs. 
Due to its critical role and selective activation, HIF-2α could be an important therapeutic target 
in CSCs. 
2.3.3 Genes activated by HIF 
Along with its co-activators, the HIF complex acts as a transcription factor for hundreds 
of genes, including VEGF, NOS, GLUT1, LDH, CA9 and MDR1 (Table 2.1) [69–107]. Many of 
these genes affect cancer progression through angiogenesis, erythropoiesis, increased glucose 
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metabolism, immune evasion, immortalization, genetic instability, increased invasion and 
metastasis, pH regulation, drug resistance, CSC maintenance and proliferation. 
Table 2.1. Selected HIF target genes and their effects on cancer progression 
Effect on cancer 
progression 
Genes activated by hypoxia inducible 
factor-1 Ref. 
Angiogenesis ANGPT2, C-MET, ID2, LEP, NOS, PDGF, SCF, SDF-1, VEGF [74–82] 
Drug resistance MDR1 [83] 
Erythropoiesis EPO [84] 
Genetic instability DEC1, DEC2, MSH2, MSH6 [85–86] 
Glucose metabolism GLUT1, GPI, HK1, HK2, LDH, MCT1, PGK1, PKM2 [87–92] 
Immortalization TERT [93] 
Immune evasion NT5E [94] 
Invasion C-MET, EDN-1, FN-1, MMP-2, MMP-14, SDF-1 [75,81,95–98] 
Metastasis C-MET, CXCR4, LOX, TWIST1, ZEB1 [75,85,99–101] 
pH regulation CA-9, CA-12 [102] 
Proliferation C-MYC, ID2, IGF-2, NOS, [76,78,103,104] 
Stem cell maintenance ABCG2, JARID1B, OCT4, NANOG, Sox2, KLF4, c-myc, miR302 [55,65–67,105–107] 
 
Two of the most essential functions of cancer biology that HIF-1 activates are 
angiogenesis and glucose metabolism [108];the former controls oxy- gen and nutrient delivery 
and the latter generates energy and synthetic intermediates for growth and survival. VEGF is an 
important growth factor in angiogenesis and vascularization and plays a significant role in 
hypoxic conditions and has been demonstrated to increase in vivo tumor size and vascularization 
[109]. VEGF also plays a critical role in embryonic development – deletion of a single allele of 
the gene in VEGF-knockout mice is lethal within two weeks of development. HIF-1 activates 
VEGF transcription by binding to its HRE and VEGF synthesis increases angiogenesis [110]. 
NOS produces nitric oxide, which promotes angiogenesis and cell proliferation, and increases 
cell survival by inhibiting apoptosis. HIF-1 binds to the NOS HRE and thus upregulates NOS 
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expression and increases cancer progression [111]. Histological studies have associated 
increased malignancy and aggressiveness in cancers with increased HIF-1 and VEGF expression, 
and NOS expression has been confirmed in many cancers, including breast, head and neck, 
prostate and colorectal [111,112]. 
HIF-1 is a transcription factor for many genes involved in the glycolytic cascade, 
including GLUT1 and LDH, which allow tumors to grow under hypoxic conditions by 
metabolizing glucose to lactate through anaerobic glycolysis [92,113]. One result of anaerobic 
glycolysis is decreased production of ROS generated by oxidative phosphorylation, which can 
prevent cellular senescence, and thus remove a constraint on tumor growth [114]. Another 
consequence of glycolysis and lactate buildup is hypoxic acidosis, which, if not prevented, would 
lead to a decrease in intra- cellular pH, cell damage and death. However, HIF-1 activates the 
synthesis of monocarboxylate transporters (e.g., MCT) that extrude lactate into the extracellular 
space [115] and CA-9 and CA-12, which use CO to generate HCO - to dampen the effects of 
acidosis and increase cell survival. Not surprisingly, higher GLUT1 levels are correlated with 
poor survival in many cancers – including breast, head and neck, esophageal, stomach, bladder, 
ovarian, colorectal, and non-small-cell lung carcinomas – and CA-9 is used as a marker for 
cancer progression [1,116]. 
In addition to activating gene expression for cancer progression, HIF-1 decreases the 
effectiveness of anticancer therapies such as radiation and chemotherapy. HIF-1 itself is 
stabilized by radiation, even doubling its activity in the two days following therapy, due to the 
re-oxygenation and release of ROS that follows radiation treatment [117,118]. The radiation-
induced production of ROS increases HIF-1α accumulation by reducing its degradation through 
an AMP- activated protein kinase (AMPK)-dependent pathway, where ROS-activated AMPK 
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inhibits the interaction between HIF-1α and VHL, thus preventing ubiquitination and subsequent 
degradation [119,120]. Increased HIF-1α levels have also been shown to decrease the 
effectiveness of chemo- therapy in various types of cancer [121–124], due to factors such as 
HIF-mediated regulation of drug efflux, cell proliferation and survival, metabolic reprogramming 
and inhibition of DNA damage [125]. One specific mechanism by which HIF-1 can decrease 
effectiveness of therapy is by activation of MDR1 and the expression of the multiple drug 
resistance phenotype, which is present in the most aggressive cancers and correlates with the 
metastatic ability of multiple solid tumor cancers [126]. In addition, many anticancer 
therapeutics, such as doxorubicin, rely on the generation of ROS for cytotoxicity, but ROS 
stabilize HIF-1α [127]. Moreover, many therapeutics contain weakly basic moieties that can 
react with the acidic tumor microenvironment and lose efficacy [128]. 
2.4 Molecular targets of HIF-1 inhibitors  
There are many different strategies for inhibiting the HIF-1 pathway. Small molecules 
have been shown to inhibit HIF activity through a variety of mechanisms including HIF-1α 
protein synthesis, HIF-1α protein stabilization, HIF-1α–HIF-1β dimerization, HIF-1 dimer DNA 
binding, and interactions with other proteins. There were two comprehensive reviews in 2012 by 
Semenza [129] and Xia et al. [130] that cover these mechanisms in detail and give fairly 
exhaustive lists of the small- molecules that inhibit at each level. 
Many HIF-1 inhibitors affect the HIF-1 pathway upstream of HIF-1α synthesis (Figure 
2.2). Cancer metabolism and regulation is a very complex system and it can be difficult to 
separate the desired effects on one pathway from another. This complexity can work for 
medicinal chemists in a synergistic manner by up- or down-regulating multiple pathways/targets 
by producing similar net results in the design and implementation of therapeutics. Conversely, 
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the inhibitors may have unexpected counter-productive effects which may contribute to the high 
late-stage clinical failures for anticancer drugs, which is around 70% for Phase II trials and 60% 
for Phase III trials [131]. These high attrition rates can, moreover, be attributed to several factors, 
including the hypoxic and acidic tumor microenvironment; veracity and fidelity of in vitro 
preclinical models; drug absorption, distribution, metabolism, excretion, and toxicity; drug 
delivery in vivo; and translation to the clinic [132]. 
 
Figure 2.2. Mechanisms of HIF inhibition 
HIF: Hypoxia inducible factor; HRE: Hypoxia response element; PHD: Prolyl hydroxylases; Ub: 
Ubiquitin chains; VHL: von Hippel-Lindau tumor suppressor protein. 
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In the field of HIF-1 inhibitors, the role of hypoxia is key. Tumor hypoxia has been 
touted as “the best validated target that has yet to be exploited in oncology” [5]. The definition of 
hypoxia has been well established at 0–5% oxygen, but there is a variance in the levels of oxygen 
defining normoxia. Atmospheric oxygen levels are approximately 20%, whereas tissues in the 
body have normal oxygen levels that range from 0 (bone marrow) to 14% (lung, liver, kidney 
and heart), with levels of approximately 10–12% in circulation [133]. Thus, in vitro assays that 
are carried out under ‘normoxic’ conditions, but are simply left open to the atmosphere ought to 
be considered ‘hyperoxic’ when compared to in vivo oxygen levels [134]. This difference in 
oxygen levels can contribute negatively to many preclinical studies and should be considered as 
a contributing factor to drug attrition. 
Another factor in tumor hypoxia is the acidic extracellular environment due to the 
increased expression of the glycolytic phenotype. This creates a unique pH gradient for tumors 
that is the opposite of that of normal tissue [135]. It has been demonstrated that weakly basic 
anti- cancer therapeutics, such as doxorubicin, are excluded from acidic tumors [136]. This 
acidic microenvironment can also contribute negatively to in vivo studies and should be 
considered as another factor contributing to drug failure.  
2.5 HIF-1 inhibitors in the clinic: hits and misses  
Transcription factors have, for a long time, been considered undruggable targets, and to 
date, no specific inhibitor of HIF has been brought to market. Multiple levels of regulation and 
the fact that multiple signaling pathways converge on HIF-α explain the diversity of compounds 
that, among other targets, inhibit HIF. Although there are many challenges to targeting HIF, 
there have been a number of compounds that have made it to clinical trials as anticancer 
therapeutics, which have also been shown to inhibit HIF activity. Some of these have failed their 
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trials, while others have been US FDA approved for patient treatment. The following illustrates a 
few of these examples (Table 2.2) and what their outcomes say for the field as a whole. 
2.5.1 Camptothecins: camptothecin, topotecan, irinotecan 
In the 1960s, camptothecin was first isolated from the bark of a native Chinese tree, 
Camptotheca acuminata, by Wall and Wani. By the mid 1970s, camptothecin was in clinical 
trials due to its anticancer activity, but it was terminated because of its serious side effects [137]. 
Research on camptothecin was not resumed until the discovery of DNA topoisomerase 1 (TOP1) 
as its primary target and the successful development of water-soluble derivatives of 
camptothecin: topotecan (Hycamtin®) and irinotecan (Camptosar, CPT-11) [138]. The 
camptothecins have a unique mechanism of action that targets TOP1, an essential human enzyme 
that relaxes DNA supercoiling by forming single strand breaks, unwinding, then religating the 
strands back together. The camptothecins act as irreversible inhibitors to the TOP1–DNA 
complex by intercalating into DNA at the protein–DNA interface, which then prevents the 
religation of the DNA strands [139]. Both irinotecan and topotecan have similar mechanisms of 
action as camptothecin. TOP1 is an upstream regulator of the HIF-1 pathway. TOP1 inhibition 
leads to HIF- 1α down-regulation due to decreased protein accumulation and translation that is 
independent of oxygen or proteasomal degradation [140]. It has been suggested that this 
mechanism could be due to the activation of a novel antisense transcript from the 5 ́ end of HIF-
1α and the removal of Pol II from the promoter-proximal pause site of the HIF-1α gene [141]. 
The mechanism of inhibition of HIF-1α translation by camptothecin and its derivatives is TOP1-
dependent but DNA- damage independent. Irinotecan was approved for treatment of colorectal 
cancer in 1996 [142] and topotecan was approved for the treatment of Stage IVB recurrent 
carcinoma of the cervix in 2006 [303]. In 2007, the FDA approved Hycamtin for treatment of 
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relapsed small cell lung cancer [304]. The successful development of these camptothecin 
derivatives would not have been possible without further elucidation of their mechanism of 
action. This case illustrates how drugs (and classes of drugs) that have unknown mechanisms of 
action and have previously failed clinical trials can be repurposed and brought to market once the 
mode of action is elucidated and the pharmacokinetics optimized. 
2.5.2 Bortezomib 
Bortezomib (Velcade®, PS-341) is a dipep- tide boronic acid-containing compound that 
reversibly inhibits the chymotryptic activity of the 20S subunit of the 26S proteasome due to the 
high binding affinity and specificity between the boron atom and the 20S subunit [143]. The 
proteasome regulates protein expression and function by degradation of ubiquitinated proteins, 
and cleanses the cell of unfolded or misfolded proteins. Bortezomib has been shown to directly 
inhibit proliferation and induce apoptosis in multiple myeloma cell lines and patient tumor cells 
resistant to conventional therapies [144]. Proteasome inhibition by bortezomib leads to 
disruption of intracellular protein metabolism. The downstream biological effects of proteasome 
inhibition are numerous, with direct effects on both multiple myeloma cells and their 
microenvironment, including inhibition of cytokine secretion, suppression of adhesion molecule 
expression and inhibition of angiogenesis [145]. Because bortezomib’s primary target is the 
proteasome, it prevents the degradation of ubiquitinated HIFα and leads to the accumulation of 
HIF-1α under normoxia. However, the stabilized HIF-1(-2) is inactive due to upregulation of 
FIH activity, which inhibits recruitment of p300 [146]. There has been other evidence that 
bortezomib does not directly affect the formation of the HIF-1-p300 complex, but interferes with 
the C-terminal domain of HIF-1α [147]. More recently, bortezomib was shown to inhibit the 
PI3K/AKT/mTOR pathway upstream of the HIF pathway in prostate cancer cells [148]. Due to 
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bortezomib’s remarkable clinical activity against multiple myeloma, it was rapidly approved by 
the FDA in 2003 to treat relapsed and refractory multiple myeloma [149]. It is unknown whether 
HIF inhibition is critical to the clinical activity of bortezomib. Bortezomib is an excellent 
example of an FDA-approved anticancer therapeutic that indirectly inhibits HIF expression and 
function and that has differing modes of action in different cancer models, which illustrates the 
complexity of the field. 
2.5.3 Romidepsin 
Romidepsin (Istodax®, FK228, FR901228) is an anticancer agent isolated from the 
bacterium Chromobacterium violaceum that was first reported by Fujisawa Pharmaceutical 
Company (now Astellas Pharma) in 1994 [65]. Its mechanism of action was demonstrated in 
1998 [150,151]. As a prodrug with a disulfide bond, romidepsin under- goes reduction to release 
a zinc-binding thiol [152]. This thiol reversibly interacts with a zinc atom in the binding pocket 
of Zn-dependent histone deacetylases (HDACs) to block their activity, classifying romidepsin as 
a HDAC inhibitor (HDACI). HDACs affect gene expression by removal of acetyl groups from 
acetylated lysine residues in histones. HDACs also deacetylate nonhistone proteins, such as 
transcription factors. In vitro, romidepsin causes the accumulation of acetylated histones, thus 
inducing cell cycle arrest and apoptosis of some cancer cell lines with IC50 values in the 
nanomolar range [153]. HDAC activity is crucial for the transactivation potential of HIF-1α and 
most HDACIs regulate acetylation of the HIF-1α/p300 complex [154]. It has also been suggested 
that the class II isozyme HDACs are involved in direct acetylation and ubiquitination of HIF-1α 
[155]. Romidepsin was approved as a treatment for cutaneous T-cell lymphoma in 2009 [305]. 
Other HDACIs are also in preclinical and clinical development, but many in the field have 
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moved to target other mechanisms of action due to high adverse effects associated with the 
HDACIs. 
2.5.4 Temsirolimus 
Temsirolimus (Torisel®, CCI-779), the ester version of rapamycin, is the first FDA 
approved inhibitor of mammalian target of rapamycin (mTOR/TORC1), which is a 
serine/threonine- specific kinase in the phosphatidylinositol 3–kinase (PI3K) related protein 
family [156]. In RCC, temsirolimus was shown to inhibit tumor growth and HIF expression by 
inhibition of the mTOR-dependent kinase cascade needed for HIF mRNA translation [157]. 
Inhibition of PI3K and its downstream target mTOR was demonstrated in prostate cancer (PC-3) 
cells to decrease HIF-1-dependent gene expression and temsirolimus was shown to suppress 
HIF-1 activation by increasing HIF-1α degradation rate in hypoxic PC-3 cells [158]. The FDA 
approved Torisel (temsirolimus) for the treatment of RCC in 2007 [306]. However, not all 
inhibitors of the P13K/AKT/mTOR pathway have had such success. 
2.5.5 Perifosine 
Perifosine is an alkylphospholipid analogue, which has demonstrated significant anti- 
proliferative activity in several human tumor model systems both in vitro and in vivo. It has a 
similar structure to miltefosine, a drug that has been approved in Europe for the treatment of 
cutaneous lymphomas and metastasis from breast cancer. Perifosine’s activity is also due to its 
effect on the PI3K/AKT/mTOR pathway, an upstream regulator of the HIF pathway. Many 
growth factors that upregulate HIF activate the PI3K–AKT–mTOR pathway, which leads to 
increased HIF-1α protein translation and stability [159]. Perifosine, which inhibits AKT in a 
dose-dependent manner, entered Phase I clinical trials in 2003 [160] and, in 2010, reached Phase 
II trial due to significant growth inhibition in vitro and in vivo in the Waldenstrom 
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macroglobulinemia model [161]. In 2012, how- ever, perifosine failed a late-stage Phase III 
study on colorectal cancer due to lack of efficacy but will continue in another Phase III study as 
part of combination therapy with bortezomib against multiple myeloma [307]. Perifosine is one 
of many compounds indirectly affecting HIF expression that showed great promise in preclinical 
models, but has failed to exhibit efficacy in human trials. 
2.5.6 2-Methoxyestradiol 
2-methoxyestradiol (2ME2) is a natural metabo- lite of estradiol and is a potent antitumor 
agent, due to its antiproliferative, antimetastatic and antiangiogenic activity. These antitumor 
activities result from its pro-apoptotic activity, micro- tubule activity and production of 
superoxides [162]. Its main potency appears to be derived from disruption of cellular 
microtubules that are necessary for HIF-1α translocation to the nucleus. 2ME2 thus retards HIF-
1 nuclear accumulation and activity in a manner that is both oxygen- and proteasome-
independent [163]. It was subsequently found that microtubule inhibitors such as 2ME2 and 
taxol also inhibit HIF-1α mRNA translation [164]. A Phase I clinical trial of 2ME2 was 
successfully concluded in 2006 [165]. In 2011, 2ME2 nanocrystal dispersion failed to show a 
significant effect in a Phase II study against castration-resistant prostate cancer [166] and in 
2012, in a second Phase II study against metastatic renal cell carcinoma due to both lack of 
objective effects and high toxicity. The cli- nicians recommended halting trials of 2ME2 in favor 
of a new 2ME2 analog in development [167]. Hopefully, this new analog, ENMD-1198, will 
have more favorable results. 
2.5.7 Echinomycin 
Echinomycin (quinomycin A, NSC 526417) is a cyclic peptide antibiotic agent of 
quinoxaline that was originally isolated from Streptomyces echinatus [168]. Echinomycin is 
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known to bind DNA in a sequence-specific manner. Binding sites for echinomycin contain the 
central sequence 5 ́-CG-3 ́ and the key recognition elements are contained in the sequences 5 ́-
ACGT-3 ́ and 5 ́-TCGT-3 ́, which are part of the DNA recognition motifs for several 
transcription factors [169]. Inhibition of HIF-1 binding to the HRE (RCGTG; where R = purine 
A or G), a step required for induction of transcription, is a potential mechanism by which 
echinomycin may inhibit HIF-1 activity [170]. Echinomycin was shown in chromatin 
immunoprecipitation experiments to selectively inhibit binding of HIF-1 to DNA [171]. Despite 
echinomycin’s in vitro apoptosis-inducing activity and the initial report of its in vivo antitumor 
effect in mice, echinomycin’s clinical development was halted in the late 1980s following 
extensive testing as a cytotoxic agent in Phase I–II trials, which failed to show significant 
activity [172]. 
2.5.8 Ansamycins: Geldanamycin, 17-AAG, 17-DMAG 
Geldanamycin (GA) is a macrocyclicpolyketide antibiotic containing a benzoquinone 
moiety and was originally isolated from Streptomyces hygroscopicus [173]. GA is a Hsp90 
inhibitor, that acts by binding the N-terminal ATP-binding domain of Hsp90, leading to the 
destabilization and eventual degradation of Hsp90 client proteins [174–176]. Hsp90, one of the 
most abundant cellular proteins, assists in protein folding and degradation and is upregulated 
during cellular stress [177,178]. HIF is a client protein of Hsp90 and the inhibition of Hsp90 has 
been shown to destabilize HIF, leading to HIF degradation and decrease in transcriptional 
activity [179,180]. GA and its derivatives 17-AAG (tanespimycin) and 17-DMAG 
(alvespimycin) have demonstrated anti-tumorigenic and -angiogenic properties both in vitro and 
in vivo. However, GA was never brought to the clinic due to its poor pharmacological properties 
and hepatoxicity in animal models [181,182]. 17-AAG was the first- in-class Hsp90 inhibitor to 
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enter Phase I trials, where it showed promise; however, it showed poor results in Phase II trials, 
most likely due to its poor bioavailability and solubility [183–186]. 17-DMAG, an orally 
available agent, has shown promise in the clinic, with success in Phase I trials, but needs further 
evaluation [187,188]. 
2.6 Conclusions 
Hypoxic conditions in the cancer micro- environment lead to increased resistance to both 
chemotherapy and radiotherapy. In most cases, the HIF pathway is the primary pathway 
responsible for this more malignant phenotype and its activation leads to increased cancer 
metastasis and poor patient prognosis. There has been much effort in this area to develop small-
molecule inhibitors of the HIF pathway (mostly focused on HIF-1) as well as upstream and 
downstream effects. There have been no approved drugs that directly inhibit the HIF pathway, 
but there have been a few that indirectly affect the HIF path- way, as well as many more that 
have failed to demonstrate therapeutic efficacy in clinical trials for cancer patients. Some of 
these failures can be accredited to a lack of specificity and/or redundancy in the complexity of 
tumor signaling/ metabolism that can overcome the inhibition effects. Another contributing 
factor to the failure of these compounds can be attributed to the lack of patient selection in 
clinical trials. Although many clinical trials evaluate the efficacy of anti- cancer therapeutics and 
examine their effects on HIF levels, patients are not selected based on their HIF-expression 
levels. If patients do not have elevated levels of HIF, therapeutics that tar- get the HIF pathway 
may be less effective. More work needs to be done to identify novel, potent and more specific 
inhibitors targeting clearly defined points in the HIF pathway. Such new agents should be used in 
combination therapy and will hopefully overcome resistance that may develop during the initial 
treatment.  
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2.7 Future Perspective  
Recently, the HIF pathway was touted as “technically undruggable or at the very least as 
extremely challenging to target by medicinal chemists using small molecules” [189]. This 
attitude can be attributed not only to the difficulty of targeting such a complex pathway, but also 
to the challenges of targeting protein–protein interactions [190]. Small molecules typically 
inhibit protein function by binding with high affinity and specificity to hydrophobic pockets on 
or near the protein’s surface. When trying to disrupt interactions between proteins, these binding 
sites may no longer be accessible and the interactions between proteins are so multifarious that 
one small molecule may not be able to interrupt the key interactions. There have been advances 
in this field of targeting protein–protein interaction, such as stapled peptide inhibitors of 
transcription factors [191] and small-molecule inhibitors of the MDM2- p53 interaction as 
anticancer therapeutics [192]. Some interesting features of the small molecules identified are that 
they tend to be large, lipophilic, and rigid structures with complex 3D shape that form few 
hydrogen bonds [193,194]. These structural differences vary from the typical Lipinksi rule of 
five for drug-like properties [195] and could portend a new paradigm for drug-like qualities for 
small molecules that inhibit protein-protein interactions. 
 27 
 
Figure 2.3. Trends of HIF inhibitors from 2000-2012 
A) Number of patents issued by year. B) Number of publications by year. C) Number of clinical 
trials by year. D) Number of citations by year. 
 
Interest in small-molecule inhibitors of the HIF pathway has steadily increased over the 
past 15 years. The number of patent applications, publications, citations and clinical trials has 
risen since the late 1990s and early 2000s (Figure 2.3). Although there have been few drugs that 
have made it all the way through clinical trials, the field is ripe and interest is increasing. It still 
remains to be seen whether inhibitors capable of distinguishing HIF-1 and HIF-2 complexes can 
be developed. In addition, new therapeutics are being developed against downstream HIF targets, 
such as MCT [91] and CA-IX [196]. Inhibitors of post-translational modifications of HIF-1α 
have also shown some promise. Kaempferol was recently shown to inactivate the p44/42 MAPK 
phosphorylation of HIF-1α, causing its mislocalization into the cytoplasm in hepatocellular 
carcinoma [197]. Results from high-throughput screenings and natural product discovery [198] 
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have also yielded new hits and lead compounds, but even more new methods need to be 
identified. Recently, novel HIF inhibitors from frankincense were identified through a new 
method using a molecularly imprinted polymer [199]. Acriflavine was identified as a HIF- 
dimerization inhibitor from a screening of drugs that had previously made it to Phase II clinical 
trials [200]. In addition, targeting the HIF-2α/-1β dimerization has been suggested as a valid 
target for anticancer therapeutics [201]. The well-known HIF/p300 interaction inhibitor chetomin 
[202] and its family, the epidithiodiketopiperazines, act via a mechanism of action involving 
disruption of the zinc-binding sites in the CH1 domain of p300 [203]. In addition, artificial a-
helices have been demonstrated to interfere with the HIF/ p300 interaction [204]. Oncolytic 
viruses dependent upon HIF expression for their replication have also been developed and 
showed strong antitumor effects [205–207]. Recently, a group of collaborators, including the 
authors, reported a new class of HIF-1 inhibitors, that appears to target the interaction between 
HIF-1 and p300 and, therefore, HIF-mediated transcription [208–214]. The lead arylsulfonamide 
compound (KCN1) showed potent anticancer activity in several cancer models [215,216]. 
Moreover, these inhibitors do not show intrinsic cytotoxicity and thus are promising compounds 
for further clinical development. 
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3 DESIGN AND SYNTHESIS OF WATER SOLUBLE HIF-1 INHIBITORS AS ANTI-
CANCER THERAPEUTICS 
The work presented in this chapter is based on a manuscript in preparation for submission 
to ACS Medicinal Chemistry Letters. This chapter includes compounds synthesized by Jalisa 
Holmes and Zeus de los Santos.  
3.1 Abstract 
Cancer is a leading cause of death and while progress has been made in this field, we 
need more effective drugs to target cancer only and not healthy cells. Thus, our goal is to target 
hypoxic tumors and specifically the HIF pathway. Another important factor besides potency is 
drug-like properties. The compounds described herein have been designed for both of these 
purposes and evaluated. 
3.2 Introduction 
 Cancer is one of the leading causes of death, second only to heart disease.1 One of the 
hallmarks of cancer is the formation of hypoxic, low oxygen, areas inside of solid tumors.2 This 
hypoxic tumor microenvironment leads to many changes such as the upregulation of pro-
angiogenic and pro-glycolytic pathways, as well as increased cell proliferation, genetic 
instability, and metastatic potential.3 A major mediator of the hypoxic response is the Hypoxia 
Inducible Factor (HIF) pathway.4 HIF consists of two parts, HIF-α, which is regulated by 
oxygen, and HIF-β, which is constitutively expressed.5 There are 3 known isoforms of HIF-α: 
HIF-1α, HIF-2α, and HIF-3α, with HIF-1α being the most common and of which there has been 
the most study. Under normoxic conditions, HIF-α is hydroxylated by prolyl hydroxylase (PHD) 
using molecular oxygen and then degraded via a VHL-dependent ubiquitination pathway.6 Under 
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hypoxic conditions, however, HIF-α and HIF-β form a heterodimer, which, along with co-
activators such as p300 and CBP, forms the active transcription complex, which binds to 5’-HRE 
(hypoxic response element) promoter regions that are found in hundreds of genes.7 Increased 
levels of HIF-α have been linked to cancer progression and poor patient outcome. HIF is 
becoming an attractive target for anti-cancer therapeutics.8 
3.3 Design 
 A library of 10,000 products containing the 2,2-dimethyl-2H-chromene moiety9 was 
screened for HIF pathway inhibition, with the identification of one compound designated KCN-1 
(Figure 3.1, 1, N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-3,4-dimethoxy-N-
phenylbenzenesulfonamide) showing potent inhibition activity (IC50 of 0.59 µM).10  
 
Figure 3.1. Lead Compound KCN-1 
 
1 was then taken on to further in vivo studies and demonstrated anticancer activity against brain, 
eye, and pancreatic cancers.11 In addition, mice treated with 1 did not show any negative side 
effects. However, due to its poor solubility in water (0.009 µM), 1 was used in a 1:1 
Cremophor:ethanol formulation. This type of formulation is non-ideal and can cause problems 









3.4 Results and Discussion 
 Based off of our previous studies, we decided to modify the structure of the lead 
compound 1 by incorporating the very water-soluble morpholine moiety into the structure. In 
order to accomplish this, we devised 4 classes of compounds (Figure 3.2): Class A, which 
incorporates a morpholinomethylphenyl or morpholinophenyl moiety instead of the 2,2-
dimethyl-2H-chromene moiety and maintains the N-phenyl group; Class B, which incorporates 
either a morpholinomethylphenyl or morpholinophenyl moiety instead of the 2,2-dimethyl-2H-
chromene moiety and substitutes the N-phenyl group for an N-cyclobutyl group; Class C, which 
has either a 2,2-dimethyl-2H-chromene or N-(2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-yl) 
moiety and either an N-ethylmorpholino or N-propylmorpholino group instead of the N-phenyl, 
and Class D, which has the 2,2-dimethyl-2H-chromene moiety with a N-phenyl-morpholine-4-
sulfonamide. 
 Synthesis of Class A compounds (Figure 3.3) was afforded in 4 steps from 2, 3, or 4-
bromomethylbenzylbromide 6a-c or in 2 steps from 4-morpholinobenzaldehyde 8d. 6a-c were 
substituted with morpholine to yield morpholinomethylbenzylbromides 7a-c in quantitative 
yield. Next, the phenyl bromides 7a-c were converted to benzaldehydes 8a-c via lithium-halogen 
exchange followed by treatment with DMF as the electrophile. The aldehydes 8a-d underwent 
reductive amination with aniline to afford the secondary amines 9a-d. Finally, 9a-d were reacted 
with 3,4-dimethoxybenzenesulfonyl chloride to afford sulfonamides 2a-d. Class B compounds 
(Figure 3.3) were synthesized in almost the same fashion as Class A, except that reductive 
amination of 8a-d was with cyclobutylamine and was not catalyzed by any Lewis acid. 
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Figure 3.2. Classes of analogs. 
A) Class A, morpholinomethylphenyl in ortho, meta, or para positions, or morpholinophenyl in 
para position; B) Class B, morpholinomethylphenyl in ortho, meta, or para positions, or 
morpholinophenyl in para position; C) Class C, n = 2 or 3; D) Class D. 
 
 Class C compounds were synthesized (Figure 3.4) from 2,2-dimethyl-2H-chromene-6-
carbaldehyde 11, which was readily synthesized from published procedures.13 The aldehyde 11 
underwent reductive amination with either ethylaminomorpholine or propylaminomorpholine to 
give secondary amines 12a-b, which were then reacted with 3,4-dimethoxybenzenesulfonyl 
chloride to afford sulfonamides 4a-b. 
 Class D compounds were synthesized (Figure 3.5) from 11 in 2 steps. First, 11 was 
underwent reductive amination with either aniline or cyclobutylamine to give secondary amines 









3a = ortho, n = 1
3b = meta, n = 1
3c = para, n = 1
3d = para, n = 0
4a, n = 2
4b, n = 3
2a = ortho, n = 1
2b = meta, n = 1
2c = para, n = 1



















Figure 3.3 Synthesis of Class A & B Compounds 
A) Synthesis of precursors; B) Synthesis of Class A. C) Synthesis of Class B; Reagents and 
conditions: (a) morpholine, K2CO3, ACN, room temperature, overnight. (b) BuLi, DMF, THF, -
78oC, 1 hr. (c) aniline, InCl3, NaBH4, ACN, 20 min. (d) 3,4-dimethoxysulfonyl chloride, K2CO3, 







6a = ortho, n = 1
6b = meta, n = 1





8a = ortho, n = 1
8b = meta, n = 1
8c = para, n = 1
9a-d 2a = ortho, n = 1
2b = meta, n = 1
2c = para, n = 1






10a-d 3a = ortho, n = 1
3b = meta, n = 1
3c = para, n = 1












8a = ortho, n = 1
8b = meta, n = 1
8c = para, n = 1


























Figure 3.4. Synthesis of Class C compounds 
Reagents and conditions: (a) amine, NaBH4, MeOH, overnight. (b) 3,4-dimethoxysulfonyl 
chloride, K2CO3, DCM, overnight. 
 
 These 11 analogs were tested for their anti-HIF activity in a LN229-HRE-LUC assay.14 
Their activities are detailed in Table 3.1. The in silico logP and logS value of these compounds 
were also investigated with ALOGPS 2.1 (Virtual Computational Chemistry Laboratory, 
http://www.vcclab.org), with results in Table 3.1.  
 
 
Figure 3.5. Synthesis of Class D compounds 
Reagents and conditions: (a) aniline, InCl3, NaBH4, ACN, 20 min; (b) 4-morpholinosulfonyl 








12a, n = 2
12b, n = 3
4a, n = 2























 Based off of these findings, it can be seen that solubility is an important factor in the 
activity of these compounds. Even compounds without the seemingly crucial 2,2-dimethyl-2H-
chromene moiety had moderate activity. This is most likely due to the increased logP and logS, 
which allow the therapeutics to be more biologically available. All of the analogs synthesized 
had more favorable logP and log S values compared to 1, which has 4.07 and -6.05, respectively. 
In the future, we plan to incorporate more soluble moieties and further probe the SAR (structure-
activity relationship) for locations to add in these soluble moieties.  
Table 3.1. Analogs and data 
Compound Structure IC50 (µM) logP LogS 
2a 
 
0.9 3.54 -4.51 
2b 
 
TBD 3.53 -4.50 
2c 
 
TBD 3.52 -4.46 
2d 
 


























1.0 2.81 -3.51 
3b 
 
>5 2.80 -3.50 
3c 
 
>5 2.79 -3.47 
3d 
 
TBD 3.05 -3.64 
4a 
 
TBD 3.02 -3.71 
4b 
 
TBD 3.34 -3.97 
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General methods and materials: All commercial chemicals were reagent grade, obtained 
from VWR, Aldrich, and Oakwood Chemicals and were used without further purification unless 
otherwise indicated. 1H and 13C spectra were obtained on a Bruker 400 NMR spectrometer at 400 
and 100 MHz, respectively, in deuterated solvent with TMS as internal reference (δ = 0.00 ppm). 
For all reactions, analytical grade solvent was used.  Anhydrous solvents were used for all 
moisture-sensitive reactions. High-resolution mass spectra were obtained by the Mass 
Spectrometry Facilities at Georgia State University on a Waters Micromass Q-Tof (ESI). 
Typical procedure for morpholine substitution: 1 equivalent of benzyl bromide was 
dissolved in acetonitrile. 1.1 equivalents of morpholine and 2 equivalents of K2CO3 were added 
and the reaction stirred overnight at room temperature. The reaction was filtered through celite 
and concentrated to give the product. 
Typical procedure for reductive amination with aniline: 1 equivalent of aldehyde, 1.5 
equivalents of NaBH4, and 0.15 equivalents of InCl3 were dissolved in anhydrous ACN under 
N2. 1.5 equivalents of aniline were added and the reaction stirred until completion as monitored 
by TLC (typically ~20 minutes). The reaction was quenched with saturated NH4Cl, taken up in 
ethyl acetate, washed with brine, dried over MgSO4, and concentrated. Purified by column 
chromatography. 
Typical procedure for reductive amination with cyclobutyl and alkylmorpholino amines: 
1 equivalent each of aldehyde and amine was dissolved in anhydrous MeOH under N2 and the 
reaction stirred overnight at room temperature. 1.6 equivalents of NaBH4 were added and the 
reaction stirred for 1 hour. The reaction was quenched with 1N NaOH, stirred for an hour, then 
 65 
taken up in ethyl acetate, washed with brine, dried over MgSO4, concentrated, and taken directly 
to the next step without further purification. 
Typical procedure for sulfonylation with 3,4-dimethoxysulfonyl chloride: 1 equivalent of 
amine was dissolved in DCM. 2 equivalents of K2CO3 were added. 2 equivalents of 3,4-
dimethoxysulfonyl chloride were added. The reaction was stirred overnight at room temperature, 
then washed with brine, dried over MgSO4, and concentrated. Purified by column 
chromatography. 
Typical procedure for sulfonylation with 4-morpholinosulfonyl chloride: 1 equivalent of 
amine was dissolved in DCE. 3 equivalents of pyridine and 1.3 equivalents  of 4-
morpholinosulfonyl chloride were added. The reaction was refluxed for 2 days, then 
concentrated, taken up in ethyl acetate, washed with saturated NH4Cl and brine, then dried over 
MgSO4, and concentrated. Purified by column chromatography. 
 
3,4-Dimethoxy-N-(4-(morpholinomethyl)benzyl)-N-phenylbenzenesulfonamide (2a) Yield: 
11%. 1H NMR (400 MHz, CDCl3): δ 7.37-7.35 (d, J = 8Hz, 1H), 7.35 (s, 1H), 7.22-7.20 (m, 6H), 
7.04-7.02 (m, 2H), 6.97-6.94 (m, 2H), 4.72 (s, 1H), 3.98 (s, 3H), 3.77 (s, 3H), 3.70-3.69 (m, 4H), 
3.44 (s, 2H), 2.40 (m, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.6, 148.7, 139.2, 135.0, 
130.2, 129.2, 129.0, 128.8, 128.4, 127.8, 127.5, 121.4, 110.4, 110.4, 66.9, 63.0, 56.2, 56.01, 54.4, 







3,4-Dimethoxy-N-(3-(morpholinomethyl)benzyl)-N-phenylbenzenesulfonamide (2b) 1H 




3,4-Dimethoxy-N-(4-morpholinobenzyl)-N-phenylbenzenesulfonamide (2d) Yield: 40%.1H 
NMR (400 MHz, CDCl3): δ 7.36-7.34 (d, J = 8 Hz, 1H), 7.21 (m, 3H), 7.13-7.11 (d, J = 8 Hz, 
2H), 7.01-6.93 (m, 4H), 6.77-6.75 (d, J = 8 Hz, 2H), 4.65 (s, 2H), 3.973 (s, 3H), 3.84-3.83 (m, 
4H), 3.77 (s, 3H), 3.11-3.10 (m, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.5, 150.5, 148.7, 
139.2, 130.3, 129.6, 129.1, 128.7, 127.7, 127.1, 121.4, 115.3, 110.4, 66.8, 56.2, 56.1, 54.1, 49.1 
ppm. HRMS (ESI) m/z calculated for C25H29N2O5S [(M + H)+] 469.1797, found 469.1796. 
 
N-cyclobutyl-3,4-dimethoxy-N-(4-(morpholinomethyl)benzyl)benzenesulfonamide (3a) 
























6.95-6.93 (d, J = 8 Hz, 1H), 4.39 (s, 2H), 4.32-4.23 (quintet, J = 8 Hz, 1H), 3.96 (s, 3H), 3.92 (s, 
3H), 3.74-3.72 (t, J = 4 Hz, 4H), 3.51 (s, 2H), 2.46 (s, 4H), 1.99-1.94 (m, 4H), 1.57-1.52 (m, 2H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 152.4, 149.0, 137.8, 132.0, 129.4, 127.1, 120.91, 110.6, 
109.8, 66.9, 63.0, 56.2, 56.2, 53.5, 52.9, 48.1, 29.2, 15.0 ppm. HRMS (ESI) m/z calculated for 
C24H33N2O5S [(M + H)+] 461.2110, found 461.2102. 
 
N-Cyclobutyl-3,4-dimethoxy-N-(3-(morpholinomethyl)benzyl)benzenesulfonamide (3b) 
Yield: 81%. 1H NMR (400 MHz, CDCl3): δ 7.44-7.41 (dd, J = 8.4, 2 Hz, 1H), 7.30-7.21 (m, 5H), 
6.95-6.93 (d, J = 8 Hz, 1H), 4.39 (s, 2H), 4.33-4.24 (quintet, J = 8 Hz, 1H), 3.95 (s, 3H), 3.91 (s, 
3H), 3.72-3.69 (t, J = 4 Hz, 4H), 3.49 (s, 2H), 2.43 (s, 4H), 1.99-1.92 (m, 4H), 1.55-1.48 (m, 2H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 152.4, 149.0, 138.7, 137.9, 131.9, 128.4, 128.1, 127.8, 
126.0, 120.9, 110.5, 109.7, 67.0, 63.3, 56.2, 56.2, 53.6, 52.9, 48.3, 29.2, 15.1 ppm. HRMS (ESI) 
m/z calculated for C24H33N2O5S [(M + H)+] 461.2110, found 461.2112. 
 
N-Cyclobutyl-3,4-dimethoxy-N-(2-(morpholinomethyl)benzyl)benzenesulfonamide (3c) 
Yield: 63%. 1H NMR (400 MHz, CDCl3): δ 7.57-7.55 (d, J = 8 Hz, 1H), 7.48-7.46 (dd, J = 8.4, 2 
Hz, 1H), 7.31-7.27 (m, 2H), 7.18-7.16 (d, J = 8 Hz, 1H), 6.96-6.94 (d, J = 8 Hz, 1H), 4.68 (s, 
2H), 4.51-4.40 (quintet, J = 8 Hz, 1H), 3.96 (s, 3H), 3.92 (s, 3H), 3.65 (m, 4H), 3.50 (s, 2H), 2.42 














149.0, 138.4, 133.4, 132.1, 130.6, 128.0, 127.4, 126.5, 121.0, 110.5, 109.7, 67.1, 61.7, 56.3, 56.2, 
53.5, 52.7, 44.5, 28.9, 15.1 ppm. HRMS (ESI) m/z calculated for C24H33N2O5S [(M + H)+] 










N-((2,2-Dimethyl-2H-chromen-6-yl)methyl)-N-phenylmorpholine-4-sulfonamide (5a) Yield: 



























1H), 6.66-6.64 (d, J =8 Hz, 1H), 6.26-6.24 (d, J = 8 Hz, 1H), 5.61-5.59 (d, J = 8 Hz, 1H), 4.702 
(s, 2H), 3.626 (m, 4H), 3.165 (m, 4H), 1.41 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 131.0, 
129.6, 129.2, 129.1, 127.9, 126.9, 122.1, 116.2, 66.3, 56.3, 46.5, 28.0 ppm. HRMS (ESI) m/z 
calculated for C22H27N2O4S [(M + H)+] 415.1695, found 415.1692. 
 
4-(4-Bromobenzyl)morpholine (7a) Yield: quantitative. 1H NMR (400 MHz, CDCl3): δ 7.42-
7.40 (d, J = 8 Hz, 2H), 7.120-7.18 (d, J = 8 Hz, 2H), 3.68-3.66 (t, J = 4 Hz, 4H), 3.40 (s, 2H), 
2.40 (s, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 136.9, 131.4, 130.8, 120.9, 66.9, 62.6, 53.6 
ppm. HRMS (ESI) m/z calculated for C11H15NOBr [(M + H)+] 256.0337, found 256.0346. 
 
4-(3-Bromobenzyl)morpholine (7b) Yield: quantitative. 1H NMR (400 MHz, CDCl3): δ 7.47 (s, 
1H), 7.35-7.34 (d, J = 8 Hz, 1H), 7.22-7.20 (d, J = 8 Hz, 1H), 7.15-7.11 (t, J = 4 Hz, 1H), 3.66-
3.64 (d, J = 8 Hz, 4H), 3.40 (s, 2H), 2.38 (s, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 140.5, 
131.9, 130.2, 129.8, 127.6, 122.5, 65.9, 62.7, 53.6 ppm. HRMS (ESI) m/z calculated for 
C11H15NOBr [(M + H)+] 256.0337, found 256.0347. 
 
4-(2-Bromobenzyl)morpholine (7c) Yield: quantitative. 1H NMR (400 MHz, CDCl3): δ 7.53-
7.51 (d, J = 8Hz, 1H), 7.47-7.45 (d, J = 8 Hz, 1H), 7.27-7.23 (t, J = 4 Hz, 1H), 7.09-7.06 (t, J = 8 









132.8, 130.8, 128.5, 127.2, 124.7, 67.6, 66.8, 62.2, 53.6 ppm. HRMS (ESI) m/z calculated for 
C11H15NOBr [(M + H)+] 256.0337, found 256.0348.  
 
4-(Morpholinomethyl)benzaldehyde (8a) Yield: 74%.1H NMR (400 MHz, CDCl3): δ 9.96 (s, 
1H), 7.82-7.80 (d, J = 8 Hz, 2H), 7.50-7.48 (d, J = 8 Hz, 2H), 3.68-3.67 (m, 4H), 3.54 (s, 2H), 
2.43 (m, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 191.9, 145.2, 135.5, 129.8, 129.5, 129.2, 
66.9, 63.0, 53.6 ppm. HRMS (ESI) m/z calculated for C12H16NO2 [(M + H)+] 206.1181, found 
206.1182. 
 
3-(Morpholinomethyl)benzaldehyde (8b) Yield: 88%.1H NMR (400 MHz, CDCl3): δ 9.92 (s, 
1H), 7.77 (s, 1H), 7.70-7.68 (d, J = 8 Hz, 1H), 7.55-7.53 (d, J = 8 Hz, 2H), 7.43-7.39 (t, J = 7.6 
Hz, 1H), 3.63 (m, 4H), 3.5 (s, 2H), 2.39 (m, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 192.3, 
138.8, 136.5, 135.2, 130.2, 129.0, 128.7, 66.7, 62.6, 53.42, 53.3 ppm. HRMS (ESI) m/z 
calculated for C12H16NO2 [(M + H)+] 206.1181, found 206.1183. 
 
2-(Morpholinomethyl)benzaldehyde (8c) Yield: 85%. 1H NMR (400 MHz, CDCl3): δ 10.37, 
(s, 1H), 7.82-7.80 (d, J = 8 Hz, 1H), 7.45-7.43 (d, J = 8 Hz, 1H), 7.37-7.33 (m, 2H), 3.76 (s, 2H), 









133.2, 130.6, 129.4, 127.9, 67.0, 66.9, 60.1, 55.5, 53.3 ppm. HRMS (ESI) m/z calculated for 
C12H16NO2Na [(M + Na)+] 206.1181, found 206.1186. 
 
N-(4-(Morpholinomethyl)benzyl)aniline (9a) Yield: 60%. 1H NMR (400 MHz, CDCl3): δ 7.23-
7.17 (m, 4H), 6.79-6.66 (m, 5H), 4.34 (s, 2H), 3.74 (m, 4H), 3.53 (s, 2H), 2.74 (m, 4H) ppm. 13C 
NMR (100 MHz, CDCl3): δ 148.2, 138.4, 136.8, 129.5, 129.3, 127.5, 118.6, 117.6, 115.1, 112.9, 
67.0, 63.2, 53.6, 48.1 ppm. HRMS m/z (ESI) calculated for C16H22NO2 [(M + H)+] 260.1651, 
found 260.1657. 
 
N-(3-(Morpholinomethyl)benzyl)aniline (9b) Yield: 60%. 1H NMR (400 MHz, CDCl3):  δ 
7.3607.17 (m, 6H), 6.76-6.65 (m, 3H), 4.35 (s, 2H), 3.73-3.72 (m, 4H), 3.52 (s, 2H), 2.45 (m, 
4H) ppm. 13C NMR (100 MHz, CDCl3): 148.1, 139.5, 138.1, 129.3, 128.6, 128.3, 128.1, 126.5, 
117.6, 112.9, 67.0, 63.4, 53.6, 48.3 ppm. HRMS (ESI) m/z calculated for C18H23N2O [(M + H)+] 
283.1810, found 283.1809. 
 
N-(2-(Morpholinomethyl)benzyl)aniline (9c) Yield: 54%. 1H NMR (400 MHz, CDCl3):  δ 










(s, 2H), 3.75 (m, 4H), 3.57 (s, 2H), 2.51 (m, 4H) ppm. 13C NMR (100 MHz, CDCl3):148.6, 
138.9, 135.8, 131.5, 130.0, 129.3, 128.2, 127.2, 113.1, 67.1, 61.7, 53.5, 46.9 ppm. HRMS (ESI) 
m/z calculated for C18H23N2O [(M + H)+] 283.1810, found 283.1805. 
 
N-(4-Morpholinobenzyl)aniline (9d) Yield: 25%. 1H NMR (400 MHz, CDCl3):  δ 7.34-7.32 (d, 
J = 8 Hz, 2H), 7.23-7.21 (d, J = 8 Hz, 2H), 6.95-6.93 (d, J = 8 Hz, 2H), 6.78-6.75 (t, J = 8 Hz, 
1H), 6.69-6.69 (d, J = 8 Hz, 2H), 4.28 (s, 2H), 4.00 (bs, 1H), 3.91-3.90 (m, 4H), 3.19-3.18 (m, 
4H) ppm. 13C NMR (100 MHz, CDCl3): δ 150.6, 148.3, 130.76, 129.3, 128.7, 117.5, 115.9, 
112.9, 67.0, 49.5, 47.8 ppm. HRMS (ESI) m/z calculated for C17H20N2O [(M + H)+] 269.1648, 
found 269.1659. 
 
N-(4-(Morpholinomethyl)benzyl)cyclobutanamine (10a) Yield: 89% unpurified. 1H NMR 
(400 MHz, CDCl3): δ 7.315-7.261 (m, 4H), 3.694-3.678 (m, 4H), 3.472 (s, 2H), 3.308-3.275 (m, 
1H), 2.425 (m, 4H), 2.221-2.207 (m, 2H), 1.633-1.618 (m, 4H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 139.35, 136.31, 129.44, 128.13, 66.99, 63.17, 53.58, 50.75, 31.10, 14.79 ppm. HRMS 
(ESI) m/z calculated for C16H25NO2 [(M + H)+] 261.1967, found 261.1961. 
 
N-(3-(Morpholinomethyl)benzyl)cyclobutanamine (10b) Yield: 88% unpurified. 1H NMR 










7.6 Hz, 1H), 2.43 (m, 4H), 2.24-2.20 (m, 2H), 1.74-1.63 (m, 4H) ppm. 13C NMR (100 MHz, 
CDCl3): 140.3, 137.9, 129.0, 128.6, 127.8, 127.1, 66.9, 63.1, 53.7, 53.6 51.0, 31.1, 14.8 ppm. 
HRMS (ESI) m/z calculated for C16H25NO2 [(M + H)+] 261.1967, found 261.1963. 
 
N-(2-(Morpholinomethyl)benzyl)cyclobutanamine (10c) 94% unpurified. 1H NMR (400 MHz, 
CDCl3):  δ 7.32-7.18 (m, 4H), 3.75 (s, 2H), 3.67 (s, 4H), 3.53 (s, 2H), 3.33-3.30 (quintet, J = 7.6 
Hz, 1H), 2.53 (s, 1H), 2.46 (s, 4H), 2.21-2.18 (m, 2H), 1.74-1.63 (m, 4H) ppm. 13C NMR (100 
MHz, CDCl3): δ 140.2, 135.7, 131.2, 130.5, 127.9, 126.7, 67.0, 61.6, 53.6, 53.5, 49.5, 30.9, 15.1 
ppm. HRMS (ESI) m/z calculated for C16H25N2O [(M + H)+] 261.1967, found 261.1968. 
 
N-(4-Morpholinobenzyl)cyclobutanamine (10d) Yield: 90% unpurified. 1H NMR (400 MHz, 
CDCl3): δ 7.23-7.21 (d, J = 8 Hz, 2H), 6.88-6.86 (d, J = 8 Hz, 2H), 3.86-3.84 (m, 4H), 3.62 (s, 
2H), 3.30-3.25 (quintet, J =6.8 Hz, 1H), 3.14-3.11 (m, 4H), 2.22-2.19 (m, 2H), 1.70-1.62 (m, 4H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 150.3, 131.9, 129.1, 115.7, 66.9, 53.5, 50.4, 49.5, 31.1, 











2,2-Dimethyl-2H-chromene-6-carbaldehyde (11) Yield: 80%. 1H NMR (400 MHz, CDCl3): δ 
9.83 (s, 1H), 7.65-7.63 (d, J = 8 Hz, 1H), 7.52 (s, 1H), 6.88-6.86 (d, J = 8 Hz, 1H), 6.38-6.36 (d, 
J = 8 Hz, 1H), 5.70-5.68 (d, J = 8Hz, 1H), 1.47 (s, 6H). 
 
N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-2-morpholinoethanamine (12a) Unpurified. 1H 
NMR (400 MHz, CDCl3): δ 7.20-7.12 (m, 1H), 7.01-6.99 (d, J = 8 Hz, 1H), 6.91 (s, 1H), 6.70-
6.68 (d, J = 8 Hz, 1H), 6.28-6.26 (d, J = 10 Hz, 1H), 5.59-5.56 (d, J = 10 Hz, 1H), 3.72 (s, 2H), 
3.66-3.64 (m, 4H), 3.09 (s, 1H), 2.66-2.64 (m, 2H), 2.47-2.44 (m, 2H), 2.35 (m, 4H), 1.39 (s, 6H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 152.0, 132.2, 130.9, 128.9, 126.2, 125.3, 122.4, 121.5, 
116.1, 73.9, 66.9, 53.6, 53.2, 44.9, 27.9 ppm. HRMS (ESI) m/z calculated for C18H27N2O2 [(M + 
H)+] 303.2073, found 303.2063. 
 
N-((2,2-Dimethyl-2H-chromen-6-yl)methyl)-3-morpholinopropan-1-amine (12b) Unpurified. 
1H NMR (400 MHz, CDCl3): δ 7.18-7.10 (m, 1H), 6.99-6.97 (d, J = 8 Hz, 1H), 6.89 (s, 1H), 
6.68-6.66 (d, J = 8 Hz, 1H), 6.26-6.23 (d, J = 10 Hz, 1H), 5.56-5.54 (d, J = 10 Hz, 1H), 3.69 (s, 
2H), 3.63 (m, 4H), 2.63 (m, 2H), 2.37-2.35 (m, 4H), 1.67-1.58 (m, 2H), 1.58 (m, 2H), 1.37 (s, 
6H) ppm. 13C NMR (100 MHz, CDCl3): δ 151.9, 132.3, 130.9, 128.8, 126.1, 122.3, 121.5, 116.1, 
73.9, 66.9, 57.3, 53.7, 47.9, 27.6, 27.9, 26.4 ppm. HRMS (ESI) m/z calculated for C19H29N2O2 












Yield: 76% unpurified. 1H NMR (400 MHz, CDCl3): δ 7.005-6.944 (m, 2H), 6.462-6.437 (d, J = 
10 Hz, 1H), 5.851-5.825 (d, J =10.4 Hz, 1H), 3.763 (s, 2H), 3.675-3.653 (m, 4H), 2.706-2.676 
(m, 2H), 2.493-2.462 (m, 2H), 2.380 (m, 4H), 1.420 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): 
δ 151.31, 148.38, 140.71, 135.26, 123.86, 123.30, 122.30, 76.78, 66.93, 58.24, 54.54, 53.63, 




(12d) Yield: 73% unpurified. 1H NMR (400 MHz, CDCl3): δ 6.988-6.928 (m, 2H), 6.450-6.425 
(d, J = 10 Hz, 1H), 5.834-5.809 (d, J = 10 Hz, 1H), 3.730 (s, 2H), 3.650-3.641 (m, 4H), 2.676-
2.643 (m, 2H), 2.381-2.344 (m, 6H), 1.694-1.659 (m, 2H), 1.407 (s, 6H) ppm. 13C NMR (100 
MHz, CDCl3): δ 151.18, 148.36, 140.70, 135.20, 123.89, 123.29, 122.24, 76.81, 57.29, 54.70, 
















N-((2,2-Dimethyl-2H-chromen-6-yl)methyl)aniline (13a) Yield: 80%. 1H NMR (400 MHz, 
CDCl3): δ 7.26-7.21 (m, 3H), 6.98-6.96 (d, J = 8 Hz, 1H), 6.88-6.86 (m, 1H), 6.79-6.72 (m, 3H), 
6.40-6.38 (d, J = 8 Hz, 1H), 5.69-5.67 (d, J = 8 Hz, 1H), 4.37 (s, 2H), 4.06 (s, 1H) 1.51 (s, 6H), 
ppm. 13C NMR (100 MHz, CDCl3): δ 150.8, 148.5, 130.6, 129.2, 128.9, 126.5, 125.5, 122.5, 
121.1, 120.5, 117.4, 113.2, 76.44, 43.11, 28.18 ppm. HRMS  (ESI) m/z calculated for C18H20NO 
[(M + H)+] 266.1545, found 266.1548. 
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4 DESIGN AND SYNTHESIS OF NOVEL BI-ARYL METHANOLIC HIF-1 
INHIBITORS AS ANTI-CANCER THERAPEUTICS 
 The work presented in this chapter is based on a manuscript in preparation for submission 
to the Journal of Medicinal Chemistry. This chapter includes compounds synthesized by Jalisa 
Holmes,§ and Krishna Damera.≠ 
4.1 Abstract 
Although there has been much progress in the battle against cancer, there is still a need 
for anti-cancer therapeutics that are not cytotoxic. To this end, we are interested in targeting the 
HIF pathway. Based off of initial screening, the compounds described herein have been designed 
to specifically inhibit the HIF pathway and have desirable pharmacological properties. 
4.2 Introduction  
Cancer is the second most prevalent cause of death in the United States, behind heart 
disease.1 Many cancers are associated with hypoxia, a lack of oxygen.  Hypoxic conditions in 
otherwise healthy cells can lead to cell necrosis and reoxygenation injuries.  Cancer cells, 
however, survive and even thrive under hypoxic conditions due to their ability to turn on gene 
expression via multiple pathways that can change metabolism into the anaerobic, glycolytic 
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pathway; promote angiogenesis; turn on immortalization, increase metastatic potential, resist 
apoptosis, and increase resistance to radiation and chemotherapies.2  
One such pathway is the hypoxia-inducible transcription factor 1 (HIF-1) pathway.3 HIF 
is a basic-loop-helix-loop motif heterodimeric transcription factor composed of two subunits: 
HIF-1α and HIF-1β. HIF-1β is constitutively expressed, but HIF-1α is regulated by oxygen 
levels.4 Under normoxic conditions, when there is enough oxygen present in the system, HIF1-α 
is dihydroxylated by HIF prolyl hydroxylases, which use molecular oxygen as the source of the 
hydroxyls, at prolines 402 and 564.5 The dihydroxylated form of HIF1-α binds to von Hippel-
Lindau tumor suppressor protein (VHL), which leads to the ubiquitination of the complex and 
subsequent proteosomal degradation.6 Under hypoxic conditions, however, HIF-1a 
hydroxylation does not occur and HIF-1α is no longer degraded. As HIF-1α accumulates, it 
binds to HIF1-β and forms the heterodimeric complex, which, along with the co-activator p300, 
forms the HIF complex that acts as transcription factor for a multitude of genes. The HIF 
transcription complex binds to hypoxic response elements (HRE) in the regulatory regions of 
many genes, such as VEGF (vascular endothelial growth factor), EPO (eythropoietin), GLUT1 
(glucose transporter 1), LDH (lactate dehydrogenase), and NOS (nitric oxide synthase).7  
Overexpression of HIF-1α occurs in many cancers, such as cervical, ovarian, lung, 
oesophagel, colon, breast, pancreatic, prostate, renal, head and neck, and brain carcinomas. In 
many cases, increased HIF-1α has been associated with increased mortality, cancer progression, 
and resistance to traditional chemotherapy, radiation, or photo-dynamic therapy.8 This can be 
attributed mostly to the hypoxic environment created in solid tumors.  As tumors grow, they 
need increased vasculature in order to receive oxygen and nutrients.  Hypoxic conditions in the 
tumor can signal expression of pro-angiogenic genes such as VEGF.  Although new vasculature 
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is established, it is often leaky and inadequate.9 This leads to resistance to therapy because the 
tumor is not accessible to the chemotherapy or radiation. Given the role of the HIF pathway in 
hypoxia and cancer progression, it is an attractive target for cancer chemotherapy. 
 
Figure 4.1. 4 lead compounds identified in the aryl sulfonamide class of HIF inhibitors. 
 
As an initial step in the development of novel small molecule inhibitors of the HIF 
pathway, we initially screened a library of 10,000 compounds from a 2,2-dimethylbenzopyran 
combinatorial library using an LN229-HRE-alkaline phosphatase assay.10 This initial screening 
yielded a few promising hits, with the lead compound identified as KCN-1 (1, Figure 4.1) having 
an IC50 of 0.59 µM.11 Since then, our collaborative team has identified additional small 
molecules such as N-cyclobutyl-N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-3,4-
dimethoxybenzenesulfonamide (2, Figure 4.1), N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-
isopropyl-3,4-dimethoxybenzenesulfonamide (3, Figure 4.1), N-((8-hydroxy-2,2-dimethyl-2H-
chromen-6-yl)methyl)-N-isopropylpyridine-2-sulfonamide (4, Figure 4.1).12 Moreover, 
computational studies have suggested a dual binding mode for these compounds to p300 and 
























classes of compounds do not have any inherent toxicity.13 Due to poor solubility, however, 1 
must be formulated in cremphor/ethanol, which has been shown to have toxicity problems in 
other anti-cancer therapeutics.14 With all of this in mind, we began to search for novel structural 
features to broaden our SAR and perhaps discover a new lead compound in this series. 
4.3 Results and Discussion 
4.3.1 Design 
 Based off of our previous results, the SAR for the aryl sulfonamide HIF inhibitors has 
become somewhat flat, with many compounds exhibiting and IC50 values in the 250-1000 nM 
range. We initially chose to keep the 2,2-dimethyl-2H-chromene moiety and the 3’,4’-
dimethoxyphenyl moiety from 1 and link them together via a methanolic linker, which was seen 
in some of the less potent hits of the initial screening. We also wanted to diversify the pool of 
analogs by making modifications in 3 places (Figure 4.2): Class 1 compounds vary in the left 
hand aryl system, Ar1; Class 2 compounds vary in the right hand aryl system, Ar2; and Class 3 
compounds vary in the linker between the two aryl groups. Since these compounds were 
designed to be both more potent and more soluble, the in silico logP and logS values were 




Figure 4.2. Three classes of analogs 
 
4.3.2 Chemistry 
4.3.2.1 Class I: Ar1 modifications.  
 Class 1A compounds were synthesized in 1 or 2 steps from readily synthesized aldehydes 
5a-c (Figure 4.3).12a, 16 First, aldehydes 5a-c were coupled with 4-bromo-1,2-dimethoxybenzene 
through lithiation and then addition reaction to yield alcohols 6a-c. Next, the double bond was 















R1 = H or OMe
X = C or N
Class 1B
R2 = tetrahydrofuran or
        tetrahydro-2H-pyran
Class 1C
R3 = morpholine, bromo
Class 2
R5-6 = H or OMe
X = C or N
Ar1 Ar2
O
Class 1 = Ar1 modifications
Class 2 = Ar2 modifications
Class 3: linker modifications
R4
Class 1D
R4 = H, OMe, or fused rings
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Figure 4.3. Synthesis of Class 1A compounds 
R1 = H, X = C, 5-7a; R1 = OMe, X = C, 5-7b; R1 = H, X = N, 5-7c; Reagents and conditions: (a) 
4-bromo-1,2-dimethoxybenzene, buLi, -78oC, 49-63%; (b) H2, Pd/C, MeOH, overnight. 
 
 Class 1B compounds were synthesized in 2 steps from commercially available 1-bromo-
4-(bromomethyl)benzene 8 (Figure 4.4). First, 8 underwent SN2 displacement with either 
tetrahydrofuran-3-ol or tetrahydro-2H-pyran-4-ol to yield ethers 9a-c. Next, after lithiation, 9a-c 
were reacted with 3,4-dimethoxybenzaldehyde to yield alcohol compounds 10a-c. 
 
Figure 4.4. Synthesis of Class 1B compounds 
R2 = (S)-tetrahydrofuran-3-ol, 10a; R2 = (R)-tetrahydrofuran-3-ol, 10; R3 = tetrahydro-2H-pyran-
4-ol, 10c. Reagents and conditions: (a) NaH, alcohol, 0oC to room temperature, overnight, 48-
85% (b) 3,4-dimethoxybenzaldehyde, buLi, -78oC, 58-94%. 
 
 Class 1C compounds were synthesized in 2 steps from commercially available 1-bromo-
4-(bromomethyl)benzene 8 (Figure 4.5). First, 8 underwent SN2 displacement with morpholine, 
or N-methylpipirizine to yield compounds 11a-b. Next, 11a- were reacted with butyl lithium and 

































Figure 4.5. Synthesis of Class 1C compounds 
R3 = morpholine, 11-12a; R3 = methylbromo, 12b; R3 = 4-methylpiperazin-1-yl, 11-12c . 
Reagents and conditions: (a) 3,4-dimethoxybenzaldehyde, BuLi, -78 oC, 85%. (b) 3,4-
dimethoxybromobenzenee, BuLi, -78 oC, 89%. 
 
 Class 1D compounds were synthesized in 1 step from commercially available starting 
materials 13 and 14, which consist of an aryl bromide and an aryl aldehyde, which were coupled 
together to yield alcohols 15a-d (Figure 4.6). 
 
Figure 4.6. Synthesis of Class 1C compounds 
R4 = H, Y = Br, Z = CHO, 15a; R4 = 3,4-dimethoxy, Y= Br, Z = CHO, 15b; R3 =2,4-dimethoxy, 
Y = Br, Z = CHO, 15c; R4 = 4-methylbromide, Y = Br, Z = CHO, 15d; R4 = benzofuran, Y = 
























4.3.2.2 Class 2: Ar2 modifications.  
 Class 2 compounds were synthesized in 1 facile step from commercially available 
starting materials 16 and 17, which consist of an aryl bromide and an aryl aldehyde, which were 
coupled to yield alcohols 18a-d (Figure 4.7). 
 
Figure 4.7. Synthesis of Class 2A compounds 
R5 = H, R6 = H, X = C, Y = CHO, Z = Br, 18a; R5 = OMe, R6 = H, X = C, Y = CHO, Z = Br, 
18b; R5 = H, R6 = OMe, X = C, Y = Br, Z = CHO, 18c, R5 = H, R6 = H, X = N, Y = CHO, Z = 
Br, 18d. Reagents and conditions: (a) BuLi, -78 oC. 
 
4.3.2.3 Class 3: Linker modifications.  
 Class 3 compounds were synthesized in 1 step from alcohol compounds 6a, 10a, and 
12b. Each alcohol was oxidized to its corresponding ketone 19a-c (Figure 4.8). 
 
Figure 4.8. Synthesis of Class 3 compounds 
Ar1 = 6-(2,2-dimethyl-2H-chromenyl), 6a, 19a; Ar1 = 1-(4-((((S)-tetrahydrofuran-3-
yl)oxy)methyl)phenyl, 10a, 19b; Ar1 = 1-(4-bromomethyl)phenyl, 12b, 19c. Reagents and 






















6a, 10a, 12b 19a-c
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4.3.3 Biology 
 For Class 1A compounds (Table 4.1), the best compound was the original compound 6a, 
with the 2,2-dimethyl-2H-chromene, with an IC50 of 0.6 µM. The addition of the methoxy group 
resulted in a 5.2-fold decrease from 6a.  
Table 4.1. Class 1A compounds and IC50 
 Structure IC50 (µM) logP logS 
6a 
 
0.6 3.68 -4.43 
6b§ 
 
3.1 3.52 -4.42 
 
 Our overall best compound was 10a of Class 1B (Table 4.2), with an IC50 value of 0.32 
µM. It is interesting to note that the diasteromer of 10a, 10b, was not as active, and, in fact, 
suffered a 10-fold loss of activity with the change of the stereocenter in the tetrahydrofuran 
moiety. In addition, exchanging the (S)-tetrahydrofuran for the larger tetrahydropyran moiety, 
compound 10c, also resulted in a 10-fold decrease in activity. This demonstrates that this 














Table 4.2. Class 1B compounds and IC50 
 Structure IC50 (µM) logP logS 
10a 
 
0.32 2.29 -3.85 
10b 
 
3.2 2.29 -3.85 
10c 
 
3.2 2.62 -4.14 
 
 Unfortunately, only one of the compounds in Class 1C showed any activity (Table 4.3). 
12b had a moderate activity of 1.0 µM. It seems that the bulky bromo substituent and morpholine 
moiety are not well-tolerated in that position. This is unusual because the addition of morpholine 
moieties in various position in the aryl sulfonamide series was tolerated. It is possible that the 
increased activity seen in morpholine-substituted aryl sulfonamides comes from an increase in 





















Table 4.3. Class 1C compounds and IC50 
 Structure IC50 (µM) logP logS 
12a 
 
>5 2.29 -3.04 
12b 
 
1.0 3.29 -4.39 
12c 
 
>5 2.41 -2.56 
 
 In addition, only one of the compounds in Class 1D showed any activity (Table 4.4). 15a 
demonstrated low activity of 2.1 µM. Methoxy groups and a fused benzopyran system were not 
tolerated. Unfortunately, the Class 2 compounds have not yet been evaluated for biological 
activity, so cannot be analyzed at this time. In addition, none of the compounds in Class 3 
demonstrated any activity. This decrease in activity can be ascribed to either loss of solubility (as 
demonstrated by increased logP and logS values when compared to the reduced compounds) or 



















Table 4.4. Class 1D compounds and IC50 
 Structure IC50 (µM) logP logS 
15a 
 
2.1 2.55 -3.01 
15b 
 
>5 2.32 -3.41 
15c 
 
>5 2.46 -3.39 
15d 
 




















Table 4.5. Class 2 compounds and IC50 
18a 
 
TBD 3.93 -4.10 
18b 
 
TBD 3.83 -4.30 
18c 
 
TBD 3.83 -4.29 
18d 
 
TBD 2.71 -3.11 
 
Table 4.6. Class 3 compounds and IC50 
 Structure IC50 (µM) logP logS 
19a 
 
>5 4.03 -5.08 
19b 
 
>5 2.75 -4.49 
19c 
 




























 In conclusion, 21 novel bi-aryl methanolic compounds were synthesized. However, only 
2/3 of these compounds have been evaluated to date for biological activity. Of those 16 that have 
been evaluated, 9 showed activity, with the best compound 10a demonstrating an activity of 0.32 
µM, which is a 1.8-fold increase in activity from the original compound 1. In addition, all of the 
compounds have better logP and logS values than those of 1, 4.97 and -6.05, respectively. The 
best compound 10a has the second lowest logP value, 2.29, which is 2.17-fold lower than 1. In 
fact, 10a has the lowest logP value of all compounds except for 12a, which has the same logP.  
4.5 Experimental  
General methods and materials 
All commercial chemicals were reagent grade, obtained from VWR, Aldrich, and Oakwood 
Chemicals and were used without further purification unless otherwise indicated. 1H and 13C 
spectra were obtained on a Bruker 400 NMR spectrometer at 400 and 100 MHz, respectively, in 
deuterated solvent with TMS as internal reference (δ = 0.00 ppm). For all reactions, analytical 
grade solvent was used.  Anhydrous solvents were used for all moisture-sensitive reactions. 
High-resolution mass spectra were obtained by the Mass Spectrometry Facilities at Georgia State 
University on a Waters Micromass Q-Tof (ESI). 
General procedure for coupling between aryl bromide and aryl aldehyde to form alcohols: 1.0 
equivalents of aryl bromide was dissolved in anhydrous THF under argon and cooled in a dry 
ice/acetone bath. After 20 min, 1.4 equivalents of BuLi was added. After 20 min, 1.4 equivalents 
of aryl aldehyde was added. The reaction was stirred in the dry ice/acetone bath for 40 min 
before the reaction temperature was brought to room temperature and then quenched with 
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saturated NH4Cl. The reaction mixture was taken up in ethyl acetate, washed with brine, dried 
over MgSO4, and purified by flash column chromatography. 
General procedure for SN2 displacement of bromide by alcohols: 1.0 equivalents of 1-bromo-4-
(bromomethyl)benzene was dissolved in anhydrous THF and cooled in an ice bath. 1.0 
equivalents of alcohol reagent and 1.5 equivalents of NaH were added and the reaction stirred 
overnight and the ice bath was allowed to warm to room temperature. The reaction was quenched 
with saturated NH4Cl, taken up in ethyl acetate, washed with brined, dried over MgSO4, and 
purified by flash column chromatography. 
 
2,2-Dimethyl-2H-chromene-6-carbaldehyde (5a). Synthesized in 2 steps from 4-
hydroxybenzaldehyde, 23%. 1H NMR (400 MHz, CDCl3): δ 9.83 (s, 1H), 7.65-7.63 (d, J = 8 Hz, 
1H), 7.52 (s, 1H), 6.88-6.86 (d, J = 8 Hz, 1H), 5.70-5.68 (d, J = 8 Hz, 1H), 1.47 (s, 6H) ppm. 
 
8-Methoxy-2,2-dimethyl-2H-chromene-6-carbaldehyde (5b).§ Synthesized in 2 steps from 
vanillin, 26%. 1H NMR (400 MHz, CDCl3): δ 9.78 (s, 1H), 7.30 (s, 1H), 7.15 (s, 1H), 6.36-6.34 
(d, J = 8 Hz, 1H), 5.69-5.67 (d, J = 8 Hz, 1H), 3.90 (s, 3H), 1.51 (s, 6H) ppm. 13C NMR (100 












2,2-Dimethyl-2H-pyrano[3,2-b]pyridine-6-carbaldehyde (5c). Synthesized in 3 steps from 2-
bromo-5-hydroxylpyridine, 23% yield. 1H NMR (400 MHz, CDCl3): δ 9.91 s, 1H), 7.75-7.73 (d, 
J = 8 Hz, 1H), 7.12-7.10 (d, J = 8 Hz, 1H), 6.58-6.56 (d, J = 8 Hz, 1H), 6.00-5.98 (d, J =8 Hz, 
1H), 1.51 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 191.9, 153.7, 145.8, 141.3, 136.3, 123.4, 
123.2, 123.0, 78.67, 28.7 ppm. 
 
 (3,4-Dimethoxyphenyl)(2,2-dimethyl-2H-chromen-6-yl)methanol (6a). Yield: 63%. 1H NMR 
(400 MHz, CDCl3): δ 7.10-7.08 (d, J = 8 Hz, 1H), 6.98 (s, 1H), 6.94 (s, 1H), 6.91-6.89 (d, J = 8 
Hz, 1H), 6.85-6.83 (d, J = 8 Hz, 1H), 6.76-6.74 (d, J = 8 Hz, 1H), 6.31-6.28 (d, J = 9.6 Hz, 1H), 
5.72 (s, IH), 5.63-5.60 (s, J = 9.6 Hz, 1H), 3.88 (s, 3H), 3.87 (s, 3H), 2.20 (s, 1H), 1.43 (s, 6H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 152.4, 149.0 148.4, 136.7, 136.3, 130.9, 127.4, 124.6, 
122.3, 121.1, 118.8, 116.2, 110.9, 109.7, 76.3, 75.5, 55.9, 55.9, 28.0, 28.0 ppm. HRMS (ESI) m/z 
calculated for C20H22O4Na [(M + Na)+] 349.1416, found 349.1419. 
 
(3,4-Dimethoxyphenyl)(8-methoxy-2,2-dimethyl-2H-chromen-6-yl)methanol (6b).§ Yield: 
49%. 1H NMR (400 MHz, CDCl3): δ 6.94-6.82 (m, 4H), 6.61 (s, 1H), 6.298-6.26 (d, J = 8Hz, 
1H), 5.71 (s, 1H), 5.63-5.61 (d, J = 8Hz, 1H), 3.88 (s, 3H), 3.87 (s, 3H), 3.84 (s, 3H), 1.48 (s, 
6H) ppm. 13C NMR (100 MHz, CDCl3): 149.0, 148.4, 148.2, 141.4, 136.5, 136.0, 131.0, 122.4, 
121.7, 118.9, 117.0, 110.9, 110.8, 109.8, 75.7, 60.4, 56.3, 55.9, 55.9, 27.9 ppm. HRMS (ESI) m/z 












(S)-3-((4-Bromobenzyl)oxy)tetrahydrofuran (9a). Yield: 48%. 1H NMR (400 MHz, CDCl3): δ 
7.36-7.34 (d, J = 8 Hz, 2H), 7.11-7.09 (d, J = 8 Hz, 2H), 4.31 (s, 2H), 4.06 (s, 1H), 3.85-3.69 (m, 
4H), 1.90-1.88 (m, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 137.3, 131.4, 129.2, 121.4, 79.3, 
72.8, 70.2, 67.0, 32.6 ppm. 
 
 (R)-3-((4-Bromobenzyl)oxy)tetrahydrofuran (9b). Yield: 85%. 1H NMR (400 MHz, CDCl3): 
δ 7.44-7.42 (d, J = 7.6 Hz, 2H), 7.19-7.17 (d, J = 7.6 Hz, 2H), 4.42 (s, 2H), 4.16 (s, 1H), 3.93-
3.74 (m, 4H), 2.03-1.94 (m, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 137.3, 131.5, 129.2, 
121.4, 79.3, 72.7, 70.2, 67.0, 32.6 ppm. GCMS (EI) m/z 256 (M).+. 
 
4-((4-Bromobenzyl)oxy)tetrahydro-2H-pyran (9c). Yield: 82%. 1H NMR (400 MHz, CDCl3): 
δ 7.45-7.43 (d, J = 7.6 Hz, 2H), 7.22-7.20 (d, J = 7.6 Hz, 2H), 4.48 (s, 2H), 3.95-3.91 (m, 2H), 
3.58-3.53 (m, 1H), 3.44-3.39 (t, J = 10.0 Hz, 2H), 1.92-1.89 (m, 2H), 1.67-1.58 (m, 2H) ppm. 
13C NMR (100 MHz, CDCl3): δ 137.9, 131.4, 129.1, 121.3, 73.6, 68.8, 65.6, 32.4 ppm. GCMS 


















Yield: 94%. 1H NMR (400 MHz, CDCl3): δ 7.26-7.24 (d, J = 7.6 Hz, 2H), 7.19-7.17 (d, J = 7.6 
Hz, 2H), 6.83 (s, 1H), 6.76-6.74 (d, J = 8.5 Hz, 1H), 6.69-6.67 (d, J = 8.4 Hz, 1H), 5.58 (s, 1H), 
4.35 (s, 2H), 4.06 (s, 1H), 3.73-3.60 (m, 10H), 1.91-1.81 (m, 2H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 148.9, 148.2, 143.9, 137.1, 136.9, 127.6 126.5, 118.9, 110.9, 109.8, 78.9, 75.3, 72.6, 




Yield: 58%. 1H NMR (400 MHz, CDCl3): δ 7.32-7.30 (d, J = 8.0 Hz, 2H), 7.26-7.24 (d, J = 7.2 
Hz, 2H), 6.88 (s, 1H), 6.83-6.81 (d, J = 8.0 Hz, 1H), 6.77-6.75 (d, J = 8.0 Hz, 1H), 5.68 (s, 1H), 
4.43 (s, 2H), 4.14 (s, 1H), 3.86-3.73 (m, 10 H), 3.39 (bs, 1H), 1.99-1.94 (m, 2H) ppm. 13C NMR 
(100 MHz, CDCl3): δ 148.9, 148.3, 143.8, 137.7, 136.9, 127.7, 126.5, 118.9, 110.9, 109.8, 78.9, 
75.5, 72.7, 70.8, 67.0, 55.9, 55.8, 32.5 ppm. HRMS (ESI) m/z calculated for C20H23O5 [(M - H)-] 
343.1545, found 343.1553. 
 
(3,4-Dimethoxyphenyl)(4-(((tetrahydro-2H-pyran-4-yl)oxy)methyl)phenyl)methanol (10c). 
Yield: 64%. 1H NMR (400 MHz, CDCl3): δ 7.30-7.28 (d, J = 7.6 Hz, 2H), 7.25-7.24 (d, J = 6.8 












4.46 (s, 2H), 3.85-3.79 (m, 2H), 3.79 (s, 3H), 3.77 (s, 3H), 3.51 (m, 1H), 3.35-3.30 (t, J = 9.6 Hz, 
2H), 1.85-1.82 (m, 2H), 1.57-1.55 (m, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 148.9, 148.3, 
143.7, 137.6, 137.0, 127.5, 126.5, 118.9, 110.9, 109.8, 75.4, 73.2, 69.2, 65.6, 55.9, 55.8, 32.3 
ppm. HRMS (ESI) m/z calculated for C21H25O5 [(M - H)-] 357.1702, found 357.1692. 
 
(3,4-dimethoxyphenyl)(4-morpholinophenyl)methanol (12a). Yield: 55%. 1H NMR (400 
MHz, CDCl3): δ 7.26-6.24 (d, J = 8 Hz, 2H), 6.92 (s, 1H), 6.87-6.80 (m, 4H), 5.70 (s, 1H), 3.85 
(s, 3H), 3.83 (s, 3H), 3.82 (m, 4H), 3.12-3.10 (m, 4H), 2.80 (s, 1H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 150.6, 148.9, 148.2, 136.9, 135.7, 127.5, 118.8, 115.6, 110.8, 109.7, 75.4, 66.8, 66.5, 
55.9, 55.87, 49.3 ppm. HRMS (ESI) m/z calculated for C19H24NO4 [(M + H)+] 330.1705, found 
330.1710. 
 
(4-(Bromomethyl)phenyl)(3,4-dimethoxyphenyl)methanol (12b). Yield: 85%. 1H NMR (400 
MHz, CDCl3): δ 7.45-7.43 (d, J = 7.6 Hz, 2H), 7.31-7.29 (d, J = 7.6 Hz, 2H), 7.13 (s, 1H), 7.05-
7.03 (d, J = 8 Hz, 2H), 6.99-6.97 (d, J = 8 Hz, 2H), 5.92 (s, 1H), 4.01 (s, 3H), 4.00 (s, 3H), 3.04 
(s, 2H), 2.57 (s, 1H) ppm. 13C NMR (100 MHz, CDCl3): δ 149.1, 148.4, 142.3, 140.9, 137.5, 

















(3,4-dimethoxyphenyl)(4-(4-methylpiperazin-1-yl)phenyl)methanol (12c)  Yield: 89%. 1H 
NMR (400 MHz, CDCl3): δ 7.26-7.24 (d, J = 8 Hz, 2H), 6.94 (s, 1H), 6.88-6.80 (m, 4H), 5.72 (s, 
1H), 3.86 (s, 3H), 3.85 (s, 3H), 3.32 (s, 1H), 3.17-3.15 (m, 4H), 2.60-2.57 (m, 4H), 2.34 (s, 3H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 150.5, 148.9, 148.2, 137.0, 135.6, 127.5, 118.7, 116.0, 
110.8, 109.6, 75.4, 55.9, 55.8, 54.9, 48.7, 45.9 ppm. 
 
(3,4-Dimethoxyphenyl)(phenyl)methanol (15a). Yield: 48%. 1H NMR (400 MHz, CDCl3): δ 
7.41-7.271 (m, 5H), 6.941 (s, 1H), 6.91-6.89 (d, J = 8 Hz, 1H), 6.85-6.83 (d, J = 8 Hz, 1H), 5.81 
(s, 1H), 3.88 (s, 3H), 3.86 (s, 3H), 2.35 (s, 1H) ppm. 13C NMR (100 MHz, CDCl3): δ 149.1, 
148.5, 143.9, 136.6, 128.5, 127.5, 126.4, 119.0, 111.0, 109.8, 76.0, 55.2, 55.9 ppm. HRMS (ESI) 
m/z calculated for C15H16O3Na [(M + Na)+] 267.0997, found 267.0993. 
 
(3,4-Dimethoxyphenyl)(3,4-dimethoxyphenyl)methanol (15b). Yield: 48%. 1H NMR (400 
MHz, CDCl3): δ 6.95 (s, 1H), 6.91-6.89 (d, J = 8 Hz, 2H), 6.86-6.84 (d, J = 8 Hz, 2H), 5.78 (s, 
2H), 3.89 (s, 6H), 3.87 (s, 6H), 2.19 (bs, 1H) ppm. 13C NMR (100 MHz, CDCl3): δ 149.0, 148.5, 
136.6, 118.9, 110.9, 109.7, 75.8, 55.93, 55.87 ppm. HRMS (ESI) m/z calculated for C17H19O5 
















(2,5-Dimethoxyphenyl)(3,4-dimethoxyphenyl)methanol (15c). Yield: 46%. 1H NMR (400 
MHz, CDCl3): δ 7.02 (s, 1H), 6.89-6.78 (m, 5H), 5.99 (s, 1H), 3.88 (s, 3H), 3.80 (s, 3H), 3.76 (s, 
3H), 3.08 (s, 1H), ppm. 13C NMR (100 MHz, CDCl3): δ 153.8, 151.0, 148.8, 148.2, 135.7, 133.3, 
118.8, 114.1, 112.7, 111.8, 110.8, 110.0, 72.0, 56.0, 55.9, 55.8, 55.7 ppm. HRMS (ESI) m/z 
calculated for C17H20O5Na [(M + Na)+] 327.1208, found 327.1200. 
 
(2,3-Dihydrobenzofuran-5-yl)(3,4-dimethoxyphenyl)methanol (15d). Yield: 65%. 1H NMR 
(400 MHz, CDCl3): δ 7.16 (s, 1H), 7.10-7.08 (d, J = 8.4 Hz, 1H), 6.92 (s, 1H), 6.88-6.86 (d, J = 
8.4 Hz, 1H), 6.82-6.80 (d, J = 8.4 Hz, 1H), 6.73-6.71 (d, J = 8.0 Hz, 1H), 5.69 (s, 1H), 4.55-4.51 
(t, J = 8.8 Hz, 2H), 3.86 (s, 3H), 3.84 (s, 3H), 3.16-3.12 (t, J = 8.8 Hz, 2H), 2.66 (bs, 1H) ppm. 
13C NMR (100 MHz, CDCl3): δ 159.5, 148.9, 148.2, 137.0, 136.4, 127.3, 126.6, 123.3, 118.6, 
110.8, 109.5, 108.9, 75.7, 71.4, 55.9, 55.8, 29.7 ppm. HRMS (ESI) m/z calculated for 
C17H18O4Na [(M + Na)+] 309.1103, found 309.1107.   
 
(2,2-Dimethyl-2H-chromen-6-yl)(phenyl)methanol (18a). Yield: 66%. 1H NMR (400 MHz, 
CDCl3): δ 7.299-7.28 (m, 5H), 7.11, 7.09 (d, J = 8 Hz, 1H), 7.00 (s, 1H), 6.76-6.74 (d, J = 8 Hz, 
1H), 6.31-6.29 (d, J = 8 Hz, 1H), 5.75 (s, 1H), 5.63-5.61 (d, J = 8 Hz, 1H), 2.40 (s, 1H), 1.45 (s, 
6H) ppm. 13C NMR (100 MHz, CDCl3): 152.4, 143.9, 136.2, 131.0, 128.4, 127.5, 127.4, 126.6, 









(2,2-Dimethyl-2H-chromen-6-yl)(4-methoxyphenyl)methanol (18b). HRMS (ESI) m/z 
calculated for C19H19O3 [(M + H)+] 295.1334, found 295.1327.   
 
(2,2-Dimethyl-2H-chromen-6-yl)(3-methoxyphenyl)methanol (18c). HRMS (ESI) m/z 
calculated for C19H19O3 [(M + H)+] 295.1334, found 295.1334.   
 
 
(2,2-Dimethyl-2H-chromen-6-yl)(pyridin-3-yl)methanol (18d).  
 
(3,4-dimethoxyphenyl)(2,2-dimethyl-2H-chromen-6-yl)methanone (19a) 1H NMR (400 MHz, 
CDCl3): δ 7.62-7.69 (dd, J = 8, 2 Hz, 1H), 7.52-7.51 (d, J = 2 Hz, 1H), 7.47- 7.45 (d, J = 8 Hz, 
1H), 7.40-7.38 (dd, J = 8, 2 Hz, 1H), 7.32-7.30 (d, J = 8 Hz, 1H), 6.93-6.91 (d, J = 8 Hz, 1H), 
6.84-6.82 (d, J = 8 Hz, 1H), 6.39-6.36 (d, J = 8 Hz, 2H), 5.71-5.68 (d, J = 8 Hz, 1H), 3.98 (s, 
3H), 3.96 (s, 3H), 1.50 (s, 6H) ppm. HRMS (ESI) m/z calculated for C20H21O4 [(M + H)+] 
















Yield: 46%. 1H NMR (400 MHz, CDCl3): δ 7.75-7.73 (d, J = 8 Hz, 2H), 7.47-7.43 (m, 3H), 
7.38-7.36 (d, J = 8 Hz, 2H), 6.90-6.88 (d, J = 8 Hz, 2H), 4.59 (m, 2H), 4.26 (s, 1H), 3.95 (s, 3H), 
3.93 (s, 3H), 3.90 (m, 2H), 3.87-3.83 (m, 2H), 2.08-2.05 (m, 2H) ppm. 13C NMR (100 MHz, 
CDCl3): 195.3, 153.0, 149.0, 142.4, 137.5, 130.2, 130.0, 127.1, 125.5, 112.1, 109.7, 79.5, 72.8, 
70.5, 67.1, 56.1, 56.1, 32.6 ppm. HRMS (ESI) m/z calculated for C20H23O5 [(M + H)+] 343.1545, 
found 343.1555.   
 
(4-(bromomethyl)phenyl)(3,4-dimethoxyphenyl)methanone (19c) Yield: 99%. 1H NMR (400 
MHz, CDCl3): δ 7.74-7.72 (d, J = 8 Hz, 2H), 7.50 (s, 1H), 7.40-7.68 (d, J = 8 Hz, 1H), 7.31-7.28 
(m, 2H), 6.93-6.91 (d, J = 8 Hz, 1H), 3.99 (s, 3H), 3.97 (s, 3H), 3.08 (s, 2H) ppm. 13C NMR (100 
MHz, CDCl3): 152.9, 145.7, 130.1, 128.3, 125.4, 116.0, 112.1, 109.7, 56.1, 37.4 ppm. MS (ESI) 
m/z calculated for C16H16O3Br [(M + H)+] 336.19, found 336.00. 
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5 DESIGN AND SYNTHESIS OF NOVEL KCN1 ANALOGS AS ANTI-CANCER 
THERAPEUTICS 
 The work presented in this chapter is based on a manuscript in preparation for submission 
to ChemMedChem. This chapter includes compounds synthesized by Jalisa Holmes,§ Zeus de los 
Santos,δ Bowen Ke,γ Suazette Mooring,⌥ and Krishna Damera.≠ 
5.1 Abstract 
In the field of cancer therapeutics, a change needs to be made from cytotoxic agents to 
direct, targeted therapy. Herein, we describe the design and synthesis of such agents that 
selectively target the HIF pathway.  
5.2 Introduction 
One of the environments in which cancerous cells thrive is hypoxia, a condition in which 
the presence of oxygen is very low or nonexistent. This condition is present in many types of 
cancers, as the cells in solid tumor masses will have low oxygen pressure due to minimized 
vasculature1. Under these hypoxic conditions, the Hypoxia Inducible Factor (HIF) pathway 
activates a number of genes that eventually lead to the upregulation of many other biological 
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pathways including cell growth, glycolysis and angiogenesis2. The basic-loop-helix-loop motif 
heterodimeric transcription factor HIF-1 complex is comprised of two subunits: HIF-1α and HIF-
1β. Normally, in cells where oxygen is present, HIF-1α is oxidized by the enzyme prolyl 
hydroxylase (PHD). The dihydroxylated form of HIF-1 α is then bound by the von Hippel-
Lindau tumor suppressor protein (VHL), which leads to ubiquitination of HIF-1α and its 
subsequent proteosomal degradation.3 In contrast, under hypoxic conditions the dihydroxylated 
form of HIF-1 is not formed. Instead, HIF-1α binds with HIF-1β to form a heterodimer, which 
binds to coactivator p300. At this point, the entire complex acts as a transcription factor of many 
genes, such as VEGF (vascular endothelial growth factor), EPO (eythropoietin), GLUT1 (glucose 
transporter 1), LDH-A (lactate dehydrogenase), and NOS (nitric oxide synthase) by binding to 5’-
HRE (hypoxic response element) promoter regions.4 The expression of this HIF-1 pathway is 
associated with several types of cancer and is also related to low success rates of various 
treatment methods5. 
Toward the goal of finding small-molecule inhibitors of the HIF pathway, our 
collaborators at Emory University, the Erwin van Meir laboratory, developed an HRE-alkaline 
phosphatase assay to screen a library of 10,000 compounds from a 2,2-dimethylbenzopyran 
combinatorial library.6 The HRE-alkaline phosphatase assay uses LN229 glioblastoma cells 
transfected with the alkaline phosphatase reporter and 6 copies of the HRE (hypoxia response 
element) for the VEGF gene.7  This initial screening yielded a few promising hits, with the lead 
compound identified as KCN-1 1 (Figure 5.1a) having an IC50 of 0.59 µM.8 KCN-1 was then 
taken to preliminary in vivo studies, where nude mice were implanted with LN229 glioblastoma 
cells on their hind flanks.  After 1 week, the mice were either injected with KCN-1 (60mg/kg; 5 
days/week) or vehicle (DMSO) only.  The KCN-1 mice had tumors that were 6-fold decreased in 
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size compared to the vehicle only mice and some of the tumors had disappeared completely.  The 
KCN-1 mice did not appear to suffer negative side effects from the KCN-1 treatment.9 It is 
important to note that these compounds do not decrease levels of HIF-1 and are not cytotoxic, in 
contrast to most anti-cancer therapeutics. With KCN-1 as the original lead compound, our 
laboratory began synthesis of a library of analogs. Over 100 compounds were synthesized. This 
initial library of analogs was screened against a human glioblastoma cell line LN229-HRE-Luc, 
with luciferase replacing alkaline phosphatase. From this initial study, N-cyclobutyl-N-((2,2-
dimethyl-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-3,4-dimethoxybenzenesulfonamide 2 (Figure 
5.1b), with IC50 0.28 µM was chosen as the optimized lead for further study.10 With such 
promising results from theses initial studies, we pursued further lead optimization and 
broadening of the library for hope of in more potent compounds and to further develop our SAR 
(structure-activity relationship).  
 
Figure 5.1. Lead compounds. 
a) Lead compound 1, b) Lead compound 2 
 
5.3 Results and Discussion 
5.3.1 Design 
Lead compounds 1 and 2 were divided into 4 parts (Figure 5.1): the left-hand core (A, 





















Table 5.1. Classes of analogs 




Class 1D Class 1E Class 1F 
  
 
Class 2A Class 2B Class 2C 
   
Class 2D Class 3 Class 4 
   
 
Analogs were designed and synthesized based off of modifications of these 4 parts.  In total, 11 
classes of analogs, for a total of 50 compounds, were devised as described in Table 5.1. Class 
1A-1F are KCN analogs: Class 1A has the A ring modified; Class 1B has the B ring modified; 
Class 1C has the C ring modified; Class 1D has a hydrogenated 2,2-dimethylpyranobenzene A 
ring, and modifications to both the B and C rings; Class 1E has both the A and B rings modified; 
and Class 1F has both the A and C rings modified. Class 2A-2D are 64b analogs: Class 2A has A 










































































Class 2D has a hydrogenated 2,2-dimethylpyranopyridine A ring. Class 3 compounds are hybrid 
1/2 analogs with the A ring from 1, the B ring from 2, and modifications to the C ring. Class 4 is 
a new class of aryl sulfonamides with the A and B rings fused together and constrained in a ring.  
5.3.2 Chemistry 
5.3.2.1 Class 1A analogs 
Class 1A analogs were synthesized in two steps (Figure 5.2) from either commercially 
available aldehydes or aldehydes readily synthesized from literature procedures (see supporting 
information S1).11 These aldehydes 15 underwent reductive amination with aniline. The 
subsequent secondary amines 16 were next reacted with 3,4-dimethoxysulfonyl chloride to yield 
the sulfonamide final products 3a-3m.  
 
Figure 5.2. Synthesis of Class 1A analogs 
R1 = 6-(2,2-dimethylchroman-yl) (3a)*, 3-(7-((tetrahydro-2H-pyran-2-yl)oxy)-2H-chromen-yl) 
(3b), 6-(7-bromo-2,2-dimethyl-2H-chromen-yl) (3c), 6-(2,2,8-trimethyl-2H-chromen-yl) (3d), 6-
(trimethyl-2H-chromene-yl) (3e), 6-(2,2-dimethyl-2,7b-dihydro-1aH-oxireno[2,3-c]chromen-yl) 
(3f)*, 4-(benzo[d][1,3]dioxol-yl), 5-(benzo[c][1,2,5]oxadiazol-yl) (3h), 4-
(morpholinomethyl)phenyl (3i), 5-(2,3-dihydrobenzofuranyl) (3j), 2-bromophenyl (3k), 6-(5,7-
difluoro-2,2-dimethyl-2H-chromen-yl) (3l), 6-(5-fluoro-2,2-dimethyl-2H-chromen-yl) with 6-(7-













room temperature, 20 minutes, 23-91%; (b) K2CO3, DCM, room temperature, overnight, 11-
84%.*3a and 3f were synthesized from 1, see Schemes 4 and supporting information 
 
5.3.2.2 Class 1B analogs 
Class 1B analogs were synthesized in two steps (Figure 5.3) from 2,2-dimethyl-2H-
chromene-6-carbaldehyde 17, which was synthesized from literature procedure (see supporting 
information S2).11 17 underwent reductive amination with various amines to form secondary 
amines 18, which were next reacted with 3,4-dimethoxysulfonyl chloride to yield the final 
products sulfonamides 4a.  
 
Figure 5.3. Synthesis of Class 1B analogs 
R2 = oxetan-3-ylmethyl (4a). Reagents and conditions: (a) InCl3, NaBH4, MeOH, room 
temperature, 20 minutes, 92%; (b) K2CO3, DCM, room temperature, overnight, 69% 
 
5.3.2.3 Class 1C analogs 
Class 1C analogs were synthesized in two steps (Figure 5.4) from 2,2-dimethyl-2H-






















((2,2-dimethyl-2H-chromen-6-yl)methyl)aniline 19. 19 was next reacted with various sulfonyl 
chlorides to yield the final products sulfonamides 5a-5d.  
 
Figure 5.4. Synthesis of Class 1C analogs 
R3 = 3-methoxyphenyl (5a), 4-(trifluoromethoxy)phenyl (5b), 4-(carboxymethyl)phenyl (5c), 
3,4-difluorophenyl (5d), 4-methoxyphenyl (5e),. Reagents and conditions: (a) InCl3, NaBH4, 
MeOH, room temperature, 20 minutes, 80%; (b) K2CO3, DCM, room temperature, overnight, 6-
69% 
 
5.3.2.4 Class 1D analogs 
Class 1D analogs were synthesized in three steps (Figure 5.5) from 2,2-dimethyl-2H-
chromene-6-carbaldehyde 17, which underwent reductive amination with various amines to yield 
secondary amines 20. 20 were next reacted with various sulfonyl chlorides to yield sulfonamides 




















Figure 5.5. Synthesis of Class 1D analogs 
R4 = phenyl, R5 = 4-methoxyphenyl (6a), R4 = oxetan-3-ylmethyl, R5 = 3,4-dimethoxyphenyl 
(6b), R4 = cyclobutyl, R5 = 3,4-dimethoxyphenyl (6c). Reagents and conditions: (a) InCl3, 
NaBH4, MeOH, room temperature, 20 minutes, 80%; (b) K2CO3, DCM, room temperature, 
overnight, 69-75%; (c) H2, MeOH, overnight, 70-99% 
 
5.3.2.5 Class 1E analogs 
Class 1E analogs were synthesized in two steps (Figure 5.6) from commercially available 
aldehyde 22.  22 underwent reductive amination with various amines to yield secondary amines 
23, which were next reacted with 3,4-dimethoxyl sulfonyl chloride to yield the final product 
































Figure 5.6. Synthesis of Class 1E analogs 
R6 = R7 = 4-(3’,4’-dimethoxybenzenesulfonyl)phenyl (7a). Reagents and conditions: (a) InCl3, 
NaBH4, MeOH, room temperature, 20 minutes, 86%; (b) K2CO3, DCM, room temperature, 
overnight, 73%. 
 
5.3.2.6 Class 1F analogs 
Class 1F analogs were synthesized in two steps (Figure 5.7) from commercially available 
aldehydes 24.  24 underwent reductive amination with aniline to yield secondary amines 25, 
which were next reacted with various sulfonyl chlorides to yield the final product sulfonamide 
8a.  
 
Figure 5.7. Synthesis of Class 1F analogs 
R8 = 5-(2,3-dihydrobenzofuran-yl), R9 = 2,4-dihydroxyphenyl (8a), R8 = phenyl, R9 = 4-2'-
bromoacetylphenyl (8b). Reagents and conditions: (a) InCl3, NaBH4, MeOH, room temperature, 






























5.3.2.7 Class 2A analogs 
Class 2A analogs were synthesized in two steps (Figure 5.8) from commercially available 
or previously synthesized aldehydes 26.  26 underwent reductive amination with 
cyclobutylamine to yield secondary amines 27, which were next reacted with 3,4-dimethoxy 
sulfonyl chloride to yield the final products sulfonamides 9a-n.  
 
Figure 5.8. Synthesis of Class 2A analogs 
R10 = 4-methoxyphenyl (9a), phenyl (9b), 2-nitrophenyl (9c), 2,4-dimethoxyphenyl (9d), 1H-
pyrrol-2-yl (9e), 4-nitrophenyl (9f), 6-(5,7-difluoro-2,2-dimethyl-2H-chromenyl) (9g), 4-
(morpholinomethyl)phenyl (9h), 5-benzo[d][1,3]dioxol-yl (9i), 5-(2,3-dihydrobenzofuranyl), (9j) 
6-(2,2,8-trimethyl-2H-chromen-yl) (9k), 3-(7-((tetrahydro-2H-pyran-2-yl)oxy)-2H-chromen-yl) 
(9l), 6-(5,7-difluoro-2,2-dimethyl-2H-chromen-yl) (9m), 6-(5-fluoro-2,2-dimethyl-2H-chromen-
yl) with 6-(7-fluoro-2,2-dimethyl-2H-chromen-yl) (9n) . Reagents and conditions: (a) NaBH4, 
MeOH, room temperature, overnight, 26-90%; (b) K2CO3, DCM, room temperature, overnight, 
11-72%. 
 
5.3.2.8 Class 2B analogs 
Class 2B analogs were synthesized in two steps (Figure 5.9) from 2,2-dimethyl-2H-
pyrano[3,2-b]pyridine-6-carbaldehyde 28, which was synthesized from literature procedure (see 













subsequent secondary amines 29 were next reacted with 3,4-dimethoxysulfonyl chloride to yield 
the final products sulfonamide 10a-b.  
 
Figure 5.9. Synthesis of Class 2B analogs 
R11 = 2-(3,4-dimethoxyphenyl)ethyl (10a), 2-morpholinoethyl (10b).Reagents and conditions: 
(a) NaBH4, MeOH, room temperature, overnight, 38%; (b) K2CO3, DCM, room temperature, 
overnight, 29-35%. 
5.3.2.9 Class 2C analogs 
Class 2C analogs were synthesized in two steps (Figure 5.10) from 2,2-dimethyl-2H-
pyrano[3,2-b]pyridine-6-carbaldehyde 28. 28 underwent reductive amination with 
cyclobutylamine to yield N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-
yl)methyl)cyclobutanamine 30, what was next reacted with  various sulfonyl chlorides to yield 




























Figure 5.10. Synthesis of Class 2C analogs 
R12 = 4-methoxyphenyl (11a), 4-(bromomethyl)phenyl (11b), 4-trifluoromethoxyphenyl (11c), 
2-methoxyphenyl (11d). Reagents and conditions: (a) NaBH4, MeOH, room temperature, 
overnight; (b) K2CO3, DCM, room temperature, overnight, 53-78% 
 
5.3.2.10 Class 2D analogs 
Class 2D analogs were synthesized in three steps (Figure 5.11) from 2,2-dimethyl-2H-
pyrano[3,2-b]pyridine-6-carbaldehyde 28.  28 underwent reductive amination with various 
amines to yield secondary amines 31, which were next sulfonylated with various sulfonyl 






















Figure 5.11. Synthesis of Class 2D analogs 
R13 = cyclobutyl, R14 = 3,4-dimethoxylphenyl (12a); R13 = cyclobutyl, R14 = 4-methoxylphenyl 
(12b). Reagents and conditions: (a) NaBH4, MeOH, room temperature, overnight; (b) K2CO3, 
DCM, room temperature, overnight, 73-78%; (c) H2, MeOH, overnight, 89-98% 
 
5.3.2.11 Class 3 analogs 
Class 3 analogs were synthesized in two steps (Figure 5.12) from 2,2-dimethyl-2H-
chromene-6-carbaldehyde 18. 18 underwent reductive amination with cyclobutylamine to yield 
N-((2,2-dimethyl-2H-chromen-6-yl)methyl)cyclobutanamine 33, which was next reacted with  

































Figure 5.12. Synthesis of Class 3A analogs 
R15 = 3,4-dimethoxyphenyl (13a), 4-bromophenyl (13b), 4-trifluoromethylphenyl (13c), 4-(3,5-
dimethylisoxazol-yl) (13d), 3,4-difluorophenyl (13e) 2-methoxyphenyl (13f). Reagents and 
conditions: (a) NaBH4, MeOH, room temperature, overnight, 90%, (b) K2CO3, DCM, room 
temperature, overnight, 56-77% 
 
5.3.2.12 Class 4 analogs 
Class 4 analogs were synthesized in 1 step (Figure 5.13) from commercially available 
secondary amines 34, which were reacted with 3,4-dimethoxysulfonyl chloride to yield the final 
products sulfonamide 14a. 
 
Figure 5.13. Synthesis of Class 4 analogs 
































38 of the analogs were evaluated for their inhibitory effects on HIF-1-mediated 
transcription under hypoxic conditions on human glioma cells LN229-HRE-Lux. Each 
compound was tested against 2 as positive controls and IC50 values were determined as listed in 
tables 2-10. 
5.3.3.1 Class 1A 
Class 1A analogs were designed to probe the importance of the features of the phenyl A 
ring to the activity of 1. The first part of the A ring examined was the double bond in the pyran 
ring. In many cases, double bonds are not preferred in therapeutics because of the possibility of 
activation and/or metabolism by CYP proteins in the liver, which can lead to hepatoxicity in 
vivo. In our case, removal of the double bond, 3a, results in only a small decrease (1.5-fold) in 
activity whereas the epoxidation product, 3f, has dramatically (>13-fold) less activity. These 
observations let us know that our compounds do not likely require epoxidation by the liver for 
activity, and that, in fact, the double bond can be removed from the compound to decrease any 
hepatotoxicity that may arise in the future. Next, the point of attachment of the chromene ring 
was examined by changing it from carbon 6 to carbon 8, 3f, which resulted in a 3-fold decrease 
in activity, confirming attachment at carbon 6 to be important. Next, substituents were 
introduced on the phenyl ring, 3c-3e, which decreased the activity by 5-fold, which suggests a 
somewhat size constrained binding pocket. Finally, various other fused and open ring systems 
were synthesized, 3g-3i, of which, only 3i displayed any activity, which is most likely due to the 
solubility effects of the morpholine moiety. 
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5.3.3.2 Class 1B 
Class 1B analogs were designed to further probe the activity of the B ring and to try to 
















milogP 3.7 it was not very active, with an IC50 value of 4 µM. This suggests that the B ring could 
be pointing into a hydrophobic pocket and adding polar moieties in this position is thus 
unfavorable. 








5.3.3.3 Class 1C 
Class 1C analogs were designed to probe the activity of the moieties on the C ring. We 
probed the activities of this site by removing the 4’-methoxy to give 5a, which resulted in a small 
1.7-fold decrease in activity. We also removed the 3’-methoxy to give 5e, (which was previously 
tested and described in our earlier work)10 which resulted in a very small 1.1-fold decrease in 
activity. We next substituted the 4’-monomethoxy for a 4’-trifluoromethoxy moiety, 5b, which 
resulted in a loss of activity. Thus, the 4’-methoxy moiety seems to be important for the 
biological activity and could possibly play a role in hydrogen bonding. We also made the 4’-











values greater than 5 µM, respectively. Thus, the methoxy substituent in the 4’ position seems to 
be needed for best activity while the 3’-methoxy is not as important. 




















5.3.3.4 Class 1D 
Class 1D analogs were designed to further probe the requirement of the double bond in 













was originally reported in compound 3a. Compounds 3a, 6a, 6b all demonstrated decreased 
activity in comparison to their non-hydrogenated counterparts. However, hybrid 6c, was more 
potent than its non-hydrogenated counterpart 16a (discussed below). 
Table 5.5. Class 1D analogs and IC50 data 
 
















5.3.3.5 Class 1E & 1F 
Class 1E and 1F analogs did not display any activity. It seems that too many changes to 

















Table 5.6. Class 1E analogs and IC50 data 
 







Table 5.7. Class 1F analogs and IC50 data 
 































5.3.3.6 Class 2A 
Class 2A analogs were designed to probe the importance of the features of the phenyl A 
ring to the activity of 2. The first strategy was to remove the fused ring feature altogether and see 
whether a simple phenyl ring with various substituents would have activity. Unfortunately, only 
one such compound, 9a, with a 4-methoxyphenyl A ring had any activity, and this activity was 
diminished by almost 14-fold from 2. 9b-g all had activities greater than 5 µM. This 
demonstrates the importance of the fused ring system to the activity. Next, a phenyl rings with a 
cyclic morpholine moiety in the 4-position was synthesized, 9h, with the design of the 
substituent filling the space occupied by the fused ring. 9h did show moderate activity, 1 µa. 
This compound contains a morpholine ring, which can increase the solubility of the compound. It 
is highly possible that increased solubility is responsible for the activity of this compound. Next, 
other fused ring systems were tried, 9i-j. Both of these compounds showed moderate activity, but 
decreased by 2.5-fold to 6.0-fold with respect to 2.  
5.3.3.7 Class 2B 
Class 2B analogs were designed to further probe the importance of the B ring to the 
activity of 2. Many such compounds had been made in our previous work, but the new 




























































































5.3.3.8 Class 2C 
Class 2C analogs were designed to further probe the importance of the C ring to the 
activity of 2. None of the compounds 11a-c showed improved activity over 2, with the best 
compound 11a having activity of 1.8 µc. It is interesting to note, moreover, that 13a, with the 3’-
methoxy removed lost potency by 6.4-fold, whereas the similar analog to 1 did not lose activity. 
































5.3.3.9 Class 2D 
Class 2D analogs were designed to further probe the requirement of the double bond in 
the A ring. All class 2D analogs contain the hydrogenated chromene in the A ring position. It is 
interesting that 12a, the hydrogenated form of 2, demonstrated slightly better activity at 0.25 µM 
compared to 0.29 µM, which is a 1.1-fold increase in potency, as well as 12b, which 











µM, which is a 1.5-fold increase in activity and makes 11a the most potent compound described 
in this paper. Both of these compounds demonstrate that the double bond in the A ring is not 
required for potency, and may be eliminated with no loss of activity for 2 analogs. 
 
Table 5.11. Class 2D analogs and IC50 data 
 












5.3.3.10 Class 3 
Class 3 analogs are hybrid 1/2 compounds, with the A ring from 1 and the B ring from 2. 
This combination seems to be acceptable, with 13a, 13b, and 13e demonstrating activity, with 
16a being the best at 0.75 µM. However, the hydrogenated counterpart to 16a, 6c, demonstrated 
activity at 0.39 µM, which is almost a 2-fold increase. This makes compound 6c the second best 

















































5.3.3.11 Class 4 
Class 4 analogs are a new class of aryl sulfonamides with the A and B rings constrained 
together into various ring structures. The design was to add more heteroatoms and possible have 
a new backbone that could easily begin a new class of compounds. Unfortunately, this type of 
compound was not active and no further synthesis was pursued. 









In conclusion, 50 analogs were synthesized, bringing the total number of analogs 
synthesized by this lab to over 200. As illustrated in Figure 5.14, a structure-activity relationship 
(SAR) was developed. For the A ring, the 2,2-dimethyl chromene with either a N or C in the 5 
position is important to the activity. Open ring structures are not well tolerated, with the 
exception of some 4-position moderately polar substituents. The double bond is not crucial for 
activity of compounds and can be eliminated with the result of better or only slightly decreased 
activity. For the B ring, only hydrophobic groups, such as aromatics or small aliphatic rings or 










activity. For the C ring, 3’,4’-dimethoxy is still the best, with the 4’-methoxy more crucial to 
activity than the 3’-methoxy. As for the D linker, aryl sulfonamides are still the best and 
combining the A and B rings was not successful.  
The overall best compound was 12a, with activity of 0.25 µM. This is slightly better than 
the previous best compound 2, which had activity of 0.28 µM. After comparison of over 200 
compounds, it appears that small structural modifications are not yielding orders of magnitude 
increased potency. In the future, other avenues will be pursued, such as dramatically changing 
the aryl sulfonamide backbone or adding water-soluble moieties to increase desired 
pharmacokinetic properties. 
 
Figure 5.14. SAR of analogs 
5.5 Experimental 
Typical procedure for reductive amination with cyclobutyl amine: 1 equivalent of aldehyde was 
dissolved in anhydrous MeOH under N2. 1.05 equivalents of cyclobutyl amine were added and 
the reaction stirred overnight at room temperature.  1.6 equivalents of NaBH4 were added and the 
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reaction stirred for 1 hour.  The reaction was quenched with saturated NH4Cl, taken up in ethyl 
acetate, washed with brine, dried over MgSO4, concentrated, and taken directly to the next step 
without further purification. 
 
Typical procedure for reductive amination with aniline: 1 equivalent of aldehyde, 1.5 equivalents 
of NaBH4, and 0.15 equivalents of InCl3 were dissolved in anhydrous ACN under N2.  1.5 
equivalents of aniline were added and the reaction stirred until completion by TLC (typically ~20 
minutes).  The reaction was quenched with saturated NH4Cl, taken up in ethyl acetate, washed 
with brine, dried over MgSO4, and concentrated.  Purified by column chromatography. 
 
Typical procedure for sulfonylation: 1 equivalent of amine was dissolved in DCM.  2 equivalents 
of K2CO3 were added.  2 equivalents of sulfonylchloride were added.  The reaction was stirred 
overnight at room temperature, then washed with brine, dried over MgSO4, and concentrated.  
Purified by column chromatography. 
 
Typical procedure for hydrogenation: 1 equivalent of alkene, 10 mol% Pd/C was dissolved in 
anhydrous MeOH.  The reaction vessel was flushed 3 x H2 and then stirred overnight at room 











Yield: 72%. 1H NMR (400 MHz, CDCl3): δ 7.36-7.34 (d, J = 8 Hz, 1H), 7.23 (m, 3H), 7.02-6.93 
(m, 5H), 6.89-6.87 (d, J = 8 Hz, 1H), 6.62-6.60 (d, J = 8 Hz, 1H), 4.63 (s, 2H), 3.97 (s, 3H), 3.77 
(s, 3H), 2.70-2.67 (t, J = 6 Hz, 2H), 1.77-1.74 (t, J = 6 Hz, 1H), 1.30 (s, 6H) ppm. 13C NMR (100 
MHz, CDCl3): δ 153.5, 152.5, 148.7, 129.8, 129.3, 129.2, 128.8, 127.7, 127.6, 126.9, 122.2, 
121.4, 120.8, 117.0, 110.4, 110.4, 74.22, 56.2, 56.1, 54.3, 32.7, 26.8, 22.3 ppm. HRMS (ESI) 




(3b) Yield: 84%. 1H NMR (400 MHz, CDCl3): δ 7.37-7.34 (dd, J = 8, 2Hz, 1H), 7.26-7.20 (m, 
4H), 7.08-7.06 (d, J = 8 Hz, 1H), 6.98-6.98 (d, J = 2 Hz, 1H), 6.95-6.93 (d, J = 8 Hz, 1H), 6.82-
6.80 (m, 1H), 6.76-6.24 (m, 1H), 6.24-6.22 (d, J = 10 Hz, 1H), 5.54-5.51 (d, J = 10 Hz, 1H), 3.99 
(s. 3H), 3.76 (s, 3H), 1.25 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.4, 150.6, 148.7, 
139.6, 130.5, 130.5, 129.9, 128.9, 128.6, 127.6, 125.7, 123.2, 122.2, 121.4, 120.9, 120.2, 110.4, 
110.4, 76.3, 56.2, 56.1, 47.9, 27.8 ppm. HRMS m/z (ESI) calculated for C22H29N2O4S [(M + H)+] 














phenylbenzenesulfonamide (3c) Yield: 81%. 1H NMR (400 MHz, CDCl3): δ 7.34-7.32 (dd, J = 
8 Hz, 2 Hz, 1H), 7.32-7.24 (m, 3H), 7.14 (s, 1H), 7.01-6.93 (m, 4H), 6.84 (s, 1H), 6.21-6.19 (d, J 
= 8 Hz, 1H), 5.63-5.61 (d, J = 8 Hz, 1H), 4.58 (s, 2H), 3.97 (s, 3H), 3.77 (s, 3H), 1.44 (s, 6H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 152.6, 149.2, 148.8, 139.0, 132.3, 131.7, 130.2, 129.3, 
129.0, 128.9, 128.0, 125.5, 122.5, 121.8, 121.4, 110.4, 110.4, 110.1, 76.7, 56.2, 53.7, 28.0 ppm. 
HRMS m/z (ESI) calculated for C26H27BrNO5S [(M + H)+] 544.0793, found 544.0790. HPLC ret 
time 25.347 min, 97%. 
 
3,4-Dimethoxy-N-phenyl-N-((2,2,8-trimethyl-2H-chromen-6-yl)methyl)benzenesulfonamide 
(3d)  Yield: 18% over 2 steps. 1H NMR (400 MHz, CDCl3): δ 7.36-7.33 (dd, J = 8, 2 Hz, 1H), 
7.23-7.22 (m, 2H), 7.02-6.97 (m, 4H), 6.94-6.92 (d, J = 8 Hz, 1H), 6.81 (s, 1H), 6.68 (s, 1H), 
6.21-6.19 (d, J = 8 Hz, 1H), 5.56-5.54 (d, J = 8 Hz, 1H), 4.59 (s, 2H), 3.97 (s, 3H), 3.77 (s, 3H), 
2.08 (s, 3H), 1.38 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.5, 150.4, 148.7, 139.2, 
130.7, 130.5, 129.2, 128.8, 127.7, 127.3, 125.4, 124.2, 122.5, 121.4, 120.5, 118.5, 110.4, 110.3, 
76.0, 56.2, 56.1, 54.3, 28.0, 15.4 ppm. HRMS m/z (ESI) calculated for C27H29NO5SNa [(M + 










yl)methyl)benzenesulfonamide (2:1) (3e) Yield: 81%. 1H NMR (400 MHz, CDCl3): δ 7.37-
7.34 (dd, J = 8, 2 Hz, 3H), 7.20-7.18 (m, 9H), 6.98-6.91 (m, 12 H), 6.69 (s, 1H), 6.66 (s, 2H), 
6.56-6.54 (d, J = 8 Hz, 2H), 6.49 (s, 1H), 6.40-6.38 (d, J = 8 Hz, 2H), 6.15-6.13 (d, J = 8 Hz, 
1H), 5.65-5.63 (d, J = 8 Hz, 2H), 5.50-5.47 (d, J = 10 Hz, 1H), 4.67 (s, 4H), 4.64 (s, 2H), 3.98 (s, 
9H), 3.78 (s, 9H), 2.35 (s, 6H), 2.24 (s, 3H), 1.36 (s, 18H) ppm. 13C NMR (100 MHz, CDCl3): δ 
152.7,152.5, 148.7, 138.9, 138.7, 138.5, 133.6, 131.4, 130.7, 130.0, 129.8, 129.2, 129.1, 128.7, 
128.6, 127.8, 125.5, 121.9, 121.6, 121.5, 120.2, 119.5, 118.7, 118.0, 113.7, 110.6, 110.6, 110.4, 
75.0, 56.2, 56.1, 52.9, 52.0, 28.0, 27.6, 19.2, 14.1 ppm.  HRMS m/z (ESI) calculated for 
C27H29NO5SNa [(M + Na)+] 502.1664, found 502.1657. HPLC ret time 20.921 min, 100%. 
 
N-((2,2-Dimethyl-2,7b-dihydro-1aH-oxireno[2,3-c]chromen-6-yl)methyl)-3,4-dimethoxy-N-
phenylbenzenesulfonamide (3f) 86.5 mg KCN-1 was dissolved in 2 mL DCM and cooled to 
















M NaOH.  Concentrated.  Purified by column chromatography, 40:1 DCM/methanol, to yield 
119 mg of off-white semi-solid.  
 
N-(Benzo[d][1,3]dioxol-5-ylmethyl)-3,4-dimethoxy-N-phenylbenzenesulfonamide (3g) Yield: 
55%. 1H NMR (CDCl3): δ 7.36-7.34 (dd, J = 8, 2 Hz, 1H), 7.27-7.24 (m, 3H), 7.03-6.93 (m, 4H), 
6.81 (s, 1H), 6.63-6.60 (m, 2H), 5.91 (s, 2H), 4.63 (s, 2H), 3.98 (s, 3H), 3.78 (s, 3H) ppm. 13C 
NMR (100 MHz, CDCl3): δ 152.5, 148.9, 147.1, 139.1, 130.3, 129.8, 129.6, 129.1, 128.8, 127.9, 
122.0, 121.5, 110.4, 109.0, 107.9, 101.0, 56.2, 56.1, 54.5 ppm. HRMS m/z (ESI) calculated for 
C22H21NO6SNa [(M + Na)+] 450.0987, found 450.0991. HPLC ret time 8.047 min, 98%. 
 
N-(Benzo[c][1,2,5]oxadiazol-5-ylmethyl)-3,4-dimethoxy-N-phenylbenzenesulfonamide (3h) 
Yield: 84%. 1H NMR (400 MHz, CDCl3): δ 7.82-7.80 (d, J = 8 Hz, 1H), 7.62-7.60 (d, J = 8 Hz, 
1H), 7.51 (s, 1H), 7.39-7.36 (dd, J = 8, 2 Hz, 1H), 7.26-7.26 (d, J = 2 Hz, 2H), 7.07-7.05 (m, 
2H), 6.99-6.96 (m, 2H), 4.80 (s, 2H), 4.00 (s, 3H), 3.77 (s, 3H) ppm. 13C NMR (400 MHz, 
CDCl3): δ 153.0, 149.0, 148.7, 140.3, 138.6, 132.3, 129.6, 129.2, 128.7, 128.3, 121.5, 116.8, 
114.9, 110.6, 110.5, 56.2, 56.1, 54.5 ppm. HRMS m/z (ESI) calculated for C21H20N3O5S [(M + 















3,4-Dimethoxy-N-(4-(morpholinomethyl)benzyl)-N-phenylbenzenesulfonamide (3i)  Yield: 
11%. 1H NMR (400 MHz, CDCl3): δ 7.37-7.35 (d, J = 8Hz, 1H), 7.35 (s, 1H), 7.22-7.20 (m, 6H), 
7.04-7.02 (m, 2H), 6.97-6.94 (m, 2H), 4.72 (s, 1H), 3.98 (s, 3H), 3.77 (s, 3H), 3.70-3.69 (m, 4H), 
3.44 (s, 2H), 2.40 (m, 4H). 13C NMR (100 MHz, CDCl3): δ 152.6, 148.7, 139.2, 135.0, 130.2, 
129.2, 129.0, 128.8, 128.4, 127.8, 127.5, 121.4, 110.4, 110.4, 66.9, 63.0, 56.2, 56.01, 54.4, 53.5. 
HRMS (ESI) m/z calculated for C26H31N2O5S [(M + H)+] 483.1954, found 483.1956. 
 
N-((2,3-dihydrobenzofuran-5-yl)methyl)-3,4-dimethoxy-N-phenylbenzenesulfonamide (3j) 
Yield: 27%. 1H NMR (400 MHz, CDCl3): δ 7.35-7.28 (dd, J = 8, 2 Hz, 1H), 7.25-7.23 (m, 3H), 
7.15 (s, 1H), 7.02-6.94 (m, 4H), 6.88-6.86 (dd, J = 8, 2 Hz, 1H), 6.61-6.59 (d, J = 8 Hz, 1H), 
4.65 (s, 2H), 4.55-4.53 (t, J = 4 Hz, 2H), 3.98 (s, 3H), 3.78 (s, 3H), 3.17-3.12 (t, J = 8 Hz, 2H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 159.7, 152.5, 148.8 139.2, 130.6, 129.2, 128.8 128.6, 
128.0, 127.8, 127.2, 125.4, 121.4, 110.5, 110.4, 108.8, 71.3, 56.2, 56.1, 54.5, 29.6 ppm. HRMS 

















N-(2-bromobenzyl)-3,4-dimethoxy-N-phenylbenzenesulfonamide (3k) Yield: 55%. 1H NMR 
(400 MHz, CDCl3): δ 7.63-7.61 (d, J = 8 Hz, 1H), 7.44-7.42 (d, J = 8 Hz, 1H), 7.37-7.35 (d, J = 
8 Hz, 1H), 7.28-7.24 (m, 3H), 7.13-7.11 (d, J = 8 Hz, 2H), 7.09-6.98 (m, 2H), 6.97-6.95 (d, J = 8 
Hz, 2H), 4.88 (s, 2H), 3.98 (s, 3H), 3.77 (s, 3H) ppm. 13C NMR (100 MHz, CDCl3): δ152.7, 
148.8, 139.4, 135.4, 132.6, 130.3, 129.7, 129.0, 128.9, 128.8, 127.9, 127.5, 123.1, 121.6, 110.4, 
56.2, 56.1, 54.1 ppm. 
 
N-((2,2-Dimethyl-2H-chromen-6-yl)methyl)-3,4-dimethoxy-N-(oxetan-3-
ylmethyl)benzenesulfonamide (4a) Yield: 69%. 1H NMR (400 MHz, CDCl3): δ 7.70-7.68 (d, J 
= 8 Hz, 1H), 7.51 (s, 1H), 7.41 (s, 1H), 7.22-7.17 (m, 1H), 7.08 (s, 1H), 6.96-6.94 (d, J = 8 Hz, 
1H), 6.51-6.48 (d, J = 8 Hz, 1H), 5.88-5.86 (d, J = 8 Hz, 1H), 4.72-4.67 (m, 2H), 4.44-4.35 (m, 
2H), 4.38 (s, 2H), 4.20 (s, 3H), 4.17 (s, 3H), 3.63-3.61 (d, J = 8 Hz, 2H), 3.32-3.22 (quintet, J = 
7.2 Hz, 1H), 1.66 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 153.0, 152.9, 149.5, 131.7, 
131.2, 128.9, 128.6, 126.2, 122.1, 121.8, 121.8, 121.3, 116.7, 111.0, 110.0, 76.7, 75.3, 75.3, 56.5, 
56.5, 53.0, 51.8, 34.8, 28.2 ppm. HRMS m/z (ESI) calculated for C24H30NO6S [(M + H)+] 














Yield: 13%. 1H NMR (400 MHz, CDCl3): δ 7.43-7.39 (m, 2H), 7.35-7.24 (m, 3H), 7.23-7.23 (m, 
2H), 7.14-7.11 (m, 2H), 7.00-6.98 (m, 2H), 6.91-6.88 (d, J = 8 Hz, 2H), 6.62-6.60 (d, J = 8 Hz, 
1H), 6.25-6.23 (d, J = 8 Hz, 1H), 5.59-5.57 (d, J = 8 Hz, 1H), 4.64 (s, 2H), 3.77 (s, 3H), 1.42 (s, 
6H) ppm. 13C NMR (100 MHz, CDCl3): δ 159.7, 139.9, 138.9, 132.3, 130.9, 129.9, 129.4, 129.1, 
128.8, 128.0, 127.9, 126.7, 122.1, 121.1, 119.8, 119.4, 116.1, 112.1, 76.3, 55.6, 54.5, 28.0 ppm. 
HRMS m/z (ESI) calculated for C25H25NO4SNa [(M + Na)+] 458.1402, found 458.1409.  
 
N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-N-phenyl-4-
(trifluoromethoxy)benzenesulfonamide (5b) Yield: 19%. 1H NMR (400 MHz, CDCl3): δ 8.14-
8.12 (d, J = 8 Hz, 1H), 7.72-7.70 (d, J = 8 Hz, 2H), 7.47-7.45 (d, J = 8 Hz, 1H), 7.33-7.24 (m, 
5H), 6.98-6.97 (d, J = 4 Hz, 2H), 6.90-6.87 (m, 2H), 6.62-6.61(d, J = 8 Hz, 1H), 6.24-6.22 (d, J 
= 8 Hz, 1H), 5.60-5.58 (d, J = 8 Hz, 1H), 4.62 (s, 2H), 1.40 (s, 6H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 152.0, 151.0, 138.6, 137.3, 131.0, 129.8, 129.5, 129.4, 129.1, 129.0, 128.1, 127.7, 
126.7, 122.0, 121.2, 121.1, 120.6, 116.1, 76.32, 54.6, 28.0 ppm. HRMS m/z (ESI) calculated for 
C25H22NO4SF3Na [(M + Na)+] 512.1119, found 512.1106.  
 
2-(4-(N-((2,2-Dimethyl-2H-chromen-6-yl)methyl)-N-phenylsulfamoyl)phenyl)acetic acid 









6.36-6.33 (d, J = 10 Hz, 1H), 5.74-5.72 (d, J = 10 Hz, 1H), 4.78 (s, 2H), 3.28 (s, 2H), 1.34 (s, 
6H) ppm. 13C NMR (100 MHz, CDCl3): δ 194.6, 181.2, 171.2, 148.6, 147.8, 141.6, 141.6, 140.5, 
137.3, 135.5, 129.6, 129.1, 128.5, 126.5, 123.5, 123.5, 123.4, 77.4, 54.2, 40.6, 29.6 ppm. MS m/z 
found for C26H25NO5S [(M+H)+] 465.2. 
 
N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-3,4-difluoro-N-phenylbenzenesulfonamide (5d) 
1H NMR (400 MHz, CDCl3): δ 7.29-7.26 (m, 4H), 6.98-6.96 (dd, J = 8, 2 Hz, 1H), 6.90-6.87 (d, 
J = 8 Hz, 2H), 6.63-6.61 (d, J = 8 Hz, 1H), 6.25-6.23 (d, J = 10 Hz, 1H), 5.61-5.58 (d, J = 10 Hz, 
1H), 4.65 (s, 2H), 1.41 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.6, 138.4, 131.0, 129.4, 
129.1, 129.1, 128.3, 127.5, 126.7, 122.0, 121.2, 118.0, 117.8, 116.2, 76.4, 54.7, 28.0 ppm. 
HRMS m/z (ESI) calculated for C24H21NO3SF2Na [(M + Na)+] 464.1108, found 464.1097. 
 
N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-4-methoxy-N-phenylbenzenesulfonamide (5e) 
Yield: 75%. 1H NMR (400 MHz, CDCl3): δ 7.76-7.74 (d, J = 8 Hz, 2H), 7.59-7.57 (d, J = 8 Hz, 
2H), 7.20 (m, 3H), 6.98-6.87 (m, 3H), 6.60-6.58 (d, J = 8 Hz, 1H), 6.24-6.21 (d, J = 10 Hz, 1H), 
5.58-5.56 (d, J = 10 Hz, 1H), 14.61 (s, 2H), 3.87 (s, 3H), 3.86 (s, 3H), 3.23 (s, 3H), 1.38 (s, 6H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 162.9, 152.4, 139.1, 130.5, 129.8, 129.1, 128.8, 128.1, 











N-((2,2-dimethylchroman-6-yl)methyl)-4-methoxy-N-phenylbenzenesulfonamide (6a) Yield: 
88%. 1H NMR (400 MHz, CDCl3): δ 7.60-7.58 (d, J = 8 Hz, 2H), 7.26-7.26 (m, 3H), 7.01-6.94 
(m, 4H), 6.87-6.85 (d, J = 8 Hz, 1H), 6.61-6.59 (d, J = 8 Hz, 1H), 4.63 (s, 2H), 3.90 (s, 3H), 
2.71-2.67 (t, J = 8 Hz, 2H), 1.77-1.74 (t, J = 8 Hz), 1.30 (s, 6H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 162.8, 162.6, 153.5, 139.3, 130.6, 129.8, 129.1, 129.1, 128.8, 127.7, 127.6, 126.9, 
120.7, 116.9, 114.1, 113.9, 74.2, 55.6, 55.6, 54.4, 41.9, 32.7, 26.8 ppm. HRMS m/z (ESI) 





ylmethyl)benzenesulfonamide (6b) Yield: 70%. 1H NMR (400 MHz, CDCl3): δ 7.57-7.45 (d, J 
= 8 Hz, 1H), 7.17-7.15 (d, J = 8 Hz, 1H), 6.99-6.97 (d, J = 8 Hz, 1H), 6.93-6.92 (m, 2H), 6.74-
6.72 (d, J = 8 Hz, 1H), 4.50-4.42 (m, 1H), 4.21-4.14 (m, 3H), 3.98 (s, 3H), 3.94 (s, 3H), 3.41-
3.98 (d, J = 8 Hz, 1H), 3.09-3.05 (m, 1H), 2.75-2.72 (t, J = 8 Hz, 1H), 1.83-1.79 (m, 2H), 1,34 (s, 












119.4, 117.4, 110.7, 109.8, 75.2, 74.4, 56.2, 52.8, 51.4, 34.6, 32.6, 26.8, 22.4 ppm. HRMS m/z 
(ESI) calculated for C24H32NO6S [(M + H)+] 462.1950, found 462.1959.  
 
N-Cyclobutyl-N-((2,2-dimethylchroman-6-yl)methyl)-3,4-dimethoxybenzenesulfonamide 
(6c) Yield: 99%. 1H NMR (400 MHz, CDCl3): δ 7.43-7.41 (d, J = 8 Hz, 1H), 7.23 (s, 1H), 7.06 
(s, 1H), 7.05-7.02 (d, J = 8 Hz, 1H), 6.94-6.92 (d, J = 8 Hz, 1H), 6.73-6.71 (d, J = 8 Hz, 1H), 
4.31 (s, 2H), 4.27-4.19 (quintet, J = 7.2 Hz, 1H), 3.96 (s, 3H), 3.90 (s, 3H), 2.70-2.74 (t, J = 8 
Hz, 2H), 2.06-1.96 (m, 4H), 1.82-1.78 (t, J = 8 Hz, 2H), 1.55-1.50 (m, 2H), 1.34 (s, 6H) ppm. 
13C NMR (100 MHz, CDCl3): δ 153.2, 148.9, 132.3, 129.3, 128.4, 126.3, 120.9, 117.0, 110.5, 
109.8, 74.2, 56.2, 56.1, 52.9, 48.1, 32.8, 29.3, 26.9, 22.5, 15.1 ppm. HRMS m/z (ESI) calculated 
for C24H31NO5SNa [(M + Na)+] 468.1821, found 468.1810. 
 
4-(N-Benzyl-3,4-dimethoxyphenylsulfonamido)phenyl 3,4-dimethoxybenzenesulfonate (7a) 
Yield: 73%. 1H NMR (400 MHz, CDCl3): δ 7.28 (s, 2H), 7.24-7.17 (m, 6H), 6.97-6.93 (m, 4H), 
6.87-6.85 (m, 3H), 4.68 (s, 2H), 3.98 (s, 3H), 3.97 (s, 3H), 3.81 (s, 3H), 3.80 (s, 3H) ppm.13C 
NMR (CDCl3): δ 153.9, 152.8, 149.1, 148.9, 148.7, 137.9, 135.5, 130.1, 129.7, 128.5, 128.4, 
127.7, 126.3, 122.8, 121.5, 110.5, 110.4, 110.4, 110.3, 56.3, 56.2, 56.2, 54.6 ppm. HRMS m/z 

















Yield: 58%. 1H NMR (400 MHz, CDCl3): δ 7.67-7.65 (d, J = 8 Hz, 1H), 7.21-7.14 (m, 4H), 
7.04-7.02 (d, J = 8 Hz, 2H), 6.88-6.86 (d, J = 8 Hz, 1H), 6.62-6.60 (d, J = 8 Hz, 1H), 6.43 (s, 
1H), 6.43-6.41 (dd, J = 8, 2 Hz, 1H), 4.88 (s, 2H), 4.56-4.52 (t, J = 8 Hz, 2H), 3.93 (s, 3H), 3.86 
(s, 3H), 3.18-3.14 (t, J = 8 Hz, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 164.7, 159.5, 158.2, 
139.3, 133.6, 129.4, 128.9, 128.7, 128.4, 127.3, 127.2, 125.3, 120.1, 108.6, 99.3, 71.3, 56.0, 55.7, 
55.7, 29.6 ppm. HRMS m/z (ESI) calculated for C23H23NO5SNa [(M + Na)+] 448.1195, found 
448.1180.  
 
4-(N-benzyl-N-phenylsulfamoyl)phenyl 2-bromoacetate (8b) Yield: 14%. 1H NMR (400 
MHz, CDCl3): δ 7.41-7.07 (m, 14H), 4.92 (s, 2H), 3.70 (s, 2H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 141.1, 136.5, 129.8, 128.9, 128.8, 128.5, 128.2, 127.7, 53.8, 27.2 ppm. MS m/z (ESI) 
calculated for C21H18NO4SBr [(M + H)+] 459.0, found 460.0. 
 
N-Cyclobutyl-3,4-dimethoxy-N-(4-methoxybenzyl)benzenesulfonamide (9a)  Yield: 47% 
over 2 steps. 1H NMR (400 MHz, CDCl3): δ 7.43-7.42 (d, J = 4Hz, 1H), 7.41-7.40 (d, J = 4 Hz, 

















4.18 (quintet, J = 7.2 Hz, 1H), 3.95 (s, 3H), 3.90 (s, 3H), 3.81 (s, 3H), 2.00-1.95 (m, 4H), 1.56-
1.49 (m, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 158.8, 152.3, 149.0, 132.1, 130.6, 128.5, 
120.9, 113.8, 110.5, 109.7, 56.2, 56.2, 55.3, 48.0, 29.3, 15.1 ppm. HRMS m/z (ESI) calculated 
for C20H25NO5SNa [(M + Na)+] 414.1351, found 414.1355. HPLC ret time 9.539 min, 96%. 
 
N-Benzyl-N-cyclobutyl-3,4-dimethoxybenzenesulfonamide (9b) Yield: 17% over 2 steps. 1H 
NMR (400 MHz, CDCl3): δ 7.45-6.96 (m, 7H), 6.96-6.94 (d, J = 8 Hz, 1H), 4.42 (s, 2H), 4.28-
4.26 (quintet, J = 7.2 Hz, 1H), 3.97 (s, 3H), 3.91 (s, 3H), 2.00-1.96 (m, 4H), 1.54-1.53 (m, 2H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 152.4, 149.0, 138.7, 132.1, 128.5, 127.2, 127.1, 120.9, 
110.6, 109.7, 56.2, 56.2, 52.9, 48.4, 29.3, 15.1 ppm. HRMS m/z (ESI) calculated for C19H24NO4S 
[(M + H)+] 362.1426, found 362.1426. HPLC ret time 8.673 min, 100%. 
 
N-Cyclobutyl-3,4-dimethoxy-N-(2-nitrobenzyl)benzenesulfonamide (9c) Yield: 42% over 2 
steps. 1H NMR (400 MHz, CDCl3): δ 8.12-8.10 (d, J = 8 Hz, 1H), 7.97-7.95 (d, J = 8 Hz, 1H), 
7.73-7.69 (t, J = 8 Hz, 1H), 7.48-7.45 (dd, J = 8, 2 Hz, 2H) 7.30-7.30 (d, J = 2 Hz, 1H), 6.99-
6.97 (d, J = 8 Hz, 1H), 4.79 (s, 2H), 4.52-4.44 (quintet, J = 7.2 Hz, 1H), 3.98 (s, 3H), 3.96 (s, 
3H), 1.99-1.98 (m, 2H), 1.89-1.84 (m, 2H), 1.56 ppm (m, 2H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 152.8, 149.2, 147.2, 135.5, 134.0, 131.1, 129.6, 128.0, 124.9, 121.0, 110.8, 109.6, 
56.3, 56.2, 52.6, 45.4, 28.9, 14.9ppm. HRMS m/z (ESI) calculated for C19H23N2O6S [(M + H)+] 












N-Cyclobutyl-N-(2,4-dimethoxybenzyl)-3,4-dimethoxybenzenesulfonamide (9d) Yield: 11% 
over 2 steps. 1H NMR (400 MHz, CDCl3): δ 7.45-7.7.42 (dd, J = 8, 2 Hz, 2H), 7.42-7.40 (d, J = 
8 Hz, 1H), 7.29-7.27 (d, J = 8 Hz, 1H), 6.95-6.93 (d, J = 8 Hz, 1H), 6.52-6.49 (dd, J = 8, 2 Hz, 
1H), 6.42-6.42 (d, J = 2 Hz, 1H), 4.40-4.36 (quintet, J = 7.2 Hz, 1H), 4.34 (s, 2H), 3.96 (s, 3H), 
3.93 (s, 3H), 3.82 (s, 3H), 3.81 (s, 3H), 2.02-1.95 (m, 4H), 1.56-1.50 (m, 2H) ppm. 13C NMR 
(100 MHz, CDCl3): δ 159.9, 157.0, 152.2, 148.9, 132.3, 129.1, 120.9, 119.2, 110.5, 109.8, 104.1, 
98.0, 56.2, 56.1, 55.4, 55.2, 52.7, 42.2, 29.0, 14.9 ppm. HRMS m/z (ESI) calculated for 
C21H27NO6SNa [(M + Na)+] 444.1457, found 444.1451. HPLC, ret time 11.057 min, 97%. 
 
N-((1H-Pyrrol-2-yl)methyl)-N-cyclobutyl-3,4-dimethoxybenzenesulfonamide (9e) Yield: 
55%. 1H NMR (400 MHz, CDCl3): δ 9.11 (s, 1H), 7.41-7.39 (dd, J = 8, 2 Hz, 1H), 7.20-7.19 (d, 
J = 2 Hz, 1H), 6.94-6.92 (d, J = 8 Hz, 1H), 6.79-6.79 (d, J = 2 Hz, 1H), 6.12-6.10 (dd, J = 8, 2 
Hz, 1H), 6.05 (s, 1H), 4.28 (s, 2H), 4.25-4.19 (quintet, J = 7.2 Hz, 1H), 3.95 (s, 3H), 3.90 (s, 
3H), 2.13-2.02 (m, 4H), 1.65-1.54 (m, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.5, 149.1, 
131.7, 128.0, 120.9, 118.5, 110.6, 109.5, 107.8, 107.1, 56.2, 56.2, 52.6, 41.2, 28.9, 15.0 ppm. 
HRMS m/z (ESI) calculated for C17H22N2O4SNa [(M + Na)+] 373.1198, found 373.1184. HPLC 













N-cyclobutyl-3,4-dimethoxy-N-(4-nitrobenzyl)benzenesulfonamide (9f) Yield: 72%. 1H NMR 
(400 MHz, CDCl3): δ 9.11 (s, 1H), 7.41-7.39 (dd, J = 8, 2 Hz, 1H), 7.20-7.19 (d, J = 2 Hz, 1H), 
6.94-6.92 (d, J = 8 Hz, 1 H), 6.79-6.79 (d, J = 1.2 Hz, 1H), 6.12-6.10 (s, 1H), 6.05 (s, 1H), 4.28 
(s, 2H), 4.25-4.19 (quintet, J = 7.2, 1H), 3.95 (s, 3H), 3.90 (s, 3H), 2.13-2.02 (m, 4H), 1.65-1.54 
(m, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.5, 149.1, 131.7, 128.0, 120.9, 118.5, 110.6, 
109.5, 107.8, 107.1, 56.2, 56.2, 52.6, 41.2, 28.9, 15.0 ppm. HRMS m/z (ESI) calculated for 





N-cyclobutyl-3,4-dimethoxy-N-(4-(morpholinomethyl)benzyl)benzenesulfonamide (9h)  
Yield: 46%. 1H NMR (400 MHz, CDCl3): δ 7.44-7.42 (dd, J = 8.4, 2 Hz, 1H), 7.34-7.25 (m, 5H), 
6.95-6.93 (d, J = 8 Hz, 1H), 4.39 (s, 2H), 4.32-4.23 (quintet, J = 8 Hz, 1H), 3.96 (s, 3H), 3.92 (s, 
3H), 3.74-3.72 (t, J = 4 Hz, 4H), 3.51 (s, 2H), 2.46 (s, 4H), 1.99-1.94 (m, 4H), 1.57-1.52 (m, 


















109.8, 66.9, 63.0, 56.2, 56.2, 53.5, 52.9, 48.1, 29.2, 15.0. HRMS (ESI) m/z calculated for 
C24H33N2O5S [(M + H)+] 461.2110, found 461.2102. 
 
N-(Benzo[d][1,3]dioxol-5-ylmethyl)-N-cyclobutyl-3,4-dimethoxybenzenesulfonamide (9i) 
Yield: 75%. 1H NMR (400 MHz, CDCl3): δ 7.43-7.40 (dd, J = 8, 2 Hz, 1H), 7.24-7.23 (d, J = 2 
Hz, 1H), 6.92-6.91 (d, J = 2 Hz, 1H), 6.81-6.74 (m, 2H), 5.96 (s, 2H), 4.30 (s, 2H), 4.26-4.21 
(quintet, J = 7.2 Hz, 1H), 3.95 (s, 3H), 3.91 (s, 3H), 2.05-1.96 (m, 4H), 1.57-1.50 (m, 2H) ppm. 
13C NMR (100 MHz, CDCl3): δ 152.4, 149.0, 147.9, 146.8, 132.5, 132.1, 120.9, 120.3, 110.6, 
109.8, 108.1, 101.0, 56.2, 56.2, 52.9, 48.3, 29.3, 15.1 ppm. HRMS m/z (ESI) calculated for 
C20H24NO6S [(M + H)+] 406.1324, found 406.1315. HPLC ret time 8.912 min, 97%. 
 
N-Cyclobutyl-N-((2,3-dihydrobenzofuran-5-yl)methyl)-3,4-dimethoxybenzenesulfonamide 
(9j) Yield: 53%. 1H NMR (400 MHz, CDCl3): δ 7.42-7.40 (dd, J = 8, 2 Hz, 1H), 7.26 (s, 1H), 
7.23-7.22 (d, J = 2 Hz, 1H), 7.05-7.03 (d, J = 8 Hz, 1H), 6.94-6.92 (d, J = 8 Hz, 1H), 6.72-6.670 
(d, J = 8 Hz, 1H), 4.58-4.54 (t, J = 8 Hz, 2H), 4.31 (s, 2H), 4.22-4.18 (quintet, J = 7.2 Hz, 1H), 
3.95 (s, 3H), 3.90 (s, 3H), 3.21-3.17 (t, J = 7.2 Hz, 2H), 2.04-1.94 (m, 4H), 1.56-1.51 (m, 2H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 159.4, 152.3, 149.0, 132.2, 130.5, 127.4, 127.0, 124.2, 
120.9, 110.5, 109.7, 108.8, 71.3, 56.2, 56.2, 52.9, 48.3, 41.9, 29.7, 29.3, 15.1 ppm. HRMS m/z 















yl)methyl)benzenesulfonamide (9k) Yield: 45%. 1H NMR (400 MHz, CDCl3): δ 7.43-7.40 (dd, 
J = 8, 2 Hz, 1H), 7.23-7.23 (d, J = 2 Hz, 1H), 6.94-7.92 (d, J = 8 Hz, 2H), 6.81 (s, 1H), 6.30-6.28 
(d, J = 8 Hz, 1H), 5.62-5.60 (d, J = 8 Hz, 1H), 4.27 (s, 2H), 4.27-4.25 (m, 1H), 3.90 (s, 3H), 3.87 
(s, 3H), 2.16 (s, 3H), 2.04-1.95 (m, 4H), 1.60-1.54 (m, 2H), 1.43 (s, 6H) ppm. MS m/z (ESI) 
calculated for C25H31NO5Na [(M + Na)+] 480.2, found 480.2.  
 
N-cyclobutyl-N-((2,2-dimethyl-2H-chromen-8-yl)methyl)-3,4-
dimethoxybenzenesulfonamide (9l) 1H NMR (400 MHz, CDCl3): δ 7.47-7.45 (dd, J =8, 2 Hz, 
2H), 7.35-7.33 (d, J =8 Hz, 1H), 6.96-6.94 (d, J =8 Hz, 1H), 6.89-8.85 (m, 2H), 6.34-6.32 (d, J 
=8 Hz, 1H), 5.62-5.60 (d, J =8 Hz, 1H), 4.38 (s, 2H), 4.36 (m, 1H), 4.00 (s, 3H), 3.93 (s, 3H), 
2.03-1.96 (m, 4H), 1.55-1.44 (m, 2H), 1.39 (s, 6H) ppm. HRMS m/z (ESI) calculated for 






















dimethoxybenzenesulfonamide (10a) Yield: 29%. 1H NMR (400 MHz, CDCl3): δ 7.45-7.42 
(dd, J = 8, 2 Hz, 1H), 7.27-7.26 (d, J = 2 Hz, 1H), 7.21-7.18 (d, J =8 Hz, 1H), 7.02-7.00 (d, J =8 
Hz, 1H), 6.93-9.91 (d, J =8 Hz, 1H), 6.74-6.72 (d, J =8 Hz, 1H), 6.60-6.57 (m, 3H), 6.43-6.41 
(d, J =10 Hz, 1H), 5.90-5.87 (d, J =10 Hz, 1H)4.41 (s, 2H), 3.95 (s, 3H), 3.90 (s, 3H), 3.85 (s, 
3H), 3.83 (s, 3H), 3.41-3.37 (m, 2H), 2.69-2.65 (t, J = 8 Hz, 2H), 1.66 (s, 6H) ppm. 13C NMR 
(100 MHz, CDCl3): δ152.5, 149.1, 149.0, 148.8, 148.2, 147.6, 140.3, 135.5, 131.5, 131.0, 123.8, 
123.6, 123.1, 121.1, 120.7, 112.0, 111.2, 110.6, 109.8, 77.3, 60.4, 56.2, 56.2, 55.9, 55.8, 53.5, 
50.4, 34.8, 28.2, 21.1, 14.2 ppm. HRMS m/z (ESI) calculated for C29H35N2O7S [(M + H)+] 
555.2165, found 555.2151. 
 
N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-3,4-dimethoxy-N-(2-
morpholinoethyl)benzenesulfonamide (10b) Yield: 35%. 1H NMR (400 MHz, CDCl3): δ 7.48-
7.46 (d, J = 8 Hz, 1H), 7.28 (s, 1H), 7.25 (s, 1H), 7.05-7.03 (d, J = 8 Hz, 1H), 6.95-6.93 (d, J = 8 
Hz, 1H), 6.39-6.36 (d, J = 10 Hz, 1H), 5.89-5.86 (d, J = 10 Hz, 1H), 4.42 (s, 2H), 3.96 (s, 3H), 
3.94 (s, 3H), 3.61-3.60 (m, 4H), 3.34-3.31 (t, J = 6 Hz, 2H), 2.40-2.37 (t, J = 6 Hz, 2H), 2.31 (m, 

















methoxybenzenesulfonamide (11a) Yield: 78%. 1H NMR (400 MHz, CDCl3): δ 7.71-7.69 (d, J 
= 8 Hz, 2H), 7.31-7.29 (d, J = 8 Hz, 2H), 7.01-6.99 (d, J = 8 Hz, 2H), 6.92-6.90 (d, J = 8 Hz, 
2H), 6.40-6.37 (d, J = 10 Hz, 2H), 5.84-5.82 (d, J = 10 Hz, 2H), 4.35 (s, 2H), 4.30-4.26 (quintet, 
J = 7.2 Hz, 1H), 3.81 (s, 1H), 1.90-1.85 (m, 4H), 1.47-1.45 (m, 2H), 1.41 (s, 6H) ppm. 13C NMR 
(100 MHz, CDCl3): δ 163.8, 150.3, 148.5, 140.1, 135.4, 131.5, 129.1, 129.0, 123.7, 123.6, 121.8, 
114.2, 76.8, 55.6, 52.7, 49.3, 41.9, 28.8, 29.2, 27.9, 15.0 ppm. HRMS m/z (ESI) calculated for 
C22H27N2O4S [(M + H)+] 415.1692, found 415.1682. HPLC ret time 15.143 min, 95%. 
 
4-(Bromomethyl)-N-cyclobutyl-N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-
yl)methyl)benzenesulfonamide (11b) Yield: 53%. 1H NMR (400 MHz, CDCl3): δ 7.81-7.79 (d, 
J = 8 Hz, 2H), 7.55-7.53 (d, J = 8 Hz, 2H), 7.46-7.44 (d, J = 8 Hz, 1H), 7.23 (s, 1H), 6.69-6.67 
(d, J = 8 Hz, 1H), 6.00-5.98 (d, J = 8 Hz, 1H), 4.56 (s, 2H), 4.51 (s, 2H), 4.36-4.32 (quintet, J = 
7.2 Hz, 1H), 1.94 (m, 4H), 1.51 (m, 2H), 1.51 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 
149.1, 148.7, 142.7, 139.3, 129.8, 129.2, 129.0 127.7, 127.6, 126.5, 122.73, 78.0, 52.8, 47.9, 
32.7, 29.0, 28.3, 14.9 ppm. HRMS m/z (ESI) calculated for C22H26N2O3SBr [(M + H)+] 
477.0848, found 477.0852. 
 
N-Cyclobutyl-N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-4-












8 Hz, 2H), 7.36-7.32 (m, 3H), 7.14-7.12 (d, J = 8 Hz, 1H), 6.54.-6.51 (d, J  =10 Hz, 1H), 6.96-
6.93 (d, J = 10 Hz, 1H), 4.50 (2, 2H), 4.34-4.33 (quintet, J = 7.2 Hz, 1H), 1.98-1.94 (m, 4H), 
1.57-1.50 (m, 2H), 1.49 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.1, 148.9, 139.5, 138.2, 
136.5, 129.3, 127.9, 124.9, 122.3, 120.9, 120.5, 76.7, 52.7, 48.6, 29.0, 28.2, 14.9 ppm. HRMS 
m/z (ESI) calculated for C22H24N2O4SF3 [(M + H)+] 467.1409, found 469.1409. 
 
N-Cyclobutyl-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-3-methoxybenzenesulfonamide 
(11d) 1H NMR (400 MHz, CDCl3): δ 7.44-7.27 (m, 5H), 7.10-7.07 (m, 2H), 6.48-6.45 (d, J = 10 
Hz, 1H), 5.91-5.89 (d, J = 10 Hz, 1H), 4.45 (s, 2H), 4.40-4.36 (quintet, J = 7.2 Hz, 1H), 3.88 (s, 
3H), 1.97-1.92 (m, 4H), 1.56-1.54 (m, 2H), 1.49 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 
159.9, 150.0, 148.6, 141.1, 135.6, 130.1, 121.9, 119.3, 119.1, 1198.9, 111.9, 111.2, 55.9, 55.6, 
52.8, 49.3, 29.7, 28.9, 28.2, 15.0 ppm. HRMS m/z (ESI) calculated for C22H27N2O4S [(M + H)+] 
415.1692, found 415.1688. 
 
N-Cyclobutyl-N-((2,2-dimethyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-3,4-
dimethoxybenzenesulfonamide (12a) Yield: 98%. 1H NMR (400 MHz, CDCl3): δ 7.45-7.43 
(dd, J = 8, 2 Hz, 1H), 7.38-7.26 (dd, J = 8, 2 Hz, 1H), 7.26 (s, 1H), 7.10-7.08 (d, J = 8 Hz, 1H), 
6.94-6.92 (d, J = 8 Hz, 1H), 4.44 (s, 1H), 4.40-4.43 (quintet, J = 7.2 Hz, 1H), 3.96 (s, 3H), 3.93 
(s, 3H), 2.91-2.87 (t, J = 10 Hz, 2H), 1.96-1.91 (m, 6H), 1.57-1.50 (m, 2H), 1.33 (s, 6H) ppm. 












110.5, 109.6, 74.8, 56.2, 52.7, 49.4, 32.8, 28.9, 26.7, 25.6, 15.0 ppm. HRMS m/z (ESI) calculated 
for C23H31N2O5S [(M + H)+] 447.1954, found 447.1958. 
 
N-Cyclobutyl-N-((2,2-dimethyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-4-
methoxybenzenesulfonamide (12b) Yield: 89%. 1H NMR (400 MHz, CDCl3): δ 7.76-7.73 (d, J 
= 8 Hz, 2H), 7.37-7.35 (d, J = 8 Hz, 1H), 7.09-7.07 (d, J = 8 Hz, 1H), 6.96-6.94 (d, J = 8 Hz, 
2H), 4.41 (s, 2H), 4.35-4.29 (quintet, J = 7.2 Hz, 1H), 3.87 (s, 3H), 2.90-2.87 (t, J = 6 Hz, 2H), 
1.96-1.89 (m, 6H), 1.52-1.48 (m, 2H), 1.36 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 162.8, 
149.6, 149.2, 141.2, 131.7, 129.2, 125.2, 120.7, 114.1, 74.8, 55.6, 52.7, 49.4, 32.8, 28.9, 26.7, 
25.6, 15.0 ppm. HRMS m/z (ESI) calculated for C22H29N2O4S [(M + H)+] 417.1848, found 
417.1848. HPLC ret time 15.036 min, 95%. 
 
N-Cyclobutyl-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-3,4-
dimethoxybenzenesulfonamide (13a) Yield: 56%. 1H NMR (400 MHz, CDCl3): δ 7.43-7.42 (d, 
J = 2 Hz, 1H), 7.41-7.40 (d, J = 2 Hz, 1H), 7.24-7.23 (d, J = 2 Hz, 1H), 7.07-7.05 (d, J = 8 Hz, 
1H), 6.99 (s, 1H), 6.94-6.92 (d, J = 8 Hz, 1H), 6.73-6.31 (d, J = 8 Hz, 1H), 6.32-6.30 (d, J = 8 
Hz, 1H), 5.63-5.61 (d, J = 8 Hz, 1H), 4.30 (s, 2H), 4.27-4.20 (m, 1H), 3.95 (s, 3H), 3.91 (s, 3H), 
2.05-1.95 (m, 4H), 1.62-1.49 (m, 2H), 1.47 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.3, 












56.2, 56.2, 52.9, 48.0, 29.3, 28.0, 15.1 ppm. HRMS m/z (ESI) calculated for C24H29NO5SNa [(M 
+ Na)+] 466.1664, found 466.1678. 
 
4-Bromo-N-cyclobutyl-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)benzenesulfonamide 
(13b) Yield: 55%. 1H NMR (400 MHz, CDCl3): δ 7.64 (m, 4H), 7.05-7.03 (dd, J = 8, 2 Hz, 1H), 
6.96-6.96 (d, J = 2 Hz, 1H), 6.74-6.72 (d, J = 8 Hz, 1H), 6.32-6.30 (d, J = 8 Hz, 1H), 5.95-5.63 
(d, J = 8 Hz, 1H), 4.31 (s, 2H), 4.30-4.28 (m ,1H), 2.02-1.96 (m, 4H), 1.55-1.53 (m, 2H), 1.45 (s, 
6H) ppm. 13C NMR (100 MHz, CDCl3): δ 132.2, 131.1, 130.0, 125.6, 127.9, 125.3, 122.2, 121.3, 
116.2, 76.3, 52.9, 48.2, 29.7, 29.3, 28.0, 15.0 ppm. HRMS m/z (ESI) calculated for 
C22H24BrNO3SNa [(M + Na)+] 484.0558, found 484.0561. HPLC ret time 26.138 min, 96%. 
 
N-Cyclobutyl-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-4-
(trifluoromethoxy)benzenesulfonamide (13c) 1H NMR (400 MHz, CDCl3): δ 7.83-7.81 (d, J = 
8 Hz, 2H), 7.33-7.31 (d, J = 8 Hz, 2H), 7.04-7.02 (d, J = 8 Hz, 1H), 6.96 (s, 1H), 6.73-6.72 (d, J 
= 8 Hz, 1H), 6.31-6.29 (d, J = 8 Hz, 1H), 5.64-5.62 (d, J = 8 Hz, 1H), 4.33 (s, 2H), 4.26-4.18 
(quintet, J = 7.2 Hz, 1H), 2.03-1.99 (m, 4H), 1.58 (m, 2H), 1.44 (s, 6H) ppm. 13C NMR (100 
MHz, CDCl3): δ 152.3, 151.9, 139.0, 131.1, 129.9, 129.1, 127.9, 125.3, 122.2, 121.3, 120.8, 
116.2, 76.3, 52.9, 48.2, 29.3, 28.0, 15.0 ppm. HRMS m/z (ESI) calculated for C23H24NO4SF3Na 











sulfonamide (13d) 1H NMR (400 MHz, CDCl3): δ 7.03-7.01 (d, J = 8 Hz, 1H), 6.91 (s, 1H), 
6.73-6.71 (d, J = 8 Hz, 1H), 6.31-6.28 (d, J = 8 Hz, 1H), 5.64-5.62 (d, J = 8 Hz, 1H), 4.41 (s, 
2H), 4.28-4.20 (quintet, J = 7.2 Hz, 1H), 2.58 (s, 3H), 2.39 (s, 3H), 2.09-2.01 (m, 4H), 1.62-1.52 
(m, 2H), 1.43 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 172.8, 157.3, 152.4, 131.2, 129.5, 
127.8, 125.2, 122.1, 121.4, 117.5, 116.3, 76.3, 52.2, 47.8, 29.3, 27.9, 15.0, 12.8, 11.1 ppm. 
HRMS m/z (ESI) calculated for C21H26N2O4SNa [(M + Na)+] 425.1511, found 425.1529. 
 
N-Cyclobutyl-N-((2,2-dimethyl-2H-chromen-6-yl)methyl)-3,4-difluorobenzenesulfonamide 
(13e) 1H NMR (400 MHz, CDCl3): δ 7.61-7.54 (m, 2H), 7.29-7.28 (m, 2H), 7.04-7.02 (d, J = 8 
Hz, 1H), 6.96 (s, 1H), 6.73-6.71 (d, J = 8 Hz, 1H), 6.32-6.29 (d, J = 10 Hz, 1H), 5.65-5.63 (d, J = 
10 Hz, 1H), 4.32 (s, 2H), 4.23-4.19 (quintet, J = 7.2 Hz, 1H), 2.06-1.99 (m, 4H), 1.58-1.52 (m, 
2H), 1.44 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.4, 148.9, 137.4, 131.1, 129.7, 128.0, 
125.3, 124.0, 122.1, 121.3, 118.1, 117.9, 117.0, 116.8, 116.3, 76.33, 52.8, 48.2, 29.3, 28.0, 15.0 

















(13f) Yield: 77%. 1H NMR (400 MHz, CDCl3): δ 7.46-7.43 (d, J = 8 Hz, 1H), 7.24 (s, 1H), 7.07-
7.05 (d, J = 8 Hz, 1H), 7.00 (s, 1H), 6.94-6.92 (d, J = 8 Hz, 1H), 6.73-6.71 (d, J = 8 Hz, 1H), 
6.32-6.30 (d, J = 8 Hz, 1H), 5.63-5.61 (d, J = 8 Hz, 1H), 4.30 (s, 2H), 4.24-4.20 (quintet, J = 7.2 
Hz, 1H), 3.95 (s, 3H), 3.91 (s, 3H), 2.00-1.97 (m, 4H), 1.59 (m, 2H), 1.43 (s, 6H) ppm. HRMS 
m/z (ESI) calculated for C23H27NO4SNa [(M + Na)+] 436.1559, found 436.1573. 
 
1-Benzyl-4-((3,4-dimethoxyphenyl)sulfonyl)piperazine (14a) 1H NMR (400 MHz, CDCl3): δ 
7.39-7.37 (d, J = 8 Hz, 1H), 7.32-7.25 (m, 5H), 7.21 (s, 1H), 6.98-6.96 (d, J = 8 Hz, 1H), 3.97 (s, 
3H), 3.93 (s, 3H), 3.50 (s, 2H), 3.05 (s, 4H), 2.55 (s, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 
152.7, 149.1, 137.5, 129.1, 128.3, 127.3, 127.3, 121.8, 110.6, 110.4, 62.6, 56.3, 56.2, 52.1, 46.1. 
53.3 ppm. HRMS m/z (ESI) calculated for C19H25N2O4S [(M + H)+] 377.1535, found 377.1531. 
 
N-((2,2-Dimethyl-2H-chromen-8-yl)methyl)aniline (16b) Yield: 91%. 1H NMR (400 MHz, 
CDCl3): δ 7.26-7.21 (m, 3H), 6.98-6.96 (d, J = 8 Hz, 1H), 6.88-6.86 (t, J = 4 Hz, 1H), 6.79-6.72 
(m, 3H), 6.40-6.38 (d, J = 8 Hz, 1H), 5.69-5.67 (d, J = 8 Hz, 1H), 4.40 (s, 2H), 4.06 (s, 1H), 1.52 
(s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 150.8, 148.5, 130.6, 129.2, 128.8, 126.5, 125.5, 










N-((7-Bromo-2,2-dimethyl-2H-chromen-6-yl)methyl)aniline (16c) Yield: 48%. 1H NMR (400 
MHz, CDCl3): δ 7.37 (s, 1H), 7.19-7.18 (m, 1H), 6.94 (s, 1H), 6.76-6.73 (t, J = 8 Hz, 1H), 6.65-
6.63 (d, J = 8 Hz, 1H), 6.29-6.26 (d, J = 8 Hz, 1H), 5.68-5.65 (d, J = 8 Hz, 1H), 4.20 (s, 2H), 
3.98 (s, 1H), 1.49 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 148.9, 148.0, 132.8, 131.8, 
131.3, 129.3, 124.5, 122.7, 122.0, 117.7, 112.9, 110.5, 76.7, 47.4, 28.0 ppm. 
 
N-((2,2,8-Trimethyl-2H-chromen-6-yl)methyl)aniline (16d) 1H NMR (400 MHz, CDCl3): δ 
7.25-7.21 (m, 2H), 7.04 (s, 1H), 6.89-6.88 (d, J = 2 Hz, 1H), 6.79-6.77 (d, J = 8 Hz, 1H), 6.70-
6.68 (dd, J = 8, 2 Hz, 1H), 6.35-6.33 (d, J = 8 Hz, 1H), 5.67-5.64 (d, J = 8 Hz, 1H), 4.20 (s, 2H), 
2.23 (s, 3H), 1.48 (s, 6H) ppm.  13C NMR (100 MHz, CDCl3): δ 150.2, 148.4, 130.8, 10.7, 129.9, 
129.3, 125.7, 123.3, 122.6, 120.8, 117.5, 112.9, 76.08, 48.1, 28.1, 15.6 ppm. 
 
N-((2,2,5-Trimethyl-2H-chromen-6-yl)methyl)aniline with N-((2,2,7-Trimethyl-2H-
chromen-6-yl)methyl)aniline (2:1) (16e) Yield: 23%. 1H NMR (400 MHz, CDCl3): δ 7.24-7.20 











6.28 (d, J = 8 Hz, 1H), 5.72-5.70 (d, J = 8 Hz, 2H), 5.58-5.56 (d, J = 8 Hz, 1H), 4.19 (s, 4H), 
4.17 (s, 2H), 3.71 (s, 3H), 2.32 (s, 9H), 1.45 (s, 12H), 1.44 (s, 6H) ppm. 
 
N-(Benzo[d][1,3]dioxol-5-ylmethyl)aniline (16g)1H NMR (400 MHz, CDCl3): δ 7.27-7.23 (m, 
2H), 6.93-6.78 (m, 4H), 6.70-6.68 (d, J = 8 Hz, 2H), 5.99 (s, 2H), 4.29, (s, 2H), 4.05 (s, 1H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 148.1, 148.0, 146.8, 133.5, 129.3, 120.9, 120.7, 117.7, 
112.9, 108.4, 108.1, 48.2 ppm. HRMS m/z (ESI) calculated for C14H14NO2 [(M + H)+] 228.1025, 
found 228.1023. 
 
N-(Benzo[c][1,2,5]oxadiazol-5-ylmethyl)aniline (16h) Yield: 32%. 1H NMR (400 MHz, 
CDCl3): δ 7.84-7.80 (m, 2H), 7.44-7.42 (d, J = 8 Hz, 1H), 7.23-7.21 (t, J = 4 Hz, 2H), 6.80-6.77 
(m, 1H), 6.66-6.64 (d, J = 8 Hz, 2H), 4.48 (s, 2H), 4.28-4.24 (quintet, J = 7.2 Hz, 1H) ppm.  
 
N-(4-(Morpholinomethyl)benzyl)aniline (16i) Yield: 60%. 1H NMR (400 MHz, CDCl3): δ 
7.23-7.17 (m, 4H), 6.79-6.66 (m, 5H), 4.34 (s, 2H), 3.74 (m, 4H), 3.53 (s, 2H), 2.74 (m, 4H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 148.2, 138.4, 136.8, 129.5, 129.3, 127.5, 118.6, 117.6, 
115.1, 112.9, 67.0, 63.2, 53.6, 48.1 ppm. HRMS m/z (ESI) calculated for C16H22NO2 [(M + H)+] 










N-((2,3-Dihydrobenzofuran-5-yl)methyl)aniline (16j) Yield: 87%. 1H NMR (400 MHz, 
CDCl3): δ 7.27-7.13 (m, 4H), 6.83-6.69 (m, 4H), 4.63-4.59 (m, 2H), 4.28 (s, 2H), 4.00 (s, 1H), 
3.25-3.21 (t, J = 8 Hz, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 159.5, 148.3, 131.5, 129.3, 
127.5, 127.5, 124.5, 117.5, 112.9, 109.2, 71.4, 65.4, 48.2, 29.8, 29.7 ppm. HRMS m/z (ESI) 
calculated for C15H16NO [(M + H)+] 226.1232, found 226.1230. 
 
N-((5,7-Difluoro-2,2-dimethyl-2H-chromen-6-yl)methyl)aniline (16l) 1H NMR (400 MHz, 
CDCl3): δ 7.23-7.17 (m, 2H), 7.03-6.99 (m, 1H), 6.77-6.63 (m, 5H), 6.38-6.36 (d, J = 8 Hz, 1H), 
5.64-5.62 (d, J = 8Hz, 1H), 4.34 (s, 3H), 1.47 (s, 6H) ppm. 
 
N-((5-Fluoro-2,2-dimethyl-2H-chromen-6-yl)methyl)aniline with N-((7-fluoro-2,2-dimethyl-
2H-chromen-6-yl)methyl)aniline (1:1) (16m) 1H NMR (400 MHz, CDCl3): δ 7.22-7.18 (m, 
4H), 7.12-7.08 (m, 1H), 6.99-6.97 (d, J = 8 Hz, 1H), 6.74-6.52 (m, 9H), 6.27-6.25 (d, J =8 Hz, 
1H), 5.70-5.67 (d, J =10 Hz, 1H), 5.57-5.55 (d, J =10 Hz, 1H), 4.30 (s, 2H), 4.29 (s, 2H), 3.94 (s, 
2H), 1.44 (s, 12H) ppm. 13C NMR (100 MHz, CDCl3): δ 148.5, 148.0, 148.0, 131.0, 129.7, 
129.7, 129.3, 129.2, 128.9, 126.9, 126.9, 121.5, 117.7, 117.7, 117.1, 115.1, 115.1, 113.0, 112.7, 















1-(2,2-Dimethyl-2H-chromen-6-yl)-N-(oxetan-3-ylmethyl)methanamine (18a) Yield: 92%. 
1H NMR (400MHz, CDCl3): δ 7.04-7.02 (d, J = 8 Hz, 1H), 6.93 (s, 1H), 6.74-6.72 (d, J = 8 Hz, 
1H), 6.32-6.30 (d, J = 8 Hz, 1H), 5.62-5.60 (d, J = 8 Hz, 1H), 4.81-4.78 (m, 2H), 4.42-4.39 (m, 
2H), 3.68 (s, 2H), 3.13-3.09 (quintet, J = 7.2 Hz, 1H), 2.96 (s, 2H), 1.68-1.45 (m, 1H), 1.45 (s, 
6H) ppm. 13C NMR (100 MHz, CDCl3): δ 152.0, 132.2, 131.0, 128.8, 128.6, 126.1, 122.2, 121.5, 
121.2, 116.2, 76.2, 76.0, 53.5, 52.4, 35.3, 29.6, 28.0 ppm. HRMS m/z (ESI) calculated for 
C16H22NO2 [(M + H)+] 260.1651, found 260.1657. 
 
N-((2,2-Dimethyl-2H-chromen-6-yl)methyl)aniline (19) 1H NMR (400 MHz, CDCl3): δ 7.26-
7.21 (m, 3H), 6.98-6.96 (d, J = 8 Hz, 1H), 6.88-6.86 (m, 1H), 6.79-6.72 (m, 3H), 6.40-6.38 (d, J 
= 8 Hz, 1H), 5.69-5.67 (d, J = 8 Hz, 1H), 4.37 (s, 2H), 4.06 (bs, 1H). 13C NMR (100 MHz, 
CDCl3): δ 150.8, 148.5, 130.6, 129.2, 128.9, 126.5, 125.5, 122.5, 121.1, 120.5, 117.4, 113.2, 
76.44, 43.11, 28.18. HRMS (ESI) m/z calculated for C18H20NO [(M + H)+] 266.1545, found 
266.1548. 
 
4-(Benzylamino)phenol (23a) 1H NMR (400 MHz, CDCl3): δ 7.39-7.32 (m, 5H), 6.71-6.69 (d, J 









CDCl3): δ 148.1, 142.1, 139.5, 128.7, 127.7, 127.3, 127.2, 116.4, 114.8, 49.6 ppm. HRMS m/z 
(ESI) calculated for C13H14NO [(M + H)+] 200.1075, found 200.1079. 
 
N-((2,3-Dihydrobenzofuran-5-yl)methyl)aniline (25a) 1H NMR (400 MHz, CDCl3): δ 7.27-
7.23 (m, 3H), 7.17-7.13 (m, 1H), 6.83-6.77 (m, 2H), 6.71-6.69 (d, J = 8 Hz, 2H), 4.63-4.59 (m, 
2H), 4.28 (s, 2H), 4.00 (s, 1H), 3.25-3.21 (t, J = 8 Hz, 2H) ppm. 13C NMR (100 MHz, CDCl3): δ 
159.5, 148.3, 131.5, 129.3, 127.5, 127.5, 124.5, 117.5, 112.9, 109.2, 71.4, 65.4, 48.2, 29.7 ppm. 
HRMS m/z (ESI) calculated for C15H16NO [(M + H)+] 226.1232, found 226.1230. 
 
N-Benzylaniline (25b) Yield: 97% 1H NMR (400 MHz, CDCl3): δ 7.61-7.53 (m, 5H), 7.44-7.42 
(d, J = 8 Hz, 2H), 7.02-6.982(m, 1H), 6.87-6.85 (d, J = 8 Hz, 2H), 4.52 (s, 2H), 4.14 (s, 1H) 
ppm. 13C NMR (100 MHz, CDCl3): δ 148.5, 139.8, 129.6, 128.9, 127.8, 127.5, 117.8, 113.2, 48.5 
ppm. 
 
N-(4-Methoxybenzyl)cyclobutanamine (27a) Not isolated. Crude product taken directly to next 
step. 
 









N-(2-Nitrobenzyl)cyclobutanamine (27c) Not isolated. Crude product taken directly to next 
step. MS m/z (ESI) calculated for C11H15N2O2 [(M + H)+] 207.1, found 207.1. 
 
N-(2,4-Dimethoxybenzyl)cyclobutanamine (27d) Not isolated. Crude product taken directly to 
next step. 
 
N-((1H-Pyrrol-2-yl)methyl)cyclobutanamine (27e) Yield: 85%. 1H NMR (400 MHz, CDCl3): 
δ 9.41 (s, 1H), 6.88-6.88 (d, J = 2 Hz, 1H), 6.26 (s, 1H), 6.15-6.15 (d, J = 2 Hz, 1H), 4.11 (s, 
2H), 3.58-3.50 (m, 1H), 2.36-2.21 (m, 4H), 2.00-1.97 (m, 1H), 1.86-1.79 (m, 1H) ppm. 13C NMR 
(100 MHz, CDCl3): δ 121.1, 118.9, 112.3, 108.8, 50.6, 42.2, 26.6, 15.4 ppm. MS m/z (ESI) 
calculated for C9H15N2 [(M + H)+] 151.1, found 151.1. 
 
N-(4-Nitrobenzyl)cyclobutanamine (27f) Yield: 26%. 1H NMR (400 MHz, CDCl3): δ 8.20-
8.18 (d, J = 8 Hz, 2H), 7.54-7.52 (d, J = 8 Hz, 2H), 3.85 (s, 2H), 3.33-3.28 (quintet, J = 7.2 Hz, 
1H), 2.36 (s, 1H), 2.27-2.21 (m, 2H), 1.81-1.65 (m, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 












N-((5,7-Difluoro-2,2-dimethyl-2H-chromen-6-yl)methyl)cyclobutanamine (27g) Not isolated. 
Crude product taken directly to next step. 
 
N-(4-(Morpholinomethyl)benzyl)cyclobutanamine (27h) 1H NMR (400 MHz, CDCl3): δ 7.32-
7.26 (m, 4H), 3.69-3.68 (m, 4H), 3.47 (s, 2H), 3.31-3.28 (m, 1H), 2.43 (m, 4H), 2.22-2.21 (m, 
2H), 1.63-1.62 (m, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 139.4, 136.3, 129.4, 128.1, 67.0, 
63.2, 53.6, 50.8, 31.1, 14.8 ppm. HRMS m/z (ESI) calculated for C16H25NO2 [(M + H)+] 
261.1967, found 261.1961. 
 
N-(Benzo[d][1,3]dioxol-5-ylmethyl)cyclobutanamine (27i) 1H NMR (400 MHz, CDCl3): δ 
6.83 (s, 1H), 6.75 (s, 2H), 5.93 (s, 2H), 3.61 (s, 2H), 3.30-3.26 (quintet, J = 7.2 Hz, 1H), 2.23-
2.18 (m, 2H), 1.83 (s, 1H), 1.72-1.62 (m, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 147.6, 146.5, 
134.3, 121.3, 108.8, 108.0, 100.9, 53.4, 50.8, 44.7, 31.3, 31.0, 15.0, 14.8 ppm. HRMS m/z (ESI) 
calculated for C12H16NO2 [(M + H)+] 206.1181, found 206.1181. 
 
N-((2,3-Dihydrobenzofuran-5-yl)methyl)cyclobutanamine (27j) 1H NMR (400 MHz, CDCl3): 













2H), 3.59 (s, 2H), 3.29-3.25 (m, 1H), 3.16-3.12 (t, J = 8 Hz, 2H), 2.21-2.20 (m, 2H), 1.68-1.61 
(m, 4H) ppm. 13C NMR (100 MHz, CDCl3): δ 159.1, 132.4, 127.9, 127.1, 125.0, 108.8, 71.2, 
53.4, 50.7, 31.1, 29.7, 14.8 ppm. HRMS m/z (ESI) calculated for C13H18NO [(M + H)+] 
204.1388, found 204.1392. 
 
N-((2,2,8-trimethyl-2H-chromen-6-yl)methyl)cyclobutanamine (27k) Not isolated. Taken on 
to next step crude.  
 
N-((2,2-Dimethyl-2H-chromen-8-yl)methyl)cyclobutanamine (27l) Yield: 90%. 1H NMR (400 
MHz, CDCl3): δ 7.09-7.07 (d, J = 8 Hz, 1H), 6.91-6.89 (d, J = 8 Hz, 1H), 6.82-6.78 (t, J = 8 Hz, 
1H), 6.34-6.32 (d, J = 8 Hz, 1H), 5.63-5.61 (d, J = 8 Hz, 1H), 3.68 (s, 2H), 3.32-3.28 (quintet, J 
= 7.2 Hz, 1H), 2.19-2.18 (m, 4H), 1.73-1.67 (m, 2H), 1.43 (s, 6H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 150.8, 130.3, 129.7, 125.3, 122.5, 120.9, 120.3, 76.2, 53.7, 46.2, 31.1, 28.1, 15.0 ppm. 













N-((5,7-difluoro-2,2-dimethyl-2H-chromen-6-yl)methyl)cyclobutanamine (27m) 1H NMR 
(400 MHz, CDCl3): δ 6.51-6.48 (d, J = 10 Hz, 1H), 6.36-6.35 (d, J = 8 Hz, 1H), 5.62-5.60 (d, J = 
8 Hz, 1H), 3.73 (d, 2H), 3.30-3.29 (m, 1H), 2.18 (m, 2H), 1.71-1.70 (m, 4H), 1.46 (s, 6H) ppm. 
 
N-((5-Fluoro-2,2-dimethyl-2H-chromen-6-yl)methyl)cyclobutanamine with N-((7-Fluoro-
2,2-dimethyl-2H-chromen-6-yl)methyl)cyclobutanamine (1:1) (27n) 1H NMR (400 MHz, 
CDCl3): δ 7.23-7.21 (d, J = 8 Hz, 1H), 7.12-7.08 (t, J = 8 Hz, 1H), 7.00-6.98 (d, J = 8 Hz, 1H), 
6.53-6.50 (m, 1H), 6.31-6.29 (d, J = 8 Hz, 1H), 5.68-5.66 (d, J = 8 Hz, 1H), 5.59-5.56 (d, J = 10 
Hz, 1H), 4.42 (s, 4H), 1.45-1.44 (m, 8H), 1.27-1.25 (m, 4H), 1.28 (s, 12H) ppm. 
 
2-(3,4-Dimethoxyphenyl)-N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-
yl)methyl)ethanamine (29a) Yield: 38%. 1H NMR (400 MHz, CDCl3): δ 7.02-6.97 (m, 2H), 
6.81-6.75 (m, 3H), 6.45-6.43 (d, J = 10 Hz, 1H), 5.88-5.86 (d, J = 10 Hz, 1H), 3.86 (s, 6H), 3.84 
(s, 2H), 2.95-2.92 (t, J = 6.8 Hz, 2H), 2.85-2.81 (t, J = 6.8 Hz, 2H), 1.46 (s, 6H) ppm. 13C NMR 
(100 MHz, CDCl3): δ 150.2, 148.9, 136.0, 135.3, 132.2, 123.8, 123.4, 122.4, 120.7, 120.7, 112.1, 
111.4, 111.4, 76.7, 55.9, 55.8, 54.1, 50.7, 35.6, 28.2 ppm. HRMS m/z (ESI) calculated for 













N-((2,2-Dimethyl-2H-pyrano[3,2-b]pyridin-6-yl)methyl)cyclobutanamine (31) 1H NMR (400 
MHz, CDCl3): δ 6.97-6.95 (d, J = 8 Hz, 1H), 6.92-6.90 (d, J = 8 Hz, 1H), 6.45-6.43 (d, J = 8 Hz, 
1H), 5.80-5.78 (d, J = 8 Hz, 1H), 3.64 (s, 2H), 3.27-3.23 (quintet, J = 7.2 Hz, 1H), 2.41 (s, 1H), 
2.15-2.11 (m, 2H), 1.69-1.52 (m, 4H), 1.38 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 151.4, 
148.3, 140.6, 135.1, 123.9, 123.3, 122.3, 76.8, 53.9, 51.9, 31.1, 30.9, 28.1, 27.8, 14.8 ppm. 
HRMS m/z (ESI) calculated for C15H21N2O [(M + H)+] 245.1654, found 245.1651. 
 
N-Cyclobutyl-N-((2,2-dimethyl-2H-pyrano[3,2-b]pyridin-6-yl)methyl)-3,4-
dimethoxybenzenesulfonamide (2), (32a) Yield = 78%. 1H NMR (400 MHz, CDCl3): δ 7.44-
7.42 (d, J = 8 Hz, 1H), 7.36-7.34 (d, J = 8 Hz, 1H), 7.26 (s, 1H), 7.07-7.05 (d, J = 8 Hz, 1H), 
6.94-6.92 (d, J = 8 Hz, 1H), 6.45-6.43 (d, J = 10 Hz, 1H), 5.90-5.87 (d, J = 10 Hz, 1H), 4.42 (s, 
2H), 7.37-7.35 (m, 1H), 3.95 (s, 3H), 3.92 (s, 3H), 1.99-1.92 (m, 4H), 1.56-1.52 (m, 2H), 1.48 (s, 
6H) ppm. 
 
N-((2,2-Dimethyl-2H-chromen-6-yl)methyl)cyclobutanamine (32) 1H NMR (400 MHz, 
CDCl3): δ 7.04-7.02 (d, J = 8 Hz, 1H), 6.95 (s, 1H), 6.73-6.71 (d, J = 8 Hz, 1H), 6.32-6.30 (d, J = 
8 Hz, 1H), 5.61-5.59 (d, J = 8 Hz, 1H), 3.60 (s, 2H), 3.32-3.26 (quintet, J = 7.2 Hz, 1H), 2.22 (m, 












128.9, 126.2, 122.3, 121.2, 116.1, 76.1, 53.5, 50.5, 31.1, 27.9, 14.8 ppm. HRMS m/z (ESI) 
calculated for C16H2NO [(M + H)+] 244.1701, found 244.1697. 
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APPENDICES: STRUCTURAL CHARACTERIZATION OF COMPOUNDS 
Appendix A: Structural Characterization of Compounds from Chapter 3 
3,4-Dimethoxy-N-(4-(morpholinomethyl)benzyl)-N-phenylbenzenesulfonamide (2a)  
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Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 20.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
6053 formula(e) evaluated with 64 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 0-50     
Minimum:                                       -1.5 
Maximum:                    5.0       20.0     50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
483.1956    483.1954        0.2       0.4      12.5      12.4       C26  H31  N2  O5  S  
 
  
100%MeOH 11:09:27  23-May-2012
m/z
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Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
2331 formula(e) evaluated with 5 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-6    O: 1-30    S: 1-10     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT      Formula 




MeOH 15:07:31  26-Feb-2013
m/z
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Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
4674 formula(e) evaluated with 14 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100    S: 0-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
461.2102  461.2110        -0.8      -1.7     9.5       5.9        C24  H33  N2  O5  S  
 
  
100%MeOH+0.1%HCOOH 12:30:52  17-May-2012
m/z
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======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.7 K
DE                 6.50 usec
DW               62.400 usec
RG                   57
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              20.47
Date_          20130312
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−92f
Current Data Parameters
SB−V−92f









































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   30
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              20.51
Date_          20130312
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
4668 formula(e) evaluated with 10 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-30    O: 1-60    S: 1-10     
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
461.2112    461.2110        0.2      0.4      9.5      243.0     C24  H33  N2  O5  S  
  
80%MeOH 13:51:56  15-Mar-2013
m/z





















































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.9 K
DE                 6.50 usec
DW               62.400 usec
RG                   57
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              21.14
Date_          20130311
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−V−91cR
Current Data Parameters
SB−V−91cR









































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  191
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              21.18
Date_          20130311
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
4668 formula(e) evaluated with 21 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-30    O: 1-60    S: 1-10     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
461.2095   461.2110        -1.5      -3.3     9.5       11.1       C24  H33  N2  O5  S  
  
diluted  in 50%ACN 16:22:35  25-Mar-2013
m/z


















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                  161
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   12
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.36
Date_          20130220
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3
NAME           SB−V−82d
Current Data Parameters
SB−V−82d














































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   46
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              18.26
Date_          20130219
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
1658 formula(e) evaluated with 7 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-6    O: 1-30    S: 1-10     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
415.1695    415.1692        0.3       0.7      10.5      1.3        C22  H27  N2  O4  S  
 
  
MeOH 14:59:03  26-Feb-2013
m/z























































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                299.0 K
DE                 6.50 usec
DW               62.400 usec
RG                 50.8
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    6
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.24
Date_          20120726
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−110
Current Data Parameters
SB−IV−110































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                299.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   27
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.26
Date_          20120726
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
106 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20    Br: 1-5     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
256.0333    256.0337        -0.4      -1.6     4.5       1.6        C11  H15  N  O  Br 
  
100%MeOH+0.1%HCOOH 13:20:16  21-Feb-2012
m/z




SARAH_SB-III-91B_BWANG-ACCU_02-21-2012_POS 100 (1.861) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Cm (98:117)
1.56e4256.0333
170.9654 409.1634
100%MeOH+0.1%HCOOH 13:20:16  21-Feb-2012
m/z



































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                292.5 K
DE                 6.50 usec
DW               62.400 usec
RG                 11.3
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.53
Date_          20130213
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            ZD−I−77
Current Data Parameters
ZD−I−77











































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                293.0 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.55
Date_          20130213
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
106 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-20    O: 1-30    Br: 1-5     
 
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
256.0348    256.0337        1.1       4.3      4.5       0.7        C11  H15  N  O  Br 
 
  
90%ACN+0.1%HCOOH 16:27:04  31-Oct-2012
m/z









90%ACN+0.1%HCOOH 16:27:04  31-Oct-2012
m/z

















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                292.6 K
DE                 6.50 usec
DW               62.400 usec
RG                 11.3
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    9
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.57
Date_          20130213
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            ZD−I−78
Current Data Parameters
ZD−I−78





































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                293.1 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.58
Date_          20130213
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
106 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    Br: 1-5     
 
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
256.0348    256.0337        1.1       4.3      4.5       0.5        C11  H15  N  O  Br 
 
  
100%MeOH 18:26:34  10-Aug-2012
m/z



























































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 20.2
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.49
Date_          20120420
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−IV−30
Current Data Parameters
SB−IV−30











































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   29
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.51
Date_          20120420
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
181 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-35    80Se: 0-1     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT      Formula 
206.1182    206.1181        0.1       0.5      5.5       5.0        C12  H16  N  O2 
 
  
in 100%MeOH+0.1%HCOOH 16:01:58  24-Apr-2012
m/z












3-(Morpholinomethyl)benzaldehyde (8b)  
 
 





















































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                   18
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   12
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              18.32
Date_          20130216
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−80b
Current Data Parameters
SB−V−80b











































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                    5
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              18.34
Date_          20130216
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
105 formula(e) evaluated with 1 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-6    O: 1-30     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT  Formula 
206.1183    206.1181        0.2       1.0      5.5       8.5       C12  H16  N  O2 
  
MeOH 14:10:36  26-Feb-2013
m/z




SARAH_SB-V-80_BWANG-ACCU_02-26-2013_ESI-POS01 142 (2.830) AM (Cen,2, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 3x3.00); Cm (134:145)
9.01e3238.1454
378.2615
MeOH 14:10:36  26-Feb-2013
m/z










2-(Morpholinomethyl)benzaldehyde (8c)  
 
 

























































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                   36
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.38
Date_          20121120
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−V−17c1
Current Data Parameters
SB−V−17c1














































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   11
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.42
Date_          20121120
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
145 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-20    O: 1-30     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 





90%MeOH+0.1%HCOOH 15:48:53  05-Dec-2012
m/z













90%MeOH+0.1%HCOOH 15:48:53  05-Dec-2012
m/z

























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 40.3
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                    7
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.04
Date_          20120426
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−37a
Current Data Parameters
SB−IV−37a




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   22
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.06
Date_          20120426
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2
























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                294.2 K
DE                 6.50 usec
DW               62.400 usec
RG                  101
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    6
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.06
Date_          20130319
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3
NAME          SB−V−107d
Current Data Parameters
SB−V−107d




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.8 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   30
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.08
Date_          20130319
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 4








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
363 formula(e) evaluated with 3 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-30    O: 1-60     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
283.1809    283.1810        -0.1      -0.4     8.5       1.7        C18  H23  N2  O  
  
80%MeOH 14:18:33  15-Mar-2013
m/z
















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.4 K
DE                 6.50 usec
DW               62.400 usec
RG                   57
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.10
Date_          20130305
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME       SB−V−93b−dry
Current Data Parameters
SB−V−93b−dry




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                293.9 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   22
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.12
Date_          20130305
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
363 formula(e) evaluated with 2 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-30    O: 1-60     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT      Formula 





in 90%MeOH 17:58:03  05-Mar-2013
m/z


























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                294.0 K
DE                 6.50 usec
DW               62.400 usec
RG                 40.3
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   15
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.53
Date_          20130212
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           ZD−I−75c
Current Data Parameters
ZD−I−75c











































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   24
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.55
Date_          20130212
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
313 formula(e) evaluated with 3 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-30    O: 1-30     
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa       PPM       DBE      i-FIT      Formula 





diluted in MeOH+0.1%HCOOH 17:08:59  12-Feb-2013
m/z




SARAH_ZD-1-75C_BWANG-ACCU_02-12-2013_ESI-POS01 126 (2.508) AM (Cen,2, 80.00, Ar,5000.0,556.28,0.70); Sm (SG, 3x3.00); Cm (125:139)
5.93e3269.1659
556.2771307.1261 397.2198 444.2669
diluted in MeOH+0.1%HCOOH 17:08:59  12-Feb-2013
m/z















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                 25.4
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.37
Date_          20120425
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−39a
Current Data Parameters
SB−IV−39a























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   26
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.40
Date_          20120425
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2







Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
284 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT      Formula 




in 100%MeOH+0.1%HCOOH 17:49:34  26-Apr-2012
m/z


































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               62.400 usec
RG                 28.5
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.24
Date_          20130221
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            SB−V−90
Current Data Parameters
SB−V−90
























































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   25
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.27
Date_          20130221
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
286 formula(e) evaluated with 2 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-30    O: 1-60     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
261.1963    261.1967        -0.4      -1.5     5.5       2.5        C16  H25  N2  O  
  
in 90%MeOH 17:37:00  05-Mar-2013
m/z


















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.9 K
DE                 6.50 usec
DW               62.400 usec
RG                   16
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    9
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.29
Date_          20130221
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            SB−V−91
Current Data Parameters
SB−V−91




































































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   21
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.31
Date_          20130221
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
286 formula(e) evaluated with 2 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-30    O: 1-60     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 





in 90%MeOH 18:08:53  05-Mar-2013
m/z











N-(4-Morpholinobenzyl)cyclobutanamine (10d)  
 
Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
153 formula(e) evaluated with 1 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-6    O: 1-30     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
247.1819    247.1810        0.9       3.6      5.5       70.6       C15  H23  N2  O 
 
  
MeOH 14:20:04  26-Feb-2013
m/z





































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.8 K
DE                 6.50 usec
DW               62.400 usec
RG                 50.8
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.45
Date_          20130118
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1



























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                   18
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   10
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.50
Date_          20130216
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            SB−V−84
Current Data Parameters
SB−V−84
























































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   15
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.53
Date_          20130216
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
234 formula(e) evaluated with 1 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-6    O: 1-30     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT      Formula 
303.2063    303.2073        -1.0      -3.3     6.5      22.6       C18  H27  N2  O2  
MeOH 14:26:13  26-Feb-2013
m/z




SARAH_SB-V-84_BWANG-ACCU_02-26-2013_ESI-POS01 58 (1.156) AM (Cen,2, 80.00, Ar,5000.0,556.28,0.70); Cm (56:70)
2.05e4303.2063
173.0970
MeOH 14:26:13  26-Feb-2013
m/z
















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.7 K
DE                 6.50 usec
DW               62.400 usec
RG                   18
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   12
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.55
Date_          20130216
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            SB−V−85
Current Data Parameters
SB−V−85





















































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.6 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   19
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.57
Date_          20130216
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
255 formula(e) evaluated with 1 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-6    O: 1-30     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
317.2237    317.2229        0.8       2.5      6.5       3.5        C19  H29  N2  O2 
 
  
MeOH 14:37:29  26-Feb-2013
m/z






























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 28.5
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.26
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−IV−53
Current Data Parameters
SB−IV−53























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   20
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.28
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2







Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
293 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100     
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 







100%MeOH+HCOOH 13:24:05  11-May-2012
m/z


































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.8 K
DE                 6.50 usec
DW               62.400 usec
RG                 50.8
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.45
Date_          20130118
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1




















































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.9 K
DE                 6.50 usec
DW               62.400 usec
RG                   36
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    7
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.11
Date_          20130207
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           JH−I−61c
Current Data Parameters
JH−I−61c














































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.6 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   15
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.12
Date_          20130207
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2





















































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                   36
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.06
Date_          20130214
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           JH−I−67b
Current Data Parameters
JH−I−67b




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   24
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.10
Date_          20130214
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2

































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                  114
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.29
Date_          20121207
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−36d
Current Data Parameters
SB−V−36d






































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   41
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.33
Date_          20121207
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
56 formula(e) evaluated with 1 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    O: 1-30     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
325.1452    325.1440        1.2       3.7      10.5      1.1         C20  H21  O4 
  
MeOH 14:45:01  26-Feb-2013
m/z













































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               62.400 usec
RG                 90.5
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.14
Date_          20130214
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           JH−I−66b
Current Data Parameters
JH−I−66b












































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   40
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.17
Date_          20130214
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











Elemental Composition Report 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
62 formula(e) evaluated with 1 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    O: 1-60     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
355.1543    355.1545        -0.2      -0.6     10.5     695.3       C21  H23  O5 
  
80% ACN 18:30:09  27-Mar-2013
m/z










80% ACN 18:30:09  27-Mar-2013
m/z


















 (R)-3-((4-Bromobenzyl)oxy)tetrahydrofuran (9b) 
 
  














































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                   16
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.34
Date_          20130130
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−64c
Current Data Parameters
SB−V−64c





































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   24
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.37
Date_          20130130
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2






























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.5 K
DE                 6.50 usec
DW               62.400 usec
RG                   16
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.40
Date_          20130130
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−65c
Current Data Parameters
SB−V−65c


































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   18
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.42
Date_          20130130
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2


























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.5 K
DE                 6.50 usec
DW               62.400 usec
RG                 11.3
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.41
Date_          20130206
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           JH−I−64b
Current Data Parameters
JH−I−64b












































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   25
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.43
Date_          20130206
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 20.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
107 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-150    H: 1-150    O: 1-30    Na: 0-1     
Minimum:                                        -1.5 
Maximum:                    5.0       20.0      50.0 
Mass        Calc. Mass      mDa       PPM       DBE      i-FIT Formula 
343.1532    343.1545        -1.3      -3.8      9.5      19.1   C20  H23  O5  
             
  
90%MeOH 17:33:22  08-Feb-2013
m/z





















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.8 K
DE                 6.50 usec
DW               62.400 usec
RG                 22.6
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   10
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.43
Date_          20130202
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−66c
Current Data Parameters
SB−V−66c



































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   22
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.45
Date_          20130202
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
57 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    O: 1-30     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
343.1553    343.1545        0.8       2.3      9.5       2.3         C20  H23  O5 
  
80%ACN+0.5%NH4OH 16:50:25  06-Feb-2013
m/z



























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.7 K
DE                 6.50 usec
DW               62.400 usec
RG                 12.7
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    9
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.47
Date_          20130202
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−67c
Current Data Parameters
SB−V−67c





























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   17
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.50
Date_          20130202
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
66 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    O: 1-30     
Minimum:                                             -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE       i-FIT       Formula 
357.1692    357.1702        -1.0     -2.8      9.5       4.0         C21  H25  O5 
  
80%ACN+0.5%NH4OH 17:02:09  06-Feb-2013
m/z














































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                294.0 K
DE                 6.50 usec
DW               62.400 usec
RG                 28.5
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   13
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              22.29
Date_          20130311
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−V−102d
Current Data Parameters
SB−V−102d
































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.6 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   29
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              22.34
Date_          20130311
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
540 formula(e) evaluated with 5 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    N: 1-30    O: 1-60     
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
330.1710    330.1705        0.5       1.5       8.5       5.0         C19  H24  N  O4  
 
  
diluted  in 50%ACN 16:13:37  25-Mar-2013
m/z






























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                  101
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.10
Date_          20121212
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            SB−V−52
Current Data Parameters
SB−V−52




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   18
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.13
Date_          20121212
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








 (3,4-dimethoxyphenyl)(4-(4-methylpiperazin-1-yl)phenyl)methanol (12c)   
 
  




















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.8 K
DE                 6.50 usec
DW               62.400 usec
RG                 50.8
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    8
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.22
Date_          20130322
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME      SB−V−104d−oil
Current Data Parameters
SB−V−104d−oil





























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   25
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.24
Date_          20130322
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2













































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                 90.5
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.12
Date_          20121205
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−46c
Current Data Parameters
SB−V−46c

















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   63
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.15
Date_          20121205
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
58 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    O: 1-30    Na: 1-2     
 
Minimum:                             -1.5 
Maximum:                    5.0         5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 
267.0993    267.0997        -0.4     -1.5      7.5      1.2        C15  H16  O3  Na 
 
  
90%MeOH+0.1%HCOOH 16:42:31  05-Dec-2012
m/z










90%MeOH+0.1%HCOOH 16:42:31  05-Dec-2012
m/z












































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                  203
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   10
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.26
Date_          20121212
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−47c
Current Data Parameters
SB−V−47c





































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   69
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.02
Date_          20121212
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
46 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    O: 1-30     
Minimum:                             -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE       i-FIT       Formula 
303.1224    303.1232        -0.8     -2.6      8.5       131.7       C17  H19  O5 
  
80%ACN+0.5%NH4OH 16:55:33  06-Feb-2013
m/z





















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.8 K
DE                 6.50 usec
DW               62.400 usec
RG                 90.5
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.22
Date_          20121205
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−V−48d
Current Data Parameters
SB−V−48d





























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   71
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.24
Date_          20121205
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
85 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    O: 1-30    Na: 1-2     
 
Minimum:                              -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE       i-FIT      Formula 
327.1200    327.1208        -0.8     -2.4      7.5       42.4       C17  H20  O5  Na  
 
  
90%MeOH+0.1%HCOOH 16:51:37  05-Dec-2012
m/z












































































































PC                 1.00
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.5 K
DE                 6.50 usec
DW               62.400 usec
RG                   64
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.08
Date_          20121113
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−V−34cR
Current Data Parameters
SB−V−34cR
































































PC                 1.40
GB       0
LB                 5.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.8 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  147
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.19
Date_          20121113
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
76 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    O: 1-30    Na: 1-2     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT      Formula 
309.1111    309.1103        0.8       2.6      8.5       46.0       C17  H18  O4  Na 
 
  
90%ACN+0.1%HCOOH 16:24:40  14-Nov-2012
m/z























Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
44 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-150    H: 1-150    O: 1-30     
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa       PPM       DBE       i-FIT      
 Formula 
295.1327    295.1334        -0.7      -2.4      10.5      76.3        C19  H19  O3 
  
90%ACN 16:52:53  22-Feb-2013
m/z













Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
44 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-150    H: 1-150    O: 1-30     
Minimum:                               -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE       i-FIT       Formula 
295.1334    295.1334        0.0       0.0       10.5      C19  H19  O3 
 
  
90%ACN 16:32:19  22-Feb-2013
m/z













 (3,4-dimethoxyphenyl)(2,2-dimethyl-2H-chromen-6-yl)methanone (19a) 
 
  



















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.2 K
DE                 6.50 usec
DW               62.400 usec
RG                  161
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.50
Date_          20130320
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
56 formula(e) evaluated with 1 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    O: 1-60     
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa       PPM       DBE       i-FIT      
 Formula 
325.1449    325.1440        0.9       2.8       10.5      10.3        C20  H21  O4 
 
  
80%MeOH 14:02:26  15-Mar-2013
m/z










































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.7 K
DE                 6.50 usec
DW               62.400 usec
RG                   57
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              21.15
Date_          20130312
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−V−101c
Current Data Parameters
SB−V−101c
































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   21
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              21.17
Date_          20130312
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
57 formula(e) evaluated with 1 results within limits (up to 100 closest results for each mass) 
Elements Used: 
C: 1-150    H: 1-150    O: 1-60     
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 






80%MeOH 14:26:16  15-Mar-2013
m/z















 (4-(bromomethyl)phenyl)(3,4-dimethoxyphenyl)methanone (19c) 
 
 




























































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.4 K
DE                 6.50 usec
DW               62.400 usec
RG                  203
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.20
Date_          20130305
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            SB−V−78
Current Data Parameters
SB−V−78















































PC                 1.00
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.0 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  200
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.24
Date_          20130305
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











ACN 14:44:42  12-Mar-2013
m/z













Appendix C: Structural Characterization of Compounds from Chapter 5 General	  methods	  and	  materials	  	  
All commercial chemicals were reagent grade, obtained from VWR, Aldrich, and Oakwood 
Chemicals and were used without further purification unless otherwise indicated. 1H and 13C 
spectra were obtained on a Bruker 400 NMR spectrometer at 400 and 100 MHz, respectively, in 
deuterated solvent with TMS as internal reference (δ = 0.00 ppm). For all reactions, analytical 
grade solvent was used.  Anhydrous solvents were used for all moisture-sensitive reactions. 
High-resolution mass spectra were obtained by the Mass Spectrometry Facilities at Georgia State 
University on a Waters Micromass Q-Tof (ESI). 
Synthesis of aldehyde compounds: Aldehydes were synthesized from either commercially 
available bromides or aldehydes in 1 to 3 steps (Scheme S1). First, the phenol was alkylated with 
3-chloro-3-methylbut-1-yne, then the compound was cyclized at high temperature to give the 
chromene moiety. The bromide was converted to aldehyde via lithium halogen exchange, 
followed by formylation with DMF. 
 
Scheme S1. Synthesis of aldehyde compoundsa 
 
X = bromo or aldehyde; Y = C or N. Reagents and conditions: (a); 3-chloro-3-methylbut-1-yne, 
DBU, ACN, overnight, 0oC to room temperature; (b) reflux in N,N-dimethylaniline, 3 hours; (c) 










15, 17, 22, 24, 26, 28
 256 
Typical procedure for o-alkylation: 1 equivalent of phenol was dissolved in ACN and cooled to 
0oC. 2 equivalents of DBU were added, then 2 equivalents of 3-chloro-3-methylbut-1-yne.  The 
reaction was stirred overnight from 0oC to room temperature.  The reaction mixture was 
concentrated, then taken up in ethyl acetate, washed 3 x 1N HCl, 1 x saturated NaHCO3, 1 x 
brine, dried over MgSO4, and concentrated.  Purified by column chromatography. 
 
Typical procedure for pyran ring-closing: The alkyne was refluxed 3 hours in N,N-
dimethylaniline.  The reaction was taken up in EA, washed 5 x 1 N HCl, 1 x saturated NaHCO3, 
1 x brine, dried over MgSO4, and concentrated.  Purified by column chromatography. 
 
Typical procedure for formylation: 1 equivalent of aryl bromide was dissolved in anhydrous 
THF under N2 and cooled to -78oC.  1.4 equivalents of butyl lithium were added.  After 30 
minutes, 1.4 equivalents of DMF were added and then the reaction stirred for 1 hour.  The 
reaction was then quenched with saturated NH4Cl, taken up in ethyl acetate, washed with brine, 
dried over MgSO4, and concentrated.  Purified by column chromatography. 
 
 
2-((2-Methylbut-3-yn-2-yl)oxy)benzaldehyde (S2b) 1H NMR (400 MHz, CDCl3): δ 10.57 (s, 
1H), 8.00-7.98 (d, J = 8 Hz, 1H), 7.67-7.66 (m, 2H), 7.28-7.25 (m, 1H), 2.76 (s, 1H), 1.87 (s, 
6H) ppm. 13C NMR (100 MHz, CDCl3): δ 190.5, 158.5, 135.0, 128.9, 128.2, 122.9, 120.9, 85.1, 






2-Bromo-4-((2-methylbut-3-yn-2-yl)oxy)benzaldehyde (S2c) Yield: 12%. 1H NMR (400 MHz, 
CDCl3): δ 9.79 (s, 1H), 7.88-7.88 (d, J = 2 Hz, 1H), 7.46-7.46 (d, J = 2 Hz, 1H), 6.37-6.34 (d, J = 
8 Hz, 1H), 5.75-5.73 (d, J = 8 Hz, 1H), 1.53 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 189.6, 
155.2, 134.8, 132.1, 130.5, 126.4, 122.3, 121.1, 111.2, 69.5, 28.5 ppm. 
 
3-Methyl-4-((2-methylbut-3-yn-2-yl)oxy)benzaldehyde (S2d) Yield: 87%. 1H NMR (400 
MHz, CDCl3): δ 9.84 (s, 1H), 7.67-7.63 (m, 3H), 2.67 (s, 1H), 2.22 (s, 3H), 1.72 (s, 6H) ppm. 
13C NMR (100 MHz, CDCl3): δ 191.2, 159.6, 131.8, 130.0, 130.0, 129.3, 128.9, 116.5, 85.1, 
74.7, 72.3, 29.6, 16.6 ppm. 
 
1-Bromo-2-methyl-4-((2-methylbut-3-yn-2-yl)oxy)benzene (S2e) 1H NMR (400 MHz, 
CDCl3): δ 7.48-7.45 (m, 1H), 7.15 (s, 1H), 7.05-7.02 (m, 1H), 2.65 (s, 1H), 3.21 (s, 3H), 1.70 (s, 
6H) ppm. 
 
4-((2-Methylbut-3-yn-2-yl)oxy)benzaldehyde (S2j) Yield: 84%. 1H NMR (400 MHz, CDCl3): 











ppm. 13C NMR (100 MHz, CDCl3): δ 190.9, 161.1, 131.2, 130.6, 119.4, 84.9, 75.2, 72.4, 29.5 
ppm. 
 
2-Bromo-1,3-difluoro-5-((2-methylbut-3-yn-2-yl)oxy)benzene (S2l) 1H NMR (400 MHz, 
CDCl3): δ 6.91-6.82 (m, 2H), 2.68 (s, 1H), 1.58 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 
161.0, 160.9, 158.5, 158.5, 156.4, 156.3, 156.1, 104.8, 104.8, 104.6, 104.5, 90.8, 90.6, 90.3, 84.7, 
75.3, 75.2, 73.3, 29.3, 29.3 ppm. 
 
2-fluoro-4-((2-methylbut-3-yn-2-yl)oxy)benzaldehyde (S2m) 1H NMR (400 MHz, CDCl3): δ 
7.44-7.40 (t, J = 8 Hz, 1H), 7.10-7.06 (dd, J = 8, 2 Hz, 1H), 6.93-6.90 (m, 1H), 2.63 (s, 1H), 1.66 
(s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 160.1, 157.7, 156.2, 156.1, 132.8, 132.8, 118.1, 
118.1, 109.1, 109.1, 101.9, 101.7, 85.2, 74.8, 73.0, 29.7, 29.4 ppm. 
 
2-Bromo-5-((2-methylbut-3-yn-2-yl)oxy)pyridine (S2n) 1H NMR (400 MHz, CDCl3): δ 8.24-
8.24 (d, J = 2 Hz, 1H), 7.45-7.42 (dd, J = 8, 2 Hz, 1H), 7.37-7.35 (d, J = 8 Hz, 1H), 2.62 (s, 1H), 
















6-bromo-2,2,5-trimethyl-2H-chromene with 6-bromo-2,2,7-trimethyl-2H-chromene (1:2) 
(S3e) Yield: 70%. 1H NMR (400 MHz, CDCl3): δ 7.31-7.28 (dd, J = 8, 2 Hz, 2H), 7.14 (s, 1H), 
6.71 (s, 1H), 6.60-6.55 (dd, J = 8, 2 Hz, 2H), 6.27-6.25 (d, J = 10 Hz, 1H), 5.72-5.69 (m, 2H), 
5.62-5.60 (d, J = 10 Hz, 1H), 2.41 (s, 6H), 2.34 (s, 3H), 1.44 (s, 20H) ppm. 
 
4-(4-bromobenzyl)morpholine (S3i)  500 mg 1-bromo-4-(bromomethyl)benzene (2.0 mmol), 
191 mg morpholine (2.2 mmol), and 455 mg K2CO3 (3.3 mmol) were dissolved in ACN and 
stirred overnight at room temperature.  The reaction mixture was filtered through celite to give a 
quantitative yield of a solid (512 mg). 1H NMR (400 MHz, CDCl3): δ 7.42-7.40 (d, J = 8 Hz, 
2H), 7.20-7.18 (d, J = 8 Hz, 2H), 3.68-3.66 (m, 4H), 3.41 (s, 2H), 2.40 (s, 4H) ppm. 13C NMR 
(100 MHz, CDCl3): δ 137.0, 131.4, 130.8, 120.9, 66.9, 62.6, 53.6 ppm. HRMS m/z (ESI) 
calculated for C11H15NOBr [(M + H)+] 256.0337, found 256.0346. 
 
6-bromo-5,7-difluoro-2,2-dimethyl-2H-chromene (S3l) 1H NMR (400 MHz, CDCl3): δ 6.91-
6.89 (d, J = 8 Hz, 1H), 6.88 (s, 1H) 5.66-5.63 (d, J = 10 Hz, 1H), 1.44 (s, 6H) ppm. 13C NMR 
(100 MHz, CDCl3): δ 160.5, 160.5, 158.1, 158.0, 156.5, 156.5, 154.1, 154.0, 153.7, 153.6, 153.6, 
153.5, 130.4, 130.4, 130.4, 114.2, 114.2, 114,2 114.2, 101.2, 101.2, 100.9, 100.9, 88.5, 88.2, 












6-bromo-2,2-dimethyl-2H-pyrano[3,2-b]pyridine (S3n) 1H NMR (400 MHz, CDCl3): δ 7.16-
7.14 (d, J = 8 Hz, 1H), 692-6.90 (d, J = 8 Hz, 1H), 6.47-6.44 (d, J = 10 Hz, 1H), 5.89-5.86 (d, J 
= 10 Hz, 1H), 1.46 (s, 6H) ppm. 
  
2,2-Dimethyl-2H-chromene-8-carbaldehyde (15b) 1H NMR (400 MHz, CDCl3): δ 10.48 (s, 
1H), 7.67-7.65 (d, J = 8 Hz, 1H), 7.20-7.18 (d, J = 8 Hz, 1H), 6.93-6.89 (t, J = 7.6 Hz, 1H), 6.38-
6.36 (d, J = 8 Hz, 1H), 5.73-5.71 (d, J = 8 Hz, 1H), 1.52 (s, 6H) ppm. 13C NMR (100 MHz, 
CDCl3): δ 189.4, 156.2, 132.1, 131.3, 127.1, 124.2, 122.3, 121.5, 120.5, 77.6, 28.2 ppm. HRMS 
m/z (ESI) calculated for C12H13O2 [(M + H)+] 189.0916, found 189.0912. 
 
5-Bromo-2,2-dimethyl-2H-chromene-6-carbaldehyde (15c) Yield = 81%. 1H NMR (400 
MHz, CDCl3): δ 9.80 (s, 1H), 7.90-7.89 (d, J = 2 Hz, 1H), 4.48-4.47 (d, J = 2 Hz, 1H), 6.38-6.36 
(d, J = 10 Hz, 1H), 5.77-5.75 (d, J = 10 Hz, 1H), 1.55 (s, 6H) ppm. 
 
2,2,8-Trimethyl-2H-chromene-6-carbaldehyde (15d) Yield: 87%. 1H NMR (400 MHz, 
CDCl3): δ 9.75 (s, 1H), 7.48-7.48 (d, J = 2 Hz, 1H), 7.33-7.32 (d, J = 2 Hz, 1H), 6.33-6.30 (d, J = 
10 Hz, 1H), 5.65-5.63 (d, J = 10 Hz, 1H), 2.18 (s, 3H), 1.43 (s, 6H) ppm. 13C NMR (100 MHz, 











carbaldehyde (1:2) (15e) Yield: 81%. 1H NMR (400 MHz, CDCl3): δ 10.11 (s, 2H), 10.08 (s, 
1H), 7.62-7.60 (d, J = 8 Hz, 2H), 7.44 (s, 1H), 6.77-6.75 (d, J = 8 Hz, 2H), 6.64-6.61 (m, 3H), 
6.36-6.33 (d, J = 8 Hz, 1H), 5.75-5.73 (d, J = 8 Hz, 2H), 5.65-5.62 (d, J = 8 Hz, 1H), 2.62 (s, 
6H), 2.59 (s, 3H), 1.45 (s, 18) ppm. 
 
Benzo[c][1,2,5]oxadiazole-5-carbaldehyde (15h) Yield: 19%. 1H NMR (400 MHz, CDCl3): δ 
10.15 (s, 1H), 8.44 (s, 1H), 8.00-7.98 (d, J = 8 Hz, 1H), 7.96-7.94 (d, J = 8 Hz, 1H) ppm. 
 
4-(Morpholinomethyl)benzaldehyde (15i) 1H NMR (400 MHz, CDCl3): δ 9.96 (s, 1H), 7.82-
7.80 (d, J = 7.6 Hz, 2H), 7.50-7.48 (d, J = 7.6 Hz, 2H), 3.68-3.67 (m, 4H), 3.54 (s, 2H), 2.43 (m, 
4H) ppm. 13C NMR (100 MHz, CDCl3): δ 191.9, 145.3, 135.6, 129.8, 129.5, 129.2, 66.9, 63.0, 
53.6 ppm. HRMS m/z (ESI) calculated for C12H16NO2 [(M + H)+] 206.1181, found 206.1182. 
 
5,7-Difluoro-2,2-dimethyl-2H-chromene-6-carbaldehyde (15l) 1H NMR (400 MHz, CDCl3): δ 
10.14 (s, 1H), 6.50-6.48 (d, J = 8 Hz, 1H), 6.37-6.34 (d, J = 10 Hz, 1H), 5.68-5.66 (d, J = 8 Hz, 

















chromene (1:1) (S3m) 1H NMR (400 MHz, CDCl3): δ 7.25-7.21 (m, 1H), 7.14-7.12 (d, J = 8 
Hz, 1H), 6.61-6.51 (m, 3H), 6.25-6.23 (d, J = 8 Hz, 1H), 5.72-5.70 (d, J = 8 Hz, 1H), 5.62-5.60 
(d, J = 8 Hz, 1H), 1.45 (s, 6H), 1.44 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3): δ 160.1, 157.7, 
155.8, 153.6, 153.5, 153.3, 153.2, 131.8, 131.8, 131.7, 131.6, 130.7, 129.8, 120.6, 119.2, 119.1, 
114.9, 114.8, 113.5, 113.4, 111.4, 111.2, 105.4, 105.2, 99.3, 99.0, 98.9, 76.6, 28.0, 27.8 ppm.  
 
5-Fluoro-2,2-dimethyl-2H-chromene-6-carbaldehyde with 7-Fluoro-2,2-dimethyl-2H-
chromene-6-carbaldehyde (1:1) (15m)  
 
2,2-Dimethyl-2H-chromene-6-carbaldehyde (17) Yield: 84%. 1H NMR (400 MHz, CDCl3): δ 
9.83 (s, 1H), 7.65-7.63 (d, J = 8 Hz, 1H), 7.52 (s, 1H), 6.88-6.86 (d, J = 8 Hz, 1H), 6.38-6.36 (d, 
J = 8 Hz, 1H), 5.70-5.68 (d, J = 8Hz, 1H), 1.47 (s, 6H) ppm. 
 
6-Bromo-2,2-dimethyl-2H-pyrano[3,2-b]pyridine (S3n) Yield: 64%. 1H NMR (400 MHz, 
CDCl3): δ 7.15-7.13 (d, J = 8 Hz, 1H), 6.91-6.89 (dd, J = 8, 2 Hz, 1H), 6.46-6.43 (dd, J = 8, 2 


















2,2-Dimethyl-2H-pyrano[3,2-b]pyridine-6-carbaldehyde (28) Yield: 67%. 1H NMR (400 
MHz, CDCl3): δ 9.88 (s, 1H), 7.72-7.70 (d, J = 8 Hz, 1H), 7.09-7.07 (d, J = 8 Hz, 1H), 6.55-6.53 
(d, J = 10 Hz, 1H), 5.98-5.95 (d, J = 10 Hz, 1H), 1.48 (s, 6H) ppm. 
 
N-((2,2-dimethyl-2H-chromen-6-yl)methyl)aniline (19) 1H NMR (400 MHz, CDCl3): δ 7.26-
7.21 (m, 3H), 6.98-6.96 (d, J = 8 Hz, 1H), 6.88-6.86 (m, 1H), 6.79-6.72 (m, 3H), 6.40-6.38 (d, J 
= 8 Hz, 1H), 5.69-5.67 (d, J = 8 Hz, 1H), 4.37 (s, 2H), 4.06 (bs, 1H). 13C NMR (100 MHz, 
CDCl3): δ 150.8, 148.5, 130.6, 129.2, 128.9, 126.5, 125.5, 122.5, 121.1, 120.5, 117.4, 113.2, 
76.44, 43.11, 28.18. HRMS (ESI) m/z calculated for C18H20NO [(M + H)+] 266.1545, found 
266.1548. 
 
N-((2,2-dimethyl-2H-chromen-6-yl)methyl)cyclobutanamine (32) 1H NMR (400 MHz, 
CDCl3): δ 7.04-7.02 (d, J = 8 Hz, 1H), 6.95 (s, 1H), 6.73-6.71 (d, J = 8 Hz, 1H), 6.32-6.30 (d, J = 
8 Hz, 1H), 5.61-5.59 (d, J = 8 Hz, 1H), 3.60 (s, 2H), 3.32-3.26 (quintet, J = 8 Hz, 1H), 2.21 (m, 
2H), 1.72-1.69 (m, 4H), 1.43 (s, 6H). 13C NMR (100 MHz, CDCl3): δ 151.9, 132.5, 130.8, 128.9, 
126.2, 122.3, 121.2, 116.1, 76.1, 53.5, 50.1, 31.1, 27.9, 14.8. HRMS (ESI) m/z calculated for 
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Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
13307 formula(e) evaluated with 42 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                    -1.5 
Maximum:                   5.0      5.0      50.0 
Mass       Calc. Mass     mDa      PPM      DBE      i-FIT      Formula 




100%MeOH+0.1%HCOOH 16:42:29  07-Feb-2012
m/z
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Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 20.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
5227 formula(e) evaluated with 71 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 0-50     
Minimum:                                       -1.5 
Maximum:                    5.0       20.0     50.0 
Mass       Calc. Mass     mDa       PPM      DBE      i-FIT       Formula 
466.1694 466.1688       0.6       1.3      13.5      2.4        C26  H28  N  O5  S  
 
  
100%MeOH 11:28:10  23-May-2012
m/z
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Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
6479 formula(e) evaluated with 30 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-50    H: 1-100    N: 1-15    O: 1-30    S: 1-6    Br: 1-5     
 
Minimum:                                     -1.5 
Maximum:                   5.0       5.0      50.0 
Mass       Calc. Mass     mDa       PPM      DBE      i-FIT      Formula 
544.0790 544.0793       -0.3      -0.6     13.5     n/a    C26  H27  N  O5  S  Br   
50%ACN+0.1%HCOOH 16:51:36  27-Jan-2012
m/z











50%ACN+0.1%HCOOH 16:51:36  27-Jan-2012
m/z
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yl)methyl)benzenesulfonamide (2:1) (3e) 
 
 





























































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  144
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   15
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.15
Date_          20111113
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME         SB−II−154R
Current Data Parameters
SB−III−154R


































































































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               20.800 usec
RG                  161
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  858
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.19
Date_          20111113
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2














Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
14388 formula(e) evaluated with 47 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                      -1.5 
Maximum:                   5.0       5.0      50.0 
Mass       Calc. Mass     mDa       PPM      DBE      i-FIT      Formula 
502.1657 502.1664       -0.7      -1.4     13.5      3.1      C27  H29  N  O5  Na  S  
 
  
100%MeOH+0.1%HCOOH 16:57:34  07-Feb-2012
m/z

















































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                 71.8
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                    7
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.29
Date_          20120204
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME         SB−III−64b
Current Data Parameters
SB−III−64b






































































PC                 1.00
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  181
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  838
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              21.52
Date_          20120209
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
10028 formula(e) evaluated with 46 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    S: 1-6    Na: 0-3     
 
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT  Formula 
450.0991 450.0987        0.4       0.9       12.5     2.1        C22  H21  N  O6  S  Na  
 
  
100%MeOH+0.1%HCOOH 14:50:25  10-Feb-2012
m/z



















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                299.0 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.35
Date_          20120614
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME     SB−II−155−HPLC
Current Data Parameters
SB−II−155−HPLC
































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6238353 MHz
PLW1        62.00000000 W
P2                18.00 usec
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D20          0.00689655 sec
D1           2.00000000 sec
CNST11        1.0000000
CNST2       145.0000000
TE                300.7 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                10404
SOLVENT           CDCl3
TD                65536
PULPROG            jmod
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.20
Date_          20120616
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3












Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
8255 formula(e) evaluated with 34 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 
426.1104  426.1124        -2.0     -4.7     13.5     122.1      C21  H20  N3  O5  S 
 
  
100%MeOH+0.1%HCOOH 15:59:33  07-Feb-2012
m/z


















3,4-Dimethoxy-N-(4-(morpholinomethyl)benzyl)-N-phenylbenzenesulfonamide (3i)   
 
 






















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  181
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.25
Date_          20120522
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−54d
Current Data Parameters
SB−IV−54d






































































PC                 1.20
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.7 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  501
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.29
Date_          20120522
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 20.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
6053 formula(e) evaluated with 64 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 0-50     
Minimum:                                      -1.5 
Maximum:                    5.0      20.0     50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 
483.1956    483.1954        0.2      0.4      12.5     12.4       C26  H31  N2  O5  S  
 
  
100%MeOH 11:09:27  23-May-2012
m/z































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.6 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              21.08
Date_          20120615
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME     SB−II−126d−HPLC
Current Data Parameters
SB−III−126d−HPLC 









































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                299.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  547
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              21.10
Date_          20120615
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
3015 formula(e) evaluated with 10 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    Na: 1-1    S: 1-50     
Minimum:                            -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
448.1198    448.1195        0.3      0.7       12.5      10.2  C23  H23  N  O5  Na  S  
 
  
100%MeOH+0.1%HCOOH 16:51:34  22-Jun-2012
m/z


















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                   64
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.41
Date_          20120327
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME               148d
Current Data Parameters
SB−III−148d



































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  161
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  438
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              18.10
Date_          20120327
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
2971 formula(e) evaluated with 8 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20    S: 1-6    Br: 1-5     
 
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
462.0375    462.0375        0.0       0.0      11.5      6.1       C21  H21  N  O4  S  Br  
  
100%MeOH+0.1%HCOOH 15:43:49  28-Mar-2012
m/z









100%MeOH+0.1%HCOOH 15:43:49  28-Mar-2012
m/z













































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 40.3
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.23
Date_          20120521
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−70c
Current Data Parameters
SB−IV−70c
























































































PC                 2.00
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.9 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  102
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.30
Date_          20120521
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 20.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
5060 formula(e) evaluated with 66 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 0-50     
Minimum:                                       -1.5 
Maximum:                    5.0       20.0     50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
460.1801  460.1794        0.7       1.5      10.5      4.4        C24  H30  N  O6  S  
 
  
100%MeOH+0.1%HCOOH 10:25:00  23-May-2012
m/z

















































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                299.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.45
Date_          20120517
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME         SB−IV−43c2
Current Data Parameters
SB−IV−43c2



























































































PC                 1.20
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.8 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                 8975
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              23.04
Date_          20120522
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 5










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
9185 formula(e) evaluated with 36 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    Na: 0-1    S: 0-50     
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 
458.1409  458.1402        0.7      1.5      13.5     876.2   C25  H25  N  O4  Na  S 
 
  
100%MeOH+0.1%HCOOH 17:02:08  29-May-2012
m/z














100%MeOH+0.1%HCOOH 17:02:08  29-May-2012
m/z






































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.8 K
DE                 6.50 usec
DW               62.400 usec
RG                   32
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.17
Date_          20120719
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
29508 formula(e) evaluated with 118 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    F: 1-6    S: 1-50    Na: 1-2     
 
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
512.1106    512.1119        -1.3     -2.5     13.5     16.4        C25  H22  N  O4  F3  
S  Na  
 
  
100%MeOH+0.1%HCOOH 13:53:44  31-Aug-2012
m/z

































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400054 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                295.9 K
DE                 6.50 usec
DW               60.800 usec
RG                  144
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.21
Date_          20110412
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1























































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                296.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  837
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.10
Date_          20110412
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               62.400 usec
RG                  128
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.36
Date_          20120830
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            ZD−I−38
Current Data Parameters
ZD−I−38





























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.8 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   42
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.40
Date_          20120830
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
18747 formula(e) evaluated with 66 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    F: 1-6    S: 1-50    Na: 1-2     
 
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 




100%MeOH+0.1%HCOOH 13:45:26  31-Aug-2012
m/z






















































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                297.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 71.8
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.03
Date_          20120605
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−84a
Current Data Parameters
SB−IV−84a























































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                297.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   30
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.06
Date_          20120605
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
 
Monoisotopic Mass, Even Electron Ions 
10789 formula(e) evaluated with 35 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa       PPM       DBE       Formula 
460.1537  460.1559        -2.2      -4.8      12.5      C25  H27  N  O4  Na  S  
 
100%MeOH+0.1%HCOOH 09:16:24  08-Feb-2012
m/z































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                  101
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.38
Date_          20120531
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−76b
Current Data Parameters
SB−IV−76b









































































PC                 1.00
GB       0
LB                 5.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               20.800 usec
RG                  114
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  440
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.19
Date_          20120601
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
4033 formula(e) evaluated with 8 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 1-50     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT      Formula 




100%MeOH+0.1%HCOOH 15:37:58  08-Jun-2012
m/z

























































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  128
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.36
Date_          20120601
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−79a
Current Data Parameters
SB−IV−79a
























































































PC                 1.20
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  711
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.53
Date_          20120601
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
3713 formula(e) evaluated with 7 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 1-50     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 




100%MeOH+0.1%HCOOH 15:34:36  08-Jun-2012
m/z

























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.30
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME        SB−IV−27f2R
Current Data Parameters
SB−IV−27f2R















































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  144
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  220
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.51
Date_          20120515
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2













Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
 
Monoisotopic Mass, Even Electron Ions 
9247 formula(e) evaluated with 53 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100    S: 0-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      Formula 
600.1365    600.1362        0.3       0.5      15.5      C29  H30  N  O9  S2  
 
  
diluted in 100%MeOH 11:57:11  04-May-2012
m/z
















































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  144
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.41
Date_          20120309
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME        SB−III−128d
Current Data Parameters
SB−III−128d









































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  146
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.44
Date_          20120309
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2












Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
5917 formula(e) evaluated with 27 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20    S: 1-6    23Na: 0-1     
 
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
448.1180  448.1195        -1.5     -3.3     12.5     9.5       C23  H23  N  O5  S Na  
 
  
in 50%ACN+0.1%HCOOH 14:07:04  14-Mar-2012
m/z













in 50%ACN+0.1%HCOOH  ITSD=556.2771 14:31:26  14-Mar-2012
m/z


























in 100%MeOH+0.1%HCOOH 12:47:58  26-Jun-2012
m/z

















































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.47
Date_          20111101
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−II−91R
Current Data Parameters
SB−II−91R





























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   56
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.53
Date_          20111101
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
7428 formula(e) evaluated with 25 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                       -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 
414.1355    414.1351        0.4      1.0       8.5      9.3        C20  H25  N  O5  Na  S  
 
  
100%MeOH+0.1%HCOOH 16:21:25  07-Feb-2012
m/z




































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                 11.3
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.20
Date_          20110922
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
4422 formula(e) evaluated with 9 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE     i-FIT       Formula 
362.1426    362.1426        0.0       0.0      8.5       1.7        C19  H24  N  O4  S  
 
  
100%MeOH+0.1%HCOOH 16:38:03  07-Feb-2012
m/z



































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.58
Date_          20111027
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2
NAME         SB−II−114R
Current Data Parameters
SB−II−114R
































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  102
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.49
Date_          20111027
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
6985 formula(e) evaluated with 22 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE     i-FIT       Formula 
407.1269    407.1277        -0.8      -2.0     9.5       15.9       C19  H23  N2  O6  S  
 
  
100%MeOH+0.1%HCOOH 16:34:04  07-Feb-2012
m/z

























































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                32768
F2 − Processing parameters
SFO1        400.1420007 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           2.00000000 sec
TE       0 K
DE                 6.50 usec
DW               96.200 usec
RG                 71.8
AQ            3.1523316 sec
FIDRES         0.158615 Hz
SWH            5197.505 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                32768
PULPROG              zg
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.36
Date_          20110726
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−II−79b
Current Data Parameters
SB−II−79b












































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE       0 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  292
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.53
Date_          20110726
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











Elemental Composition Report 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
9546 formula(e) evaluated with 32 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE       i-FIT      Formula 
444.1451  444.1457        -0.6      -1.4     8.5       8.7       C21  H27  N  O6  Na  S  
 
  
100%MeOH+0.1%HCOOH 15:39:25  07-Feb-2012
m/z


















































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                 50.8
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   22
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.04
Date_          20111113
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−III−7b
Current Data Parameters
SB−III−7c


























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               20.800 usec
RG                  161
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   86
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.10
Date_          20111113
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
4999 formula(e) evaluated with 11 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE     i-FIT       Formula 
373.1184  373.1198        -1.4      -3.8     7.5       1.4    C17  H22  N2  O4  Na  S  
 
  
100%MeOH+0.1%HCOOH 17:02:13  07-Feb-2012
m/z



























































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                   64
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.53
Date_          20110921
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME         SB−II−113d
Current Data Parameters
SB−II−113d









































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                300.0 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   25
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.59
Date_          20110921
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
6985 formula(e) evaluated with 19 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6     
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
407.1258  407.1277        -1.9     -4.7     9.5      343.6      C19  H23  N2  O6  S  
  
100%MeOH+0.1%HCOOH 16:10:35  07-Feb-2012
m/z





























N-cyclobutyl-3,4-dimethoxy-N-(4-(morpholinomethyl)benzyl)benzenesulfonamide (9h)   
 
 











































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.43
Date_          20120430
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−44c
Current Data Parameters
SB−IV−44c
































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                300.0 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                10240
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              23.52
Date_          20120515
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
4674 formula(e) evaluated with 14 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100    S: 0-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
461.2102  461.2110        -0.8      -1.7     9.5       5.9        C24  H33  N2  O5  S  
  
100%MeOH+0.1%HCOOH 12:30:52  17-May-2012
m/z




























































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                  128
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                    7
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.12
Date_          20120302
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME        SB−III−117c
Current Data Parameters
SB−III−117c
































































PC                 1.00
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  118
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.13
Date_          20120302
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
2340 formula(e) evaluated with 10 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20    S: 1-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass     mDa      PPM      DBE      i-FIT      Formula 
406.1315   406.1324        -0.9     2.2     9.5      11.6        C20  H24  N  O6  S  
 
  
100%MeOH+0.1%HCOOH 14:30:23  06-Mar-2012
m/z








100%MeOH+0.1%HCOOH 14:30:23  06-Mar-2012
m/z






















































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               60.800 usec
RG                 71.8
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.58
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME        SB−III−110b
Current Data Parameters
SB−III−110b












































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   23
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.20
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
2301 formula(e) evaluated with 8 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20    S: 1-6     
Minimum:                                       -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass     mDa       PPM      DBE      i-FIT       Formula 
404.1547      404.1532       1.5       3.7      9.5       3.4        C21  H26  N  O5  S  
  
100%MeOH+0.1%HCOOH 14:11:55  06-Mar-2012
m/z




































































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                297.0 K
DE                 6.50 usec
DW               62.400 usec
RG                  203
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.22
Date_          20120712
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
556 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100    S: 0-6     
Minimum:                                       -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE       i-FIT       Formula 




100%MeOH+0.1%HCOOH 12:39:52  17-May-2012
m/z

























































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               60.800 usec
RG                  181
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   17
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              22.30
Date_          20120619
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME      SB−IV−72−HPLC
Current Data Parameters
SB−IV−72−HPLC













































































































PC                 1.40
GB       0
LB       0 Hz
SSB      0
WDW                  no
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.9 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                10000
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               8.05
Date_          20120620
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2














Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
7830 formula(e) evaluated with 21 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 1-50     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass     mDa      PPM      DBE      i-FIT      Formula 
555.2151    555.2165        -1.4      -2.5     13.5      23.6       C29  H35  N2  O7  S  
 
  
in 100%MeOH+0.1%HCOOH 12:18:29  26-Jun-2012
m/z













SARAH_SB-IV-72-HPLC_BWANG-ACCU_06-26-2012_ESI-POS03 70 (1.304) AM (Cen,4, 80.00, Ar,5000.0,609.28,0.70); Cm (53:71)
3.01e4555.2151
515.2535 539.2903


























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               60.800 usec
RG                   18
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.52
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME         SB−III−109
Current Data Parameters
SB−III−109












































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.6 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   14
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.56
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.9 K
DE                 6.50 usec
DW               60.800 usec
RG                  144
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.10
Date_          20120517
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2
NAME          SB−IV−51c
Current Data Parameters
SB−IV−51c















































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                300.0 K
DE                 6.50 usec
DW               20.800 usec
RG                  128
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  408
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.38
Date_          20120519
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 6











Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
4890 formula(e) evaluated with 10 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100    S: 0-6    Br: 1-5     
 
Minimum:                                     -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 
477.0852   477.0848        0.4      0.8      10.5     3.8    C22  H26  N2  O3  S  Br  
100%MeOH+HCOOH 13:16:13  11-May-2012
m/z








100%MeOH+HCOOH 13:16:13  11-May-2012
m/z



















































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                300.0 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  141
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.28
Date_          20120519
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 6










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 20.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
18673 formula(e) evaluated with 254 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 0-50    F: 1-6     
 
Minimum:                                -1.5 
Maximum:                    5.0      20.0     50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 




100%MeOH+0.1%HCOOH 10:40:40  23-May-2012
m/z
































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                300.0 K
DE                 6.50 usec
DW               60.800 usec
RG                  144
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.40
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−47c
Current Data Parameters
SB−IV−47c














































PC       0
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  403
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.43
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2






















































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  128
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.36
Date_          20120601
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−79a
Current Data Parameters
SB−IV−79a
























































































PC                 1.20
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  711
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.53
Date_          20120601
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3











Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
3713 formula(e) evaluated with 7 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 1-50     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
447.1958 447.1954        0.4       0.9      9.5       5.4        C23  H31  N2  O5  S  
  
100%MeOH+0.1%HCOOH 15:34:36  08-Jun-2012
m/z






























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                   64
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              19.16
Date_          20120305
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME        SB−III−119a
Current Data Parameters
SB−III−119a
































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                299.1 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   48
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              19.20
Date_          20120305
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
2613 formula(e) evaluated with 13 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20    S: 1-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
4.1848  417.1848        0.0       0.0      9.5       0.5        C22  H29  N2  O4  S  
 
 
100%MeOH+0.1%HCOOH 14:39:34  06-Mar-2012
m/z



































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               60.800 usec
RG                  128
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                    9
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.00
Date_          20120622
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME     SB−IV−63b−HPLC−B
Current Data Parameters
SB−IV−63b−HPLC−B












































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.6 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   42
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.03
Date_          20120622
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
3521 formula(e) evaluated with 16 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    Na: 1-1    S: 1-50     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass     mDa       PPM      DBE      i-FIT       Formula 
466.1678    466.1664        1.4       3.0      10.5      3.2      C24  H29  N  O5  Na  S  
 
  
in 100%MeOH+0.1%HCOOH 12:37:07  26-Jun-2012
m/z












































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               62.400 usec
RG                  203
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.10
Date_          20130404
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            SB−I−94
Current Data Parameters
SB−I−94




























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.0 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  212
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.16
Date_          20130404
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
10169 formula(e) evaluated with 25 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3    S: 1-6    Br: 1-5     
 
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
484.0561   484.0558        0.3      0.6      10.5     16.2      C22  H24  N  O3  Na  S  Br  
  
100%MeOH+0.1%HCOOH 15:51:35  07-Feb-2012
m/z






























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                299.5 K
DE                 6.50 usec
DW               62.400 usec
RG                  203
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   32
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.30
Date_          20120727
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            ZD1−34C
Current Data Parameters
ZD1−34C
































































PC                 1.20
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                299.9 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  366
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.25
Date_          20120727
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
24118 formula(e) evaluated with 80 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    F: 1-6    S: 1-50    Na: 1-2     
 
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
490.1278  490.1276        0.2      0.4      10.5     1.0        C23  H24  N  O4  F3  S  Na  
  
100%MeOH+0.1%HCOOH 13:49:58  31-Aug-2012
m/z





















































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                299.4 K
DE                 6.50 usec
DW               62.400 usec
RG                   64
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   35
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.42
Date_          20120727
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            ZD1−35C
Current Data Parameters
ZD1−35C



































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                300.0 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   36
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.48
Date_          20120727
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
4305 formula(e) evaluated with 20 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 1-50    Na: 1-2     
 
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
425.1529  425.1511        1.8       4.2      9.5       1.4    C21  H26  N2  O4  S  Na  
  
100%MeOH+0.1%HCOOH 13:36:08  31-Aug-2012
m/z





























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                294.0 K
DE                 6.50 usec
DW               62.400 usec
RG                  203
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.02
Date_          20130118
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME            ZD−I−39
Current Data Parameters
ZD−I−39









































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                294.7 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  113
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              10.05
Date_          20130118
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2









Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
14806 formula(e) evaluated with 47 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    F: 1-6    S: 1-50    Na: 1-2     
 
Minimum:                                      -1.5 
Maximum:                    5.0      5.0      50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
442.1255    442.1264        -0.9     -2.0     10.5     0.7       C22  H23  N  O3  F2  S  Na  
  
100%MeOH+0.1%HCOOH 13:41:23  31-Aug-2012
m/z


















Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
7783 formula(e) evaluated with 25 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 0-50    Na: 0-1     
 
Minimum:                                       -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 







100%MeOH+0.1%HCOOH 15:03:08  04-Jun-2012
m/z



























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                298.8 K
DE                 6.50 usec
DW               62.400 usec
RG                   18
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              18.51
Date_          20121004
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME         SB−IV−154b
Current Data Parameters
SB−IV−154b





















































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                299.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   26
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              18.54
Date_          20121004
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Odd and Even Electron Ions 
2076 formula(e) evaluated with 11 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-20    O: 1-30    S: 1-10     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
377.1531    377.1535        -0.4      -1.1     8.5       2.2       C19  H25  N2  O4  S 
 
  
90%MeOH+0.1%HCOOH 16:38:40  05-Dec-2012
m/z



















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  101
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.05
Date_          20120406
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−4C2
Current Data Parameters
SB−IV−4C2











































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.7 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   75
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.08
Date_          20120406
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2







Elemental Composition Report 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
22 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    O: 1-20     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
189.0912    189.0916        -0.4      -2.1     6.5       n/a         C12  H13  O2 
  
100%MeOH+0.1%HCOOH 17:06:43  13-Apr-2012
m/z
































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.8 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                    6
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              18.54
Date_          20110816
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1


























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                   16
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.39
Date_          20110921
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME         SB−II−120a
Current Data Parameters
SB−II−120a




































































































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   32
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.45
Date_          20110921
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2


















   





























































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.02
Date_          20111019
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1







4-(Morpholinomethyl)benzaldehyde (15i)  
 
  











































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 20.2
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.49
Date_          20120420
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−IV−30
Current Data Parameters
SB−IV−30











































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   29
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.51
Date_          20120420
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
181 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-35    80Se: 0-1     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT      Formula 
206.1182    206.1181        0.1       0.5      5.5       5.0        C12  H16  N  O2 
 
  
in 100%MeOH+0.1%HCOOH 16:01:58  24-Apr-2012
m/z







































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 28.5
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.26
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−IV−53
Current Data Parameters
SB−IV−53























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   20
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.28
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2







Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
293 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM     DBE      i-FIT       Formula 




100%MeOH+HCOOH 13:24:05  11-May-2012
m/z







































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                  128
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                    2
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.17
Date_          20120130
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME               KC13
Current Data Parameters
KC13

















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   22
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.30
Date_          20120130
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2







Elemental Composition Report 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
485 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-30    Na: 0-3     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
228.1023    228.1025        -0.2      -0.9     8.5       6.2        C14  H14  N  O2 
 
  
100%MeOH+0.1%HCOOH 16:50:02  07-Feb-2012
m/z




SARAH_KC13_BWANG_02072012_POS_ACCUMASS566 86 (1.599) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Cm (76:87)
4.77e3228.1023
556.2771381.2076
















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  203
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.08
Date_          20111031
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1







N-(4-(morpholinomethyl)benzyl)aniline (16i)  
 
  


































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 40.3
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                    7
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.04
Date_          20120426
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−37a
Current Data Parameters
SB−IV−37a




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   22
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.06
Date_          20120426
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2

























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               60.800 usec
RG                 25.4
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              20.35
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME        SB−III−111b
Current Data Parameters
SB−III−111b























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   38
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              20.40
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2







Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
181 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
226.1230    226.1232        -0.2      -0.9     8.5       0.3        C15  H16  N  O 
 
  
100%MeOH+0.1%HCOOH 16:43:22  02-Mar-2012
m/z





















































































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               60.800 usec
RG                 40.3
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.54
Date_          20120517
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−IV−68
Current Data Parameters
SB−IV−68





























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.9 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   35
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              17.56
Date_          20120517
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 20.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
271 formula(e) evaluated with 5 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100     
Minimum:                                      -1.5 
Maximum:                    5.0      20.0     50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
260.1657   260.1651        0.6      2.3      6.5      52.6        C16  H22  N  O2  
 
 
100%MeOH+0.1%HCOOH 10:51:20  23-May-2012
m/z














N-((2,2-dimethyl-2H-chromen-6-yl)methyl)aniline (19)  
 
 















































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 28.5
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.26
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−IV−53
Current Data Parameters
SB−IV−53























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   20
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              12.28
Date_          20120509
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2







Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
293 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100     
Minimum:                                        -1.5 
Maximum:                    5.0       5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT      Formula 
266.1548    266.1545        0.3       1.1       9.5       3.1         C18  H20  N  O  
 
  
100%MeOH+HCOOH 13:24:05  11-May-2012
m/z











2,2-dimethyl-2H-chromene-6-carbaldehyde (21)  
 
  



















































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                293.8 K
DE                 6.50 usec
DW               62.400 usec
RG                 50.8
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time               9.45
Date_          20130118
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1























































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                   57
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.13
Date_          20120403
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−IV−1c
Current Data Parameters
SB−IV−1c








































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   48
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.17
Date_          20120403
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
131 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20     
Minimum:                              -1.5 
Maximum:                    5.0      5.0       50.0 
Mass        Calc. Mass      mDa      PPM      DBE      i-FIT       Formula 
200.1079    200.1075        0.4       2.0      7.5       2.0        C13  H14  N  O 
  
100%MeOH+0.1%HCOOH 15:45:18  13-Apr-2012
m/z




SARAH_SB-IV-1C_BWANG-ACCU_04-13-2012_ESI-POS01 28 (0.520) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Cm (28:29)
2.06e3200.1079
244.1705
100%MeOH+0.1%HCOOH 15:45:18  13-Apr-2012
m/z






































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                  114
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.35
Date_          20111104
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−III−3f
Current Data Parameters
SB−III−3b/c


































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               20.800 usec
RG                  161
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  408
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              18.58
Date_          20111105
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2











































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                 25.4
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.37
Date_          20120425
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−39a
Current Data Parameters
SB−IV−39a























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   26
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.40
Date_          20120425
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2







Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
284 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
261.1961    261.1967        -0.6      -2.3     5.5       7.3        C16  H25  N2  O  
 
  
in 100%MeOH+0.1%HCOOH 17:49:34  26-Apr-2012
m/z




























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                   57
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              20.28
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2
NAME         SB−III−116
Current Data Parameters
SB−III−116




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   33
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              20.31
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3







Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
145 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
206.1181    206.1181        0.0       0.0      5.5       1.9        C12  H16  N  O2 
 
  
100%MeOH+0.1%HCOOH 16:35:25  02-Mar-2012
m/z









N-((2,3-Dihydrobenzofuran-5-yl)methyl)cyclobutanamine (27j)  
 
 














































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.2 K
DE                 6.50 usec
DW               60.800 usec
RG                   57
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              20.28
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2
NAME         SB−III−116
Current Data Parameters
SB−III−116




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.3 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   33
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              20.31
Date_          20120301
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 3







Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
143 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
204.1392    204.1388        0.4       2.0      5.5       1.5        C13  H18  N  O 
  
100%MeOH+0.1%HCOOH 15:50:19  29-Feb-2012
m/z

















Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
556 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-100    S: 0-6     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
244.1707   244.1701        0.6       2.5      6.5       33.5       C16  H22  N  O 
 
  
100%MeOH+0.1%HCOOH 12:39:52  17-May-2012
m/z




































































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                299.1 K
DE                 6.50 usec
DW               60.800 usec
RG                   57
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.22
Date_          20120517
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−56c
Current Data Parameters
SB−IV−56c












































































PC                 0.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                299.9 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                  100
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              14.27
Date_          20120517
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2










Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 20.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
2194 formula(e) evaluated with 15 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-200    H: 1-200    N: 1-15    O: 1-100    S: 0-50     
Minimum:                                       -1.5 
Maximum:                    5.0       20.0     50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
355.2025  355.2022        0.3       0.8      9.5       126.5      C21  H27  N2  O3  
 
  
100%MeOH+0.1%HCOOH 10:33:36  23-May-2012
m/z




























































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                295.2 K
DE                 6.50 usec
DW               60.800 usec
RG                 22.6
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.44
Date_          20120228
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME         SB−III−106
Current Data Parameters
SB−III−106























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                295.6 K
DE                 6.50 usec
DW               20.800 usec
RG                  114
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.47
Date_          20120228
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
238 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
245.1651    245.1654        -0.3      -1.2     6.5       24.4       C15  H21  N2  O 
  
100%MeOH 15:40:49  29-Feb-2012
m/z












dimethoxybenzenesulfonamide (2), (32a) 
 
  



















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                297.7 K
DE                 6.50 usec
DW               60.800 usec
RG                  144
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              19.28
Date_          20120228
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1



























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                   32
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.15
Date_          20120405
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME           SB−IV−9a
Current Data Parameters
SB−IV−9a




















































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
SFO2        400.1416006 MHz
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
NUC2                 1H
CPDPRG2         waltz16
======== CHANNEL f2 ========
SFO1        100.6253441 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
======== CHANNEL f1 ========
D11          0.03000000 sec
D1           2.00000000 sec
TE                298.6 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631988 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   21
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.18
Date_          20120405
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
 
Monoisotopic Mass, Even Electron Ions 
227 formula(e) evaluated with 2 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 




100%MeOH+0.1%HCOOH 15:32:23  13-Apr-2012
m/z























































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
TD0                   1
DELTA        1.89999998 sec
d11          0.03000000 sec
D1           2.00000000 sec
TE                298.5 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   38
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              15.24
Date_          20120403
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2
































4-((2-Methylbut-3-yn-2-yl)oxy)benzaldehyde (S2j)  
 
  


































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                   16
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              16.51
Date_          20120425
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1



















































































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                298.1 K
DE                 6.50 usec
DW               60.800 usec
RG                   18
AQ            3.9845889 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.54
Date_          20110928
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1








4-(4-Bromobenzyl)morpholine (S3i)  
 
 






































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400000 MHz
SI                65536
F2 − Processing parameters
PLW1        16.00000000 W
P1                13.50 usec
NUC1                 1H
SFO1        400.1424710 MHz
======== CHANNEL f1 ========
TD0                   1
D1           1.00000000 sec
TE                299.0 K
DE                 6.50 usec
DW               62.400 usec
RG                 50.8
AQ            4.0894465 sec
FIDRES         0.122266 Hz
SWH            8012.820 Hz
DS                    2
NS                    6
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.24
Date_          20120726
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−IV−110
Current Data Parameters
SB−IV−110































PC                 1.40
GB       0
LB                 1.00 Hz
SSB      0
WDW                  EM
SF          100.6152830 MHz
SI                32768
F2 − Processing parameters
PLW13        0.29159999 W
PLW12        0.36000001 W
PLW2        16.00000000 W
PCPD2             90.00 usec
CPDPRG[2        waltz16
NUC2                 1H
SFO2        400.1416006 MHz
======== CHANNEL f2 ========
PLW1        62.00000000 W
P1                 9.00 usec
NUC1                13C
SFO1        100.6253441 MHz
======== CHANNEL f1 ========
TD0                   1
D11          0.03000000 sec
D1           2.00000000 sec
TE                299.4 K
DE                 6.50 usec
DW               20.800 usec
RG                  203
AQ            1.3631488 sec
FIDRES         0.366798 Hz
SWH           24038.461 Hz
DS                    4
NS                   27
SOLVENT           CDCl3
TD                65536
PULPROG          zgpg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              13.26
Date_          20120726
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 2








Elemental Composition Report 
 
Single Mass Analysis 
Tolerance = 5.0 PPM   /   DBE: min = -1.5, max = 50.0 
Element prediction: Off  
Number of isotope peaks used for i-FIT = 3 
Monoisotopic Mass, Even Electron Ions 
106 formula(e) evaluated with 1 results within limits (all results (up to 1000) for each mass) 
Elements Used: 
C: 1-100    H: 1-100    N: 1-15    O: 1-20    Br: 1-5     
Minimum:                                       -1.5 
Maximum:                    5.0       5.0      50.0 
Mass        Calc. Mass      mDa       PPM      DBE      i-FIT       Formula 
256.0333    256.0337        -0.4      -1.6     4.5       1.6        C11  H15  N  O  Br 
  
100%MeOH+0.1%HCOOH 13:20:16  21-Feb-2012
m/z




SARAH_SB-III-91B_BWANG-ACCU_02-21-2012_POS 100 (1.861) AM (Cen,4, 80.00, Ar,5000.0,556.28,0.70); Cm (98:117)
1.56e4256.0333
170.9654 409.1634
100%MeOH+0.1%HCOOH 13:20:16  21-Feb-2012
m/z

























































































PC                 1.00
GB       0
LB                 0.30 Hz
SSB      0
WDW                  EM
SF          400.1400066 MHz
SI                65536
F2 − Processing parameters
SFO1        400.1424710 MHz
PLW1        12.22599983 W
P1                14.00 usec
NUC1                 1H
======== CHANNEL f1 ========
D1           1.00000000 sec
TE                295.0 K
DE                 6.50 usec
DW               60.800 usec
RG                  101
AQ            3.9846387 sec
FIDRES         0.125483 Hz
SWH            8223.685 Hz
DS                    2
NS                   16
SOLVENT           CDCl3
TD                65536
PULPROG            zg30
PROBHD   5 mm PABBO BB−
INSTRUM           spect
Time              11.43
Date_          20110203
F2 − Acquisition Parameters
PROCNO                1
EXPNO                 1
NAME          SB−I−131a
Current Data Parameters
02/03/11
CDCl3
H1
SB−I−131a
N
O
Br
